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1. Abstract 
Evidence from human and animal studies has highlighted the sensitivity of the 
developing fetus to environmental insults, such as maternal undernutrition, during 
gestation. These nutritional perturbations to the intrauterine milieu may engender 
a legacy of deleterious health consequences in adulthood. This thesis presents a 
series of studies which test the `mis-ŵĂƚĐŚ ‘ ĨĞƚĂů ƉƌŽŐƌĂŵŵŝŶŐ ƚŚĞŽƌǇ ? ƚŚĂƚ ŝƐ ?
whether a nutritionally poor diet prenatally interacts with a nutritionally excessive  
diet postnatally to overtly increase risk factors for adult disease. The effect of a 
maternal global energy restriction is contrasted against a maternal specific protein 
restriction, each fed during either early or late gestation. Adult offspring were 
subsequently exposed to an obesogenic environment (elevated feed with increased 
lipid content whilst restricting physical activity). Offspring metabolic flexibility and 
competence were assessed through routine blood samples throughout postnatal 
life and at 7, 18 and 24 months of age by glucose (GTT) and insulin (ITT) tolerance 
tests and body composition by dual energy x-ray absorptiometry. In general males 
appeared more susceptible to developmental programming than females at a 
number of timepoints. Furthermore, an increased first-phase or incremental area-
under-the-insulin-response curve was observed in 1) offspring following maternal 
protein restriction in early gestation at 7 and 24 months of age, despite maternal 
protein restriction in late gestation significantly reducing birthweight and 2) in 
offspring exposed to maternal energy restriction during late gestation at 24 months 
of age in response to a GTT. Since, in both groups, the response of all offspring to an 
ITT (from a euglycemic baseline) was similar, infers that developmental 
programming in sheep followed by nutritional excess is first revealed as affecting 
either the pancreas (~insulin hypersecretion) or the liver (hepatic insulin resistance, 
reduced first-pass insulin metabolism). The studies illustrate the importance of 
habitual consumption of ĂŶǭŽƉƚŝŵĂů ?balanced diet through gestation on postnatal 
health, especially in light of the current obesity epidemic.  
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1. Literature Review  
1.1 Global Health 
Over the past 30 years the incidence of metabolic syndrome, and the components 
of it, have rapidly increased in prevalence within westernised populations. The 
metabolic syndrome is classically comprised of (to varying extents); obesity, glucose 
intolerance, insulin resistance (both constituents of type 2 diabetes), hypertension 
and dyslipidemia (Alberti et al., 2006). 
 
Obesity is defined as having a Body Mass Index (BMI) equal to or greater than 
30kg/m
2
. Figure 1.1 shows that in the UK alone between 1994 and 2007 there was a 
significant increase in the number of obese individuals, both males (13.8 to 24%) 
and females (17.3 to 24%). This data also shows that in England in 2007, 65% of 
men and 56% of women were either overweight (BMI 25-29.99) or obese (BMI 
>=30).  
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Figure 1.1 Change in BMI of the English population between 1994-2007 
Graphs showing the change in population BMI in England for males (top) and females (bottom) 
between 1994 & 2007. Sample size per gender per year ranged between 3000-8000. All subjects 
were aged between 16-100yrs. Data obtained from (www.who.int/en, 2010)(accessed August 
20th 2010).  
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The prevalence of overweight and obesity in the United States is even greater than 
in the UK. Table 1.1 shows that 1 in 3 U.S. adults are obese, with 2 in 3 being 
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% of U.S. Males  % of U.S. Females 
Year >= 25 >=30 >= 25 >=30 
1960-1962 49.4 10.7 41.2 16.1 
1995-1995 46 21 28 23 
2003-2006 72.1 32.4 61.3 34.3 
Table 1.1 Change in BMI of the United States population between 1960-2006 
Data showing the change in BMI (kg/m
2
) for males and females in the U.S. population between 
1960 & 2006. Sample size per gender per year ranged between 2000-3000. All subjects were 
aged between 20-100yrs. Data obtained from (www.who.int/en, 2010)(accessed August 20th 
2010). 
  Year 2000 2030 
Ranking  Country People with diabetes (millions) 
1 India 31.7 79.4 
2 China 20.8 42.3 
3 U.S. 17.7 30.3 
Table 1.2 Diabetes estimates for the year 2000 and 2030. 
The 3 counties shown are estimated to have the highest current (2000) and future (2030) 
diabetes incidence globally (Wild et al., 2004). 
 
 
overweight. The number of obese males in the U.S. has tripled between 1962-2006 
from 10.7 to 32.4%, while the number of obese females has doubled in the same 
period of time. 
 
Associated with the current global epidemic of obesity is the sharp rise in 
individuals diagnosed with type 2 diabetes. Wild et al., (2004) estimated that the 
number of people diagnosed with type 2 diabetes globally in the year 2000 was 171 
million people, which is 2.8% of the world population, they expect this value to rise 
to 366 million by 2030 (4.4% of the global population) (Table 1.2). Their estimate is 
based on the global obesity rate remaining at that of the year 2000, with an aging, 
more urbanised global population.  
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1.2 Obesity & Type 2 Diabetes 
Insulin resistance develops as the insulin sensitive tissues become desensitised to its 
action and increasing quantities of insulin are required to elicit the same response. 
Insulin is an anabolic hormone released from the pancreatic beta cells of the 
endocrine pancreas (Islets of Langerhans). Glucose stimulated insulin secretion is 
the primary mechanism for postprandial glucose uptake, with the majority (90%) of 
the glucose being taken up by the skeletal muscle and the rest by the liver and 
adipose tissue. Insulin resistance is characterised by hyperinsulinemia and 
euglycaemia, when the pancreas is unable to produce sufficient insulin to maintain 
euglycaemia, possibly due to exhaustion, then hyperglycaemia prevails, which is a 
key pathology in type 2 diabetes. Other effects of insulin resistance include the 
reduced ability of insulin to inhibit lipolysis in adipose tissue and gluconeogenesis in 
the liver (Mlinar et al., 2007). These effects exacerbate homeostatic dysregulation 
of plasma lipids and glucose in individuals with obesity and/or high glucose/fat 
intake. 
 
The risk of developing insulin resistance can be accounted for by genetic and 
epigenetic factors, as well as lifestyle choices such as diet and physical activity 
levels, but some susceptibility is not accounted for by these factors. Insulin 
resistance is multifaceted and is generally, but not exclusively, associated with 
excessive lipid storage. Adipose tissue is the primary site for plasma lipid uptake and 
over the last 15 years much research has been conducted into the importance of 
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adipose tissue as an endocrine organ. Adipokines, cytokines secreted by adipose 
tissue, have been linked with the pathogenesis of insulin resistance. The adipokines 
concerned are tumor necrosis factor alpha  ?dE&ɲ ?, adiponectin, interleukin-6 (IL6), 
resistin, leptin (Arner, 2005) and Retinol Binding Protein 4 (Wolf, 2007). The 
physiological locality of adipose tissue affects its functionality, specifically the 
endocrine activity of the tissue, with central/abdominal adipose tissue secreting 
higher levels of adipokines than peripheral tissue (Anghel & Wahli, 2007). Changes 
in adipokine secretion and sensitivity have been implicated in the pathogenesis of 
insulin resistance (Arner, 2005; Guilherme et al., 2008),  with Retinol Binding 
Protein 4 (RBP4) being associated with decreased PI3K signalling following insulin 
stimulation (Wolf, 2007). As well as increased adipokine secretion, adipocytes 
secrete increasing volumes of pro-inflammatory cytokines in the obese state. 
FacƚŽƌƐ ƐƵĐŚ ĂƐ /> ? ? dE&ɲ ĂŶĚ DŽŶŽĐǇƚĞ ŚĞŵŽĂƚƚƌĂĐƚĂŶƚ WƌŽƚĞŝŶ-1 (MCP1) 
ƐƚŝŵƵůĂƚĞ :E< ĂŶĚ /ʃ< ƐŝŐŶĂůůŝŶŐ ƉĂƚŚǁĂǇƐ ? ǁŚŝĐŚ ĂƌĞ ĂƐƐŽĐŝĂƚĞĚ ǁŝƚŚ ŝŶƐƵůŝŶ
resistance (Kahn et al., 2006; Guilherme et al., 2008). It is not just the fat accretion 
in adipose tissue that affects systemic insulin resistance; ectopic intramuscular fat 
deposition (Mlinar et al., 2007) and Non-Alcoholic Fatty Liver disease (Ciba & 
Widhalm, 2007; Fan et al., 2007; Holland et al., 2007; Parekh & Anania, 2007) have 
both been identified in the pathogenesis of insulin resistance. Therefore any 
inherent mechanisms that lead to the localisation of fatty acids in any of these 
compartments (ectopic deposition and visceral adipose tissue accumulation) would 
greatly increase the risk of the developing insulin resistance (Holland et al., 2007).  
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1.3 Glucose Uptake & Metabolism 
This sub chapter aims to give an overview of glucose uptake and metabolism. 
Further details can be found in texts related to metabolism and nutrition such as 
Frayn (2003) or McDonald et al., (2002).  
1.3.1 OVERVIEW OF RESPIRATION  
Glucose is a 6-carbon (hexose) sugar molecule that is either unbound as a 
monosaccharide or linked to other hexose molecules to form larger, complex 
polysaccharides. It is a key metabolic substrate and is produced in photosynthesis 
whilst degraded in respiration resulting in ATP synthesis from ADP molecules. The 
initial anaerobic phase of respiration is glycolysis, where energy is produced 
throughout the conversion of glucose to 2 pyruvate molecules. The pyruvate 
molecules are then moved from the cytosol to the mitochondria to undergo 
oxidative decarboxylation producing acetyl-CoA. In the presence of oxygen, Acetyl-
CoA enters the krebs cycle leading to the reduction of the electron transporters 
NAD
+ 
and FAD to NADH and FADH2 respectively, as well as producing CO2 and H2O. 
The coenzymes NADH and FADH2 then go through oxidative phosphorylation, 
generating ATP, CO2 and H2O.  
1.3.2 PANCREATIC GLUCOSE SENSING 
Polysaccharides found in food are digested to liberate monosaccharides which are 
then absorbed into the portal blood stream (covered in Chapter 1.7). The endocrine 
pancreas reacts to the stimulus of an elevated glucose level (hyperglycaemia) and 
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acts to return euglycaemia. The pancreas has both exocrine and endocrine 
functions. The endocrine pancreas accounts for approximately 2% of the pancreatic 
ƚŝƐƐƵĞŵĂƐƐ ?ŽĨǁŚŝĐŚ ? ?A?ĂƌĞɴĐĞůůƐŽĨƚŚĞ/ƐůĞƚƐŽĨ>ĂŶŐĞƌŚĂŶƐ ?Glucose is taken up 
ŝŶƚŽ ƚŚĞɴĐĞůůƐ by Glut 2 glucose transporters, these transporters have a high Km 
meaning that the higher the blood glucose concentration, the greater their affinity 
for glucose. Therefore the glucose uptake is proportionate to the plasma glucose 
concentration. The ɴĐĞůl metabolises the glucose to produce ATP. ATP sensitive K+ 
channels are then closed, causing depolarisation, opening voltage sensitive Ca
2+
 
channels. The influx of calcium ions leads to the exocytosis of insulin containing 
vesicles, thus depositing insulin into the hepatic portal vein.  
1.3.3 HEPATIC ANABOLISM 
The portal blood reaching the liver, which is hyperglycaemic and hyperinsulinaemic, 
stimulates glucose and insulin clearance by the hepatocytes. Glucose, as in the 
pancreas, enters the hepatocyte via Glut 2 transportation. The insulin initiates a 
switch from catabolism to anabolism, involving the inhibition of gluconeogenesis, 
which is a de novo glucose synthetic pathway generating glucose from non 
carbohydrate carbon backbones such as volatile fatty acids, lactate, amino acids and 
glycerol. Insulin also modulates the storage of glucose as glycogen (glycogenesis) by 
switching on glycogenic pathways and inhibiting glycogenolytic pathways. 
Glycogenolysis and gluconeogenesis in the liver are fundamental pathways involved 
in maintaining systemic euglycaemia in the fasted state and hence must be 
inhibited in the fed state to prevent prolonged hyperglycaemia. Although skeletal 
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muscle cells also store glucose as glycogen, skeletal muscle glycogen stores can not 
influence systemic levels due to the lack of glucose 6 phosphatase expression, 
which is a key hepatic enzyme allowing glucose to leave the hepatocyte and enter 
the circulation.  
1.3.4 SKELETAL MUSCLE INSULIN STIMULATED GLUCOSE UPTAKE 
In the fasted euglycaemic state, Glut 1 transporters are primarily responsible for 
basal glucose uptake in all cells. In the fed state however, the insulin and exercise 
sensitive glucose transporter, Glut 4, accounts for the mass glucose clearance from 
the blood into the skeletal muscle (~90%), and to a lesser extent the adipose tissue 
as well. Following the first pass of glucose and insulin through the liver, 
approximately 70% of the plasma insulin has been removed by the liver. The 
remaining insulin binds with the insulin receptor located in the plasma membrane 
of skeletal muscle and adipose cells. Stimulation of the insulin receptor leads to a 
downstream cascade of intracellular phosphorylation signalling effects. In brief, 
auto-phosphorylation of the insulin receptor (IR) causes the phosphorylation of 
insulin receptor substrate (IRS), consequently activating Phosphatidylinositol-3-
kinase (PI3K). PI3K enables ƚŚĞ ƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ŽĨ WŚŽƐƉŚĂƚŝĚǇůŝŶŽƐŝƚŽů  ? ? ? ? ? ?
Bisphosphate (PIP2) into PIP3 ?ǁŚŝĐŚŝŶƚƵƌŶďŝŶĚƐƚŽ ? ?-Phosphoinositide dependent 
kinase-1 (PDK1), thus activating it. Activated PDK1 is then able to phosphorylate 
Phospho-Kinase B (PKB, also called Akt), as well as Phospho-Kinase C (PKC). PKB 
then modulates the translocation of Glut 4 vesicles to the plasma membrane, 
facilitating insulin stimulated glucose uptake in these tissues. PKB also 
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phosphorylates 'ůǇĐŽŐĞŶ^ǇŶƚŚĂƐĞ<ŝŶĂƐĞ ?ɴ ?'^< ?ɴ ?causing its deactivation, thus 
ƉƌĞǀĞŶƚŝŶŐ ƚŚĞ '^< ?ɴ ŝŶŚŝďŝƚŝŽŶŽĨ glycogen synthase. Active glycogen synthase is 
then able to convert glucose into its stored form, glycogen. The plethora of anabolic 
effects insulin stimulates in skeletal muscle goes far beyond simple glucose uptake 
and storage, including inhibition of lipolysis, elevated protein and fatty acid 
synthesis, as well as increased cell survival/decreased apoptosis, as shown in Figure 
1.2.  
 
It is important to note that another major stimulator of glucose uptake in skeletal 
muscle is exercise, as modulated by AMPK activation, with many similar biochemical 
outcomes to insulin signalling, for AMPK signalling details see recent reviews by 
Hardie (2011b, a). 
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Figure 1.2 Insulin Stimulated Glucose Uptake in Skeletal Muscle 
Diagram showing insulin signal transduction in skeletal muscle. Insulin stimulation causing GLUT4 
translocation to the plasma membrane leading to glucose uptake. The insulin signal also initiates 
the downstream cascade resulting in, glycogen, protein and fatty acid synthesis, cell survival and 
inhibition of glycogenolysis, lipolysis, protein degradation and apoptosis. In brief, red (kinases), 
light green (phosphatases), dark green (enzymes), light blue (transcription factor), arrows 
(stimulatory effects), blunt ends (inhibitory effects) and dashed lines (translocation). The diagram 
and legend details were taken from www.cellsignalling.com (2010).  
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1.3.5 EMBRYONIC AND FETAL DEVELOPMENT 
1.3.5.1 Early Development 
Mammalian development starts with embryogenesis, which is initiated after 
fertilisation, the fusion of the male and female gametes, producing a zygote. The 
zygote then undergoes a period of rapid mitotic cell divisions, termed cleavage, 
producing the blastocyst, containing the inner cell mass, which goes on to form the 
embryo, and the trophoblast, which develops into the placenta. The blastocyst  
starts to form three distinctive germ layers, the endoderm, mesoderm and 
ectoderm (Twyman, 2001). Implantation occurs around this time, with the 
blastocyst imbedding into the uterine lining. The germ layers continue to develop, 
producing a multitude of different cell fates via organogenesis.  The developing 
ĞĐƚŽĚĞƌŵ ?ƐŵĂũŽƌƉƌŽĚƵĐƚ ŝƐ ƚŚĞ ŶĞƌǀŽƵƐsystem; the bones, cartilage, connective 
tissues, muscles and notochord develop from the mesoderm, while the endoderm 
forms the gastrointestinal, urinary and respiratory tracts.  
1.3.5.2 Skeletal Muscle Development 
Skeletal muscle develops as part of a process termed myogenesis during 
embryogenesis. In most mammals, (excluding rodents) myogenesis is completed 
prenatally, thus setting the myofibre number in skeletal muscle before birth 
(Brameld et al., 1998). The myogenic lineage originates from the somite segments, 
which are derived from the dorsal mesoderm region of the developing embryo 
(Twyman, 2001). The newly formed somites then divide again creating the 
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sclerotome and the dermomyotome; of which it is the dermomyotome which 
segregates again to form the dermatome and the myotome (Christ & Brand-Saberi, 
2002; Buckingham et al., 2003). The production of Sonic hedgehog (Shh) from the 
notochord and floor plate stimulates the commitment of the myotome to two 
separate fates; epaxial myotome producing the musculature of the back, and the 
hypaxial myotome forming the limbs and ventral body muscle (Yun & Wold, 1996; 
Twyman, 2001; Buckingham et al., 2003). Epithelial cells delaminate from the 
various myotome surfaces to form myogenic progenitor cells. Delamination is 
initiated and controlled by wnt (1, 2 & 4) secretions by the dorsal neural tube for 
epaxial myotome delamination and by the ectoderm region for hypaxial myotome 
delamination (Twyman, 2001).  
 
Following delamination the myogenic progenitor cells migrate to their final 
destination, where they will eventually form part of the functional musculoskeletal 
apparatus (Christ & Brand-Saberi, 2002; Buckingham et al., 2003). The hypaxial cells 
which are destined for the limb buds are promoted towards this region by c-met 
(via pax-3) and Lbx1 (Christ & Brand-Saberi, 2002; Buckingham et al., 2003). The 
hypaxial cells are prevented from differentiating prematurely during their migration 
by the inhibitory effect of Bone Morphogenetic Protein 4 (BMP4) secreted from the 
lateral mesoderm (Twyman, 2001). Due to the variation in distance covered by 
migrating progenitor cells some cells are determined and even differentiated before 
others have finished proliferating. 
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Myogenic progenitor cells undergo hyperplasia (proliferation) during migration 
whilst under the control of several transcription factors. These include pax-3, c-met, 
Msx1 and Mox2, as well as SIX 1 and 4 (with cofactors Dach2 and Eya 2,4) (Yun & 
Wold, 1996; Buckingham et al., 2003).  
 
Following progenitor cell proliferation, determination occurs. Determination is the 
transition of myogenic progenitor cells into myoblasts, and thus the commitment to 
a myogenic fate. Determination results in the production of transcription factors 
that control the differentiation of the cells into myotubes. This developmental 
process is fundamentally controlled by Myogenic Determination factor (MyoD) and 
Myogenic factor 5 (Myf5) (Sassoon, 1993; Yun & Wold, 1996), which can be 
collectively referred to as the Determination Class Muscle Regulatory Factors 
(MRFs). MRFs are characterised by their basic Helix-Loop-Helix (bHLH) structure. 
They can either form homodimers or heterodimers with E proteins, which 
consequently bind to E boxes. E boxes are consensus sequences found within a 
major groove binding site on the promoter/enhancer region of responsive myogenic 
genes, with the sequence CANNTG (Yun & Wold, 1996; Langlands et al., 1997; 
Berkes & Tapscott, 2005). Inhibitory mechanisms operate to regulate MRF-MRF/E-
protein complex formation, and its binding to the E box, these include Twist and Id 
(Inhibitor of DNA binding) 1-4. Benezra et al., (1990) postulated that Id could be 
expressed as a mechanism for controlling and preventing premature determination 
during precursor migration and proliferation. Ids bind to Determination Class MRFs 
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and E proteins with a high affinity, but due to their helix-loop-helix structure and 
hence lack of basic, amino terminal DNA binding region they are unable to bind to 
the E box DNA region (Yun & Wold, 1996; Langlands et al., 1997).  
 
Myf5 and MyoD are only expressed once the progenitor cell completes its migration 
to the limb bud (Tajbakhsh & Buckingham, 1994). This suggests that migration has 
to be completed for determination to occur. The potency of Myf5 and MyoD 
transcription factors can be seen by their ability to induce myogenic protein 
expression in non-muscle cells, in vitro, such as myogenic protein expression by 
fibroblasts (Davis et al., 1987). Mutation to these genes shows dramatic effects on 
skeletal muscle cell development. The double null Myf5/MyoD mutant developed 
by Rudnicki et al., (1993) shows the absence of these genes prevents the 
development of the myoblast population and hence muscle fibres. Consequently 
following migration these progenitor cells develop into non-myogenic fates, such as 
adipocytes (Tajbakhsh & Buckingham, 1994). MyoD and Myf5 appear to have very 
similar effects on gene expression. Single deletions of these genes by Kablar et al., 
(1998) showed that functional muscle still develops in the embryos. In depth 
analysis of these embryos does however show some developmental abnormalities. 
Null Myf5 embryos have defects related to trunk skeletal muscle. Whereas null 
MyoD embryos show early limb and branchial arch muscle development is delayed. 
These deletions show the possible specific developmental mechanisms controlled 
by these two MRFs.  
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Myf5 and MyoD have the effect of turning on the genes which will control terminal 
differentiation of the myoblasts into myotubes. These genes include the 
Differentiation Class MRFs (myogenin/Myf4 & MRF4/Myf6) and the Myocyte 
Enhancer Factor 2 (MEF2) (Yun & Wold, 1996). These MRFs also activate genes 
causing the synthesis of proteins such as M-cadherin, myosin heavy and light chain, 
as well as creatine kinase (Berkes & Tapscott, 2005). Following myoblast 
proliferation the cell exits the cell cycle. This is a specialised and permanent G0/G1 
arrest which prevents the myoblasts from proliferating and dividing further (Yun & 
Wold, 1996). The exit from the cell cycle is under the control of myogenin 
expression and the protein p21 (Andres & Walsh, 1996). The myoblast becomes a 
quiescent muscle cell and consequently undergoes terminal differentiation (Naya & 
Olson, 1999).  
 
Differentiation can be defined as the expression of tissue specific genes, leading to 
specific protein synthesis giving a cell its tissue specific phenotype. Terminal 
differentiation is the transition from mononucleated myoblasts into myotubes 
containing functional contractile proteins, then finally into multinucleated 
myofibres (Krauss et al., 2005). The MRF myogenin is required for terminal 
differentiation of myoblasts and it is aided downstream by the MEF2s (Yun & Wold, 
1996). Null mutations of the myogenin gene in murine models lead to perinatal 
death. The musculature of these models contained significant levels of myoblasts, 
but depleted levels of myofibres, showing failure of the myoblasts to terminally 
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differentiate (Hasty et al., 1993; Yun & Wold, 1996; Brameld et al., 1998). Myogenin 
can therefore be shown to be crucial for the proper development of muscle in utero 
and its function is unique within the MRF family (Berkes & Tapscott, 2005).  
 
MEF2s work by enhancing the efficiency of binding by MRFs, via the MCM1, 
Adamous, Deficiens, serum response factor (MADS) box (Yun & Wold, 1996; Pell & 
Schofield, 1999; Christ & Brand-Saberi, 2002). Yun & Wold (1996) proposed that this 
could be attributed to various interactions between MEF2 and the MRF-E complex 
(MRF-E protein heterodimer in association with an E box). In particular the binding 
of MRF-E heterodimer to MEF2 homodimers, whilst at the same time interacting 
with their respective DNA elements, E and MADS box (Pell & Schofield, 1999). This 
interaction stimulates improved expression of myogenic proteins containing the 
MRF consensus sequence in their enhancer region, specifically myogenin (Pell & 
Schofield, 1999). MEF2s cannot themselves initiate myogenic differentiation, in the 
same way as Myf5 and MyoD do in fibroblasts for instance, but they do significantly 
enhance it in the presence of the MRFs (Muntoni et al., 2002). 
 
The final MRF involved in myogenesis, is MRF4. Its expression fluctuates during 
embryonic development between the period of determination and terminal 
differentiation. The exact function of this transcription factor is hard to isolate. It 
has been shown to partially restore skeletal development in myogenin deficient 
mutants, whilst also facilitating skeletal development in Myf5/MyoD double null 
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mice (Berkes & Tapscott, 2005). Therefore MRF4 can be seen to be subservient to 
the actions of the determination (Myf5/MyoD) and differentiation (myogenin) 
specific MRFs (Berkes & Tapscott, 2005). The most published function of MRF4 is in 
the maturation of myotubes to myofibres, downstream of myogenin (models shown 
by (Yun & Wold, 1996; Brameld et al., 1998; Pell & Schofield, 1999; Sartorelli & 
Caretti, 2005).   
 
Reviews by Maltin et al., (2001) and Du et al., (2010) exquisitely highlight the effects 
of fetal programming in ruminants on in utero skeletal muscle development.  
1.3.5.3 Adipose tissue development 
Adipose tissue can be characterised into two distinct populations, white and brown 
adipose tissue (WAT & BAT respectively). BAT is traditionally considered rare in 
humans postnatally, with it helping to regulate energy expenditure and 
thermogenesis during fetal and neonatal life, white adipose tissue is a storage site 
for triglycerides (Gesta et al., 2007). Adipocytes are derived from the same pool of 
mesendermal cells as myoblasts, which develop into skeletal muscle tissue. 
Following the proliferation of these progenitor cells, there is commitment to 
becoming pre-adipocytes, under the stimulation of bone morphogenic protein 4 
(BMP4) (Tang et al., 2004). Once committed to the adipogenic lineage, pre-
adipocytes undergo four phases of differentiation; growth arrest due to cell-cell 
contact, hormone stimulated mitotic clonal expansion, early and subsequent 
terminal differentiation (Otto & Lane, 2005; Gesta et al., 2007; Lefterova & Lazar, 
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2009). The two major transcription factors regulating end stage differentiation are 
peroxisome proliferator-ĂĐƚŝǀĂƚĞĚ ƌĞĐĞƉƚŽƌ ŐĂŵŵĂ  ?WWZɶ ? ĂŶĚ d ?ĞŶŚĂŶĐĞƌ-
binding proteins (C/EBPs). Differentiated adipocytes are classified by their fatty acid 
synthetic potential, ability to uptake glucose following insulin stimulation and their 
production and secretion of adipokines such as leptin (Otto & Lane, 2005; Anghel & 
Wahli, 2007; Gesta et al., 2007; Lefterova & Lazar, 2009). Postnatally, the adipose 
tissue mass can expand by hypertrophy (increase in cell volume, namely triglyceride 
accretion), cell division and commitment of adult mesenchymal stem cells into pre-
adipocytes and consequently mature adipocytes (Otto & Lane, 2005; Anghel & 
Wahli, 2007; Gesta et al., 2007; Lefterova & Lazar, 2009).  
 
Reviews by Mostyn & Symonds (2009) and Taylor & Poston (2007) highlight the 
contribution intrauterine factors have on prenatal and postnatal adipose tissue 
function.   
1.3.5.4 Hepatic development 
Approximately 78% of the adult liver is made from heptocytes (Motta, 1984). The 
hepatocytes have a heterogeneous function, termed metabolic zonation, whereby 
the nature of the vascular supply to the cell determines the relative anabolic or 
catabolic nature of the cell. Hyatt et al.,  (2008) for instance state that the greater 
the oxygen and substrate supply the greater the gluconeogenic activity and the 
lower the glycolytic activity, and vice versa in cells with a low nutrient supply. While 
skeletal muscle and adipose tissue develop from the mesoderm, the liver originates 
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from the entoderm (Twyman, 2001). The key early molecular regulator of 
hepatogenesis appears to be Fibroblast Growth Factor (FGF), which the immature 
cardiac tissue secretes during development while the developing foregut is in close 
proximity (Serls et al., 2005). Later commitment and differentiation to the 
hepatocyte lineage are invoked primarily by FGF, BMPs and Wnt signalling, with 
terminal differentiation being orchestrated by transcription factors such as the 
Hepatocyte Nuclear Factors (HNFs) (Si-Tayeb et al., 2010). For a more 
comprehensive review of hepatogenesis see Si-Tayeb et al., (2010). Hyatt et al., 
(2008) further detail the specific effect of modifying the intrauterine environment 
on hepatic development and function.  
1.3.5.5 Pancreatic Development 
Several reviews have been published on the transcriptional regulation of 
pancreagenesis (Wilson et al., 2003; Jensen, 2004; Servitja & Ferrer, 2004; Habener 
et al., 2005), with specific interest in this area related to developing a method for 
ŐĞŶĞƌĂƚŝŶŐ ŐůƵĐŽƐĞ ƐĞŶƐŝƚŝǀĞ ŝŶƐƵůŝŶ ƐĞĐƌĞƚŝŶŐ ĐĞůůƐ  ?ɴ-like cells) from host 
progenitors as a treatment primarily for type 1 diabetes. The fetal pancreas 
develops from the endoderm germ layer, buddy off either side of the foregut and 
then recapitulating later in development.  
 
The changes in structure (Figure 1.3) and key transcription factors (Figure 1.4), 
highlighted by murine knock out studies, has been reviewed and eloquently shown 
by Habener et al.,  (2005) and Servitja & Ferrer (2004), respectively.  
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Of the transcription factors involved, pancreatic duodenal homeobox gene-1 (Pdx-1) 
ŚĂƐďĞĞŶƐŚŽǁŶƚŽďĞǀŝƚĂůŝŶƚŚĞƉƌŽŵŽƚŝŽŶŽĨƚŚĞɴĐĞůůƉŚĞŶŽƚǇƉĞ(Habener et al., 
2005). 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Diagram showing the major structural changes throughout pancreatic development  
Diagram taken from Habener et al., (2005)  showing the major structural changes in the murine 
pancreas throughout pancreagenesis. Dorsal (DP) and Ventral (VP) buds. Embryonic days (e) 
throughout murine gestation. 
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For further detail of the development of these organs, specifically following in utero 
restriction, then see (Dahri et al., 1995; Fowden & Hill, 2001; Holemans et al., 2003; 
Remacle et al., 2007). 
 
Figure 1.4 dƌĂŶƐĐƌŝƉƚŝŽŶĨĂĐƚŽƌŵŽĚƵůĂƚŝŽŶŽĨŵƵƌŝŶĞɴĐĞůůĚĞvelopment in the pancreas 
&ŝŐƵƌĞƚĂŬĞŶĨƌŽŵ^ĞƌǀŝƚũĂ ?&ĞƌƌĞƌ ?Ɛ(2004) review. The figure shows the changes in pancreatic 
ƚƌĂŶƐĐƌŝƉƚŝŽŶ ĨĂĐƚŽƌƐ ? ĂƐ ĞůƵĐŝĚĂƚĞĚ ƚŚƌŽƵŐŚŵŽƵƐĞŐĞŶĞ ŬŶŽĐŬ ŽƵƚŵŽĚĞůŝŶŐ ? ĂƐ ƉĂƌƚ ŽĨ ɴ ĐĞůů
development within the Islets of Langerhans.  
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1.4 Fetal Programming  
^ŝŶĐĞƚŚĞĞĂƌůǇ ? ? ? ? ?ƐŚƵŵĂŶĞƉŝĚĞŵŝŽůŽŐŝĐĂůŽďƐĞƌǀĂƚŝŽŶƐŚĂǀĞƉŽŝŶƚĞĚƚŽǁĂƌĚƐĂ
link between birthweight and postnatal health status. The seminal work published 
by D.J. Barker & C.N. Hales pointed to a correlation between low birth weight and 
increased risk of cardiovascular disease and type 2 diabetes in later life. Their work 
ůĞĚ ƚŽ ƚŚĞ  “dŚƌŝĨƚǇ WŚĞŶŽƚǇƉĞ ,ǇƉŽƚŚĞƐŝƐ ? ? ǁŚŝĐŚ ƉƵƚ ĨŽƌǁĂƌĚ Ă  “ƉƌŽŐƌĂŵŵŝŶŐ ?
effect of adversity in the fetal environment on postnatal metabolism, and 
consequently adult health (Hales & Barker, 1992, 2001). Low birth weight is now a 
well recognised surrogate marker of intrauterine growth restriction (Jensen et al., 
2007), although birthweight can also be affected by many other factors such as 
genetic lineage, epigenetic imprinting, endocrine function (both fetal and maternal) 
and gestational age at birth (Kuzawa, 2004).  
 
A working hypothesis of fetal physiological programming put forward by Schwartz & 
Morrison (2005) (derived from (Lucas, 1991) ƐƚĂƚĞĚ “ĂĚũƵƐƚŵĞŶƚƐŵĂĚĞĚƵƌŝŶŐĨĞƚĂů
life in response to adverse changes in the biological environment with permanent 
consequences that may have been advantageous in fetal life but confer disease 
ĂĨƚĞƌďŝƌƚŚ ? ?dŚŝƐŝƐƚŚĞďĂƐŝƐŽĨƚŚĞŽƌŝĞƐƐƵĐŚĂƐƚŚĞ “dŚƌŝĨƚǇWŚĞŶŽƚǇƉĞ,ǇƉŽƚŚĞƐŝƐ ? ?
 “&ĞƚĂů KƌŝŐŝŶƐ ,ǇƉŽƚŚĞƐŝƐ ? ?  “WƌĞĚŝĐƚŝǀĞ ĚĂƉƚŝǀĞ ZĞƐƉŽŶƐĞ ? ĂŶĚ  “DŝƐ-Match 
dŚĞŽƌǇ ? ? /ƚ ƉƵƚƐ ĨŽƌǁĂƌĚ ƚŚĞ ŝĚĞĂ ƚŚĂƚ ƚŚĞ ĨĞƚƵƐ adapts to its perceived plane of 
nutrition in utero, metabolically, biochemically and physiologically. As the maternal 
plane of nutrition would historically reflect the nutrient availability postnatally, it 
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would follow that adaptations to optimise fetal metabolism would be beneficial in 
postnatal life also. In pre-civilised times these preparatory mechanisms may have 
been positively selected for, as they would optimise postnatal chances of survival. 
Unfortunately in the rapidly developing world that we live in today the in utero 
milieu may not be representative of the postnatal environment. Therefore, the 
prenatal adaptations may be detrimental at a time of increased nutrient supply and 
longevity.   
 
The incidence of fetal under nourishment, and the adaptations associated with it, 
followed by postnatal over nutrition is increasing globally. Fetal programming has 
been implied as a potential confounding factor behind the pending epidemic of 
metabolic syndrome in developing counties going through rapid economic growth 
such as India and China (Yajnik, 2004b, a). The traditional dietary intakes of the 
ƉŽƉƵůĂƚŝŽŶƐ ĨƌŽŵ ƚŚĞƐĞ ĐŽƵŶƚŝĞƐ ŝƐ ƌĂƉŝĚůǇ ƵŶĚĞƌŐŽŝŶŐ ǭŶƵƚƌŝƚŝŽŶ ƚƌĂŶƐŝƚŝŽŶ ? ƚŽ Ă
more westernised dietary regiment (Prentice & Moore, 2005; Popkin, 2006; 
Prentice, 2006) Maternal malnourishment coupled with postnatal over nutrition 
could also be seen in offspring who have migrated from a nutrient deprived 
maternal lifestyle into a country where food is plentiful. Intrauterine growth 
restriction is also possible in developed countries; predominately caused by reduced 
placental blood flow leading to fetal nutrient restriction. Other risk factors include 
maternal age, maternal lifestyle, socio-economic background and medical factors 
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prior to or during pregnancy (Valero De Bernabe et al., 2004; Gluckman et al., 
2008). 
1.5 Fetal Programming Models 
Following on from the initial human epidemiological evidence, the past 10 years 
have seen much research into elucidating the molecular mechanisms behind fetal 
programming. A degree of work has been conducted on human subjects, most of 
the studies have concentrated on humans with a birthweight in the bottom centile 
(Hovi et al., 2007) or members of the Dutch famine cohort, who are the offspring 
(or subsequent progeny) of a large collection of Dutch families who were subjected 
to famine (<1000kcal/person/day) for 7 months during the winter of 1944-1945 at 
the end of World War II (Stein et al., 2004). The limitations of human work have 
been met with the use of animal models, such as maternal nutrient restriction (total 
calorie or low protein), hypoxia, placental embolisation (reducing blood flow from 
the placenta to the fetus) and pharmacological intervention (elevation of fetal 
glucocorticoid levels) (Martin-Gronert & Ozanne, 2007). Various animal species 
have been used in this work from primates to large farm animals (sheep and pigs) to 
small lab animals (rats, mice, guinea pigs), with rats being the animal of choice for 
most researchers. Unfortunately no biological system (in vivo, in vitro, ex vivo) or 
species is totally reflective of the human condition, the choice of model will depend 
on the specific question being asked, as well as other non-biological considerations 
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such as resource availability (time, finance, equipment, expertise in working with a 
particular material or method).  
 
Fetal nutrient restriction has been shown to have deleterious effects on the 
musculoskeletal system and body composition. Low birth weight has been 
correlated with adult lean tissue mass and muscle strength (Yliharsila et al., 2007). 
Reduced secondary skeletal muscle fibre number is a consistent interspecies 
(humans, sheep, pigs, rats  & guinea pigs) response observed following in utero 
nutrient deprivation (Dwyer et al., 1994; Dwyer et al., 1995; Greenwood et al., 
2000; Maltin et al., 2001; Brameld, 2004; Zhu et al., 2004; Fahey et al., 2005a; 
Quigley et al., 2005; Zhu et al., 2006; Daniel et al., 2007; Jensen et al., 2007; 
Mallinson et al., 2007). These studies and others have also found a greater 
proportion of glycolytic muscle fibres (type IIB/IIX) at the expense of oxidative fibres 
(type I and IIA) in response to maternal nutrient restriction during early to mid 
gestation (Zhu et al., 2006; Daniel et al., 2007; Jensen et al., 2007). Late gestation 
maternal nutrient restriction (Greenwood et al., 1999) or maternal intrauterine 
constraint via twinning (McCoard et al., 2000) cause reduced skeletal muscle 
hypertrophy, thus reduced muscle mass and birthweight , without causing changes 
in fibre number and type, (for review see Du et al., (2010)). Oxidative fibres express 
more insulin sensitive glucose transporter (GLUT4) (Gaster et al., 2000), so the 
combined effect of reduced fibre number and decreased proportion of oxidative 
fibres will reduce the mass of tissue capable of postprandial glucose uptake 
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(assuming compensatory hypertrophy does not occur). Maternal nutrient 
restriction/low birth weight has also been shown to reduce the expression of 
signalling proteins involved in the insulin intracellular signalling pathway in skeletal 
muscle in both humans and animal models. These proteins include Protein Kinase C 
ǌĞƚĂ  ?W<ɺ ? ? '>hd ? ?Phosphoinositide 3-ŬŝŶĂƐĞ ŝƐŽĨŽƌŵƐ  ?W/ ?< ? Ɖ ? ?ɲ ĂŶĚ Ɖ ? ? ?ɴ
(p110ɴ rat only) (Ozanne et al., 2005; Vaag et al., 2006). Along with these 
quantitative changes in protein expression from nucleic DNA, changes have also 
been observed in mitochondrial function in response to in utero nutrient restriction 
(Park et al., 2003; Lee et al., 2005), with reduced mitochondrial protein expression 
being associated with decreased aerobic capacity and consequently hyperglycemia. 
In utero ŶƵƚƌŝĞŶƚƌĞƐƚƌŝĐƚŝŽŶŚĂƐĂůƐŽďĞĞŶƐŚŽǁŶƚŽĚĞĐƌĞĂƐĞƉĂŶĐƌĞĂƚŝĐɴ-cell mass 
and insulin secretion in postnatal life (Blondeau et al., 1999; Simmons et al., 2001; 
Bertin et al., 2002; Boujendar et al., 2002; Limesand et al., 2005; Styrud et al., 2005; 
Limesand et al., 2006), as well as increased gluconeogenesis in the liver (Burns et 
al., 1997; Desai et al., 1997) and decreased lipolysis (Martin-Gronert & Ozanne, 
2007) and glucose uptake (Gardner et al., 2005) in adipose tissue.  
 
Increased adiposity and greater risk of obesity are common findings from in utero 
nutrient restriction observations, such as those made of the Dutch Hunger Famine 
cohort (Ravelli et al., 1976; Ravelli & Belmont, 1979; Ravelli et al., 1999, 2000). 
Increased ectopic intramuscular fat deposition (Lane et al., 2001; Zhu et al., 2006; 
Daniel et al., 2007), non-alcoholic fatty liver disease (Choi et al., 2007) and 
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increased abdominal adiposity (Guan et al., 2005; Vaag et al., 2006) have also been 
observed following maternal nutrient restriction. It appears that a key effect of 
intrauterine nutrient restriction, or other manipulations in maternal gestational 
diet, are changes in postnatal appetite, both in the preference for different foods 
and the quantity of foods consumed (Vickers et al., 2000; Bellinger et al., 2004; 
Bellinger & Langley-Evans, 2005; McMillen et al., 2006; Bayol et al., 2007; Erhuma et 
al., 2007a; Sebert et al., 2009). These studies are of relevance to the study design of 
this period of work, as we tried to elucidate whether changes in insulin resistance 
were associated with differences in appetite, lipid deposition and localisation. The 
propensity to thrive generated by in utero restriction, as outlined by the `Predictive 
ĚĂƉƚŝǀĞ ZĞƐƉŽŶƐĞ ? ƚŚĞŽƌǇ ŽĨ ĨĞƚĂů ƉƌŽŐƌĂŵŵŝŶŐ ? ǁŽƵůĚ ƐƵŐŐĞƐƚ ƚŚĂƚ ĚĞůĞƚĞƌŝŽƵƐ
consequences would follow should offspring be exposure to an abundant 
nutritional environment, especially when their requirement to undergo physical 
activity has been depleted.  
1.6 Ovine Models of Fetal Programming 
The ovine model has historically been well utilised in fetal physiological 
investigation, predominately due to the similarities between the lamb and human 
baby development. Although selective breeding and artificial insemination have 
caused sheep to increase the frequency of multiple fetal pregnancies, sheep 
generally give birth to singletons or twins like humans. A ewe will generally give 
birth to a ~4.5kg lamb following a 147 day pregnancy, while a human gives birth to a 
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~3.5kg baby with gestation lasting between 259 W294 days. As well as the absolute 
fetal weight being comparable to the human new born, the maternal to fetal weight 
ratio is also akin. The nature of ovine singleton pregnancy not only makes it 
comparable to the human condition, but also facilitates fetal investigation, which 
would be harder in a species with a larger litter size such as the pig. Ovine fetal 
organogenesis is analogous to human development, with organs developing at 
similar rates and times during critical windows of gestation. Lambs are born 
precocial, like human babies, unlike the altrical rat offspring who undergo 
considerable postnatal development, in line with third trimester development in a 
human or sheep fetal tissues (Symonds & Budge, 2009).  
 
ZĞƐĞĂƌĐŚƐƚĂƌƚĞĚŝŶƚŚĞĞĂƌůǇ ? ? ? ? ?ƐƚŽĐŚĂƌĂĐƚĞƌŝƐĞŵĂƚĞƌŶĂůŶƵƚƌŝĞŶƚƌĞƋƵŝƌĞŵĞŶts 
in ewes (Phillipson, 1959; Thomson & Aitken, 1959). JJ Robinson and colleagues 
then developed the field further (detailed in Chapter 5), firstly by investigating 
nutrition requirements and then by looking at the effect of maternal nutrition on 
fetal development (Robinson & Forbes, 1967; Guada & Robinson, 1974; Robinson, 
1977, 1980). Early intrauterine physiological examination of ovine development and 
metabolism has given a vital background into processes controlling fetal and 
placental growth and function (Fowden, 1979; Jenkin et al., 1979; Fowden, 1980; 
Gow et al., 1981; Brockman & Laarveld, 1986; Fowden et al., 1986; Gu et al., 1987; 
Fowden & Hay, 1988; Jones et al., 1988; Challis et al., 1989).  
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&ŽůůŽǁŝŶŐ ƚŚĞ ƌĞůĞĂƐĞ ŽĨ ĂƌŬĞƌ ?Ɛ ƐĞŵŝŶĂů ǁŽƌŬ(Barker & Osmond, 1986) linking 
early development with postnatal health, the area of ovine fetal research slowly 
changed to incorporate the postnatal consequences of intrauterine insults, such as 
undernutrition.   
 
ĞůŽǁ ŝƐ Ă ƐĞůĞĐƚĞĚ ƌĞǀŝĞǁ ŽĨ ƚŚĞ ůŝƚĞƌĂƚƵƌĞ ? ƵƐŝŶŐ ƚŚĞ ƐĞĂƌĐŚ ƚĞƌŵƐ  “ƐŚĞĞƉ ? ĂŶĚ
 “ƵŶĚĞƌŶƵƚƌŝƚŝŽŶ ? ǁŝƚŚ ƚŚĞ WƵďDĞĚ ƐĞĂƌĐŚ ĞŶŐŝŶĞ ? KĨƚŚĞ  ? ? ? ĂƌƚŝĐůĞƐ ƚŚĂƚ ǁĞƌĞ
found, 26 were reviews, two of which were of significant relevance (Greenwood & 
Bell, 2003; Oliver et al., 2007). As the specific area of interest for this review was 
postnatal health, all fetal physiology papers were removed, which left 40 original 
articles related to the offspring of undernourished ewes. Two articles (in grey 
below) have been added to the review, as they were not highlighted by the search, 
although they should fit with search terms, these articles are used for comparison in 
later chapters. 
 
The one paper published prior to the Barker & Osmond (1986) paper highlighted in 
this search related to the parameters of interest is a paper by Lawlor & Hopkins 
(1981) who describe the effect of ewe undernutrition during pregnancy on ewe 
lactation, lamb growth and body composition.  
Below, the remaining papers are characterised into groups, with the main effects 
highlighted.  
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x Muscle; early nutrient restriction (50%) causes a reduction in fast twitch fibres 
(Nordby et al., 1987; Fahey et al., 2005a; Daniel et al., 2007) 
x Glucose; elevated insulin response to a GTT in males following early and late 
energy restriction 
(Oliver et al., 2002; Gardner et al., 2005; Ford et al., 2007; Poore et al., 2007; 
Cripps et al., 2008; Husted et al., 2008; Rhodes et al., 2009; Todd et al., 2009; 
Smith et al., 2010)  
x Mitochondrial; increased UCP2 and VDAC in the lungs and adipose tissue 
following late gestation maternal energy restriction. Increased VO2 max in 24 
month old late gestation restricted offspring.  
(Mostyn et al., 2003; Jorgensen et al., 2009) 
x Hypothalamic Wpituitary Wadrenal axis, cardiovascular and renal function; 
hypertension, cardiac hypertrophy, reduced renal clearance and endothelial 
dysfunction, greater mean arterial pressure, adrenocorticotropic hormone and 
cortisol responses, blunted baroreflex sensitivity during angiotensin II infusion. 
(Hawkins et al., 2000; Oliver et al., 2002; Bloomfield et al., 2003a; Borwick et al., 
2003; Symonds et al., 2003; Gardner et al., 2004; Gopalakrishnan et al., 2004; 
Khan et al., 2005; Gardner et al., 2006; Chadio et al., 2007; Cleal et al., 2007a; 
Williams et al., 2007; Chan et al., 2009; Kotsampasi et al., 2009b; Torrens et al., 
2009; Long et al., 2010; Poore et al., 2010).  
x Behaviour; reduced ewe/lamb bonding, increased emotional reactivity and 
changes in side preference 
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(Dwyer et al., 2003; Erhard et al., 2004; Hernandez et al., 2009; Hernandez et 
al., 2010) 
x Fertility; reduced ovulation rate, reduced Sertoli cell number, changes in female 
offspring lactation performance, reduced progesterone secretion and fertility.  
(Rae et al., 2002; Kotsampasi et al., 2009a; Blair et al., 2010; Long et al., 2010) 
x Immune; reduced immune response to vaccination 
(Eckersall et al., 2008) 
x Growth and the GH Axis; various reprogramming events in the prolactin-GH-IGF-
1 axis. 
(Hyatt et al., 2004; Cleal et al., 2007b)  
x Adrenal; decreased adrenal weight and reduced methylation of the proximal 
binding site for the IGF2/H19 gene. 
(Zhang et al., 2010) 
x Appetite; reduced energy intake when obese and decreased hypothalamic gene 
expression. 
(Sebert et al., 2009)  
 
The above show the wide ranging physiological effects that have been observed in 
offspring following ovine prenatal energy restriction. As individual studies utilised 
different critical windows of gestation without a consistent postnatal phenotype, it 
suggests that fetal programming is modulated differentially depending upon the 
gestational period that the restriction is imposed.  
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1.7 Ruminant Nutrition 
Species such as humans, pigs and rats are monogastrics with one stomach, whereas 
some herbivorous species such as sheep and cows are termed ruminants, as they 
have four stomachs, the rumen being the largest and most important. Monogastric 
species, such as the omnivorous animals listed above, extract the majority of their 
nutrients from digestion of the food they consume. The digestion of food 
macronutrients into constituent components (polysaccharides to sugars, proteins to 
amino acids and lipids to fatty acids) is a result of mechanical and chemical 
degradation, with a relatively low level of nutrient production due to microbial 
digestion (in monogastrics). Food is ingested in the mouth and undergoes 
mechanical disruption by the teeth and chemical degradation by saliva. The bolus of 
food then enters the stomach via the oesophagus, where it is exposed to a highly 
acidic soup of digestive enzymes secreted from the stomach. The stomach contents 
then enter the small intestine (duodenum, jejunum and ileum), which is a far less 
acidic environment than the stomach where digestion is completed and nutrient 
absorption takes place. In the duodenum secretions from the duodenal glands (e.g. 
bicarbonate), exocrine pancreas (trypsin and chymotrypsin for proteolysis and 
lipase for lipolysis) and liver/gall bladder (bile salts for lipid emulsification and 
facilitation of lipolysis) are mixed with the chyme. The brush border of the small 
intestine also secretes locally acting enzymes, which complete the membraneous 
phase of digestion e.g. breakdown of oligosaccharides to monosaccharides or 
cleavage of individual amino acids from peptides. The jejunum and ileum have 
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many folds, with finger like projections (villi), themselves with smaller projections 
(microvilli) exponentially increasing the surface area available for nutrient 
absorption. Nutrients are absorbed into the brush border cells via diffusion, 
facilitated diffusion or co-transported (such as glucose and amino acids) with 
sodium. These nutrients are then rapidly transported from the cytoplasm into the 
portal blood to help maximise the concentration gradient between the lumen of the 
small intestine and intracellular concentration of the brush border cells. The portal 
blood flows to the liver via the pancreas and mixes with the endocrine pancreatic 
secretions. Upon first pass through the liver, remaining blood nutrients are either 
used for immeĚŝĂƚĞ ĞŶĞƌŐǇ ƉƌŽǀŝƐŝŽŶ  ?ŽǆŝĚĂƚŝŽŶ ? Žƌ  ‘ƐƚŽƌĞĚ ? ĂƐ ŐůǇĐŽŐĞŶ
(carbohydrate), esterified into triglyceride and stored in the adipose tissue (NEFA), 
while amino acids are utilised in protein synthesis.  
 
Ruminants have developed many ways of increasing the nutrient availability from 
their largely high insoluble fibre diets, for review see McDonald et al., (2002). One 
of these mechanisms is rumination, which is a process the ruminant uses to move 
partially digested material from the rumen back into the mouth for further 
mastication, thus increasing mechanical (teeth) and chemical (salivary enzymes) 
degradation. Ruminants utilise microbial fermentation in a mutualistic symbiotic 
manner as a means of digesting complex carbohydrates, containing a high 
ƉƌŽƉŽƌƚŝŽŶ ŽĨ ɴ-linked polysaccharides such as cellulose, that are otherwise 
undegradable by mammalian digestion. The microorganisms in the rumen include 
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various species of bacteria, protozoa and fungi. These organisms digest the fibrous 
material consumed by the ruminant (containing cellulose, starch, hemicelluloses, 
fructans and pectins for instance) by the use of extracellular enzymes to eventually 
produce simple sugars. These simple sugar products, along with any dietary intake, 
are then absorbed by the rumen microorganisms and converted into pyruvate. The 
pyruvate is then metabolised, producing volatile fatty acids (VFAs) such as acetate, 
propionate, butyrate, lactate, succinate and formate. Other products of rumen 
pyruvate metabolism are carbon dioxide and methane; these are subsequently 
removed by eructation. The VFAs are then absorbed directly across the wall of the 
ruminant stomachs, which is especially important in helping to maintain the pH of 
the rumen liquor.  
 
Regarding ruminant protein uptake, the microorganisms are once again crucial 
(summarised in Figure 1.5). Microorganisms in the rumen hydrolyse degradable 
protein into peptides and then amino acids, these amino acids are then used to 
synthesize microbial proteins. Some amino acids may be deaminated into non-
protein nitrogen, such as ammonia. Ammonia is also produced by the degradation 
of other non-protein nitrogen sources such as from the hydrolysis of urea. This 
ammonia can be re-utilised by the microbiota to produce microbial proteins, or it 
can be absorbed by the host either through the wall of the rumen or from the small 
intestine following passage through the abomasum. Once the ammonia is in the 
mammalian blood stream it is converted to urea in the liver. The urea can either be 
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incorporated into saliva and ingested or secreted by glands in the rumen 
(replenishing the rumen nitrogen content), finally, urea can be excreted out of the 
ruminant by the kidneys in urine. As microbes and non-degraded protein reach the 
abomasum and small intestine they then undergo proteolysis in line with 
monogastric digestion detailed above, with the amino acids being absorbed by the 
host.  
 
 
 
Figure 1.5 Diagram showing flow of nitrogenous compounds during ruminant digestion 
The diagram shows the flow of nitrogen during ruminant feeding. With blue arrows representing 
digestible protein, orange arrows indigestible dietary protein, green host nitrogen cycling and 
pink host endogenous enzymatic secretions.  The diagram is taken from (www.smallstock.info, 
2010). 
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The microbial flora are also involved in the digestion of dietary lipids consumed by 
the ruminant. Triglycerides are hydrolysed in the rumen by bacterial lipases to form 
long chain non-esterified fatty acids. The majority of fatty acids consumed by 
ruminants are C18 polyunsaturated, either linoleic or linolenic. These free fatty acids 
are hydrogenated forming the C18 saturated fatty acid stearic acid. Unlike the short 
carbon chain volatile fatty acids produced by microorganism metabolism of 
pyruvate, these long chain fatty acids cannot be absorbed across the wall of the 
ruminant stomach, and so they pass to the small intestine for digestion by the hosts 
enzymes and absorption.  
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1.8 Aims & Hypothesis 
1.8.1 AIM 
The aim of this programme of work was to investigate the effect of in utero nutrient 
restriction (global, i.e. energy restriction or specific, i.e. protein restriction) at 
specific periods of gestation on fetal growth and development and subsequent 
adult male and female offspring glucose-insulin metabolism in the sheep. A further 
aim of the study was to challenge the programmed metabolic phenotype in the 
adult with acquired obesity.  
 
1.8.2 HYPOTHESES 
1) Programmed metabolic disease in the sheep is evident when nutrient restriction 
is unbalanced (i.e. low protein) rather than balanced (i.e. global energy restriction). 
2) Maternal protein restriction during late (as oppose to early) gestation 
compromises fetal growth and development leading to low birth weight and early 
signs of risk factors for metabolic disease in the adult offspring. 
3) Maternal nutritional programming of metabolic disease is sex-specific in the 
sheep. 
4) Adult-onset obesity exacerbates metabolic dysfunction and reveals overt 
metabolic disease in the adult male and female offspring. 
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2. General Methods 
2.1 Background 
2.1.1 OVERVIEW 
Two studies were set up at the Macaulay Institute in Scotland to investigate the 
effect of maternal nutrient restriction on fetal development and postnatal 
metabolism, immunity and behaviour. One study looked at the effect of restricted 
dietary energy supply, whereas the second looked at the effect of restricted dietary 
protein supply. Both studies investigated the effects of restriction during early or 
late gestation. Early gestation was deemed up to 65 days after conception and late 
gestation was from day 66 to term. The nutrient restriction periods were chosen to 
correspond with periods of either no or partial fetal luteinising and follicle 
stimulating hormone production (i.e. none up to day 65 and some thereafter) but 
also, partially, coincided with the phases of fetal muscle development, which is 
largely proliferative up to day 85 and differentiating (hypertrophic) thereafter 
(Fahey et al., 2005b). 
Although the designs for the two studies (Protein & Energy) are comparable and 
they ran in parallel, they are statistically treated as two separate studies as the low 
protein study was begun two months after the low energy study. We found this to 
have effects on the condition of the ewes entering each study, on average birth 
weights and also various other unquantifiable effects such as the quality of the 
pasture when the lambs were born, which meant that the pre-mating and postnatal 
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supplementation levels were different (Gootwine & Rozov, 2006).  
2.1.2 ETHICS 
All procedures were performed in accordance with the UK Animals (Scientific 
Procedures) Act, 1986 and were approved by the relevant local ethical review 
committees of the Macaulay Institute and the University of Nottingham. 
2.2 Maternal Low Energy Study 
2.2.1 STUDY DESIGN 
1 month prior to mating, 87 Scottish blackface ewes were brought inside and barn 
housed. They were weighed and body condition scored (BCS) 12 times between 50 
days prior and partition. Animals with a low BCS were given elevated feed rations 
(Green Keil; see 2.5.2.1, with ad libitum hay). Ewes were oestrus synchronised with 
a progesterone sponge (Cronolone, 30 mg; Intervet, Cambridge, UK) for 2 weeks. 
The following day ewes were mated naturally to Scottish blackface rams. Ewes were 
then assigned to one of three experimental groups; Control Energy (CE), whom 
received 100% live weight maintenance requirement (1M; (AFRC, 1993)) throughout 
gestation to term; Low Energy Late (LEL), which were fed 1M between day 0-65 and 
then 0.7M from day 66 to day 128 and then realigned with control (1M) (Table 2.1); 
Low Energy Early, which were fed 0.65M until day 65 of gestation and then 
switched to 1M until term (Table 2.1). On day 65 a group of control and LEE ewes 
were euthanised, and maternal, placental and fetal tissues were collected. The 
remaining LEE ewes were switched to control feed, whilst the LEL group were 
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 Control  Restricted 
 Single     Twin      Single     Twin       
Gestatio
n Period    
(days) 
Energy 
Requirement 
(MJ) 
Green 
Keil (g) 
Energy 
Requirement 
(MJ) 
Green 
Keil (g) 
Energy 
Requirement 
(MJ) 
Green 
Keil (g) 
Energy 
Requirement 
(MJ) 
Green 
Keil (g) 
<65 8 600 8 600 LEE 5.2 330 5.2 330 
65-70 8 600 8 600 LEL 5.6 370 5.6 370 
70-80 8.3 620 8.5 640 LEL 5.8 380 5.9 400 
80-90 9.1 700 9.6 750 LEL 6.3 430 6.7 470 
90-100 9.8 760 10.6 840 LEL 6.8 480 7.4 540 
100-110 10.6 840 11.6 930 LEL 7.4 540 8.1 600 
110-120 11.3 900 12.7 1040 LEL 7.9 580 8.8 670 
120-128 12 970 13.7 1130 LEL 8.5 640 9.6 750 
128-
birth 
12.8
# 
1300 14.7
# 
1500 
LEL 
#
Moved to control intake  
Table 2.1 Maternal Low Energy Study Dietary Rationing 
The restricted treatment groups were fed a 65% ration of their live weight maintenance requirement 
until day 65 (LEE) and a 70% restriction until day 128 (LEL). The nutritional intake increased in late 
gestation to reflect the increased energetic demand of the ewe due to the developing fetus. 
#
At day 
128 all animals were put on 100% maintenance requirement. For the first two weeks postnatally all 
ewes were offered 1.5kg green keil (see 2.5.2.1) and access to hay ad libitum. Ewes were scanned on 
day 70 to assess litter size (singleton or twin), as nutritional requirement increases with litter size. All 
maternal diets were supplemented with 250g hay (1.7MJ).  
 
switched from control to restricted feed rations. The nutrient restriction was 
gradually, over a period of 2 weeks, removed prior to term to mitigate any effect of 
the prenatal restriction on lactation and thus confound the results. Ewes were 
weighed and had their body condition score (BCS; (Russel et al., 1969)) measured 
up to weaning. For overview see Figure 2.1. 
 
2.2.2 DIETARY DESIGN 
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2.3 Maternal Low Protein Study 
2.3.1 STUDY DESIGN 
In similarity to the Low Energy study, 74 Scottish Blackface ewes were brought into 
barn housing one month prior to mating to help improve and align their body 
condition. A progesterone sponge was inserted for 2 weeks and the ewes were 
mated to Scottish blackface rams the day after the sponge was removed. They were 
weighed and body condition scored (BCS) 12 times between 50 days prior and 
partition. The low protein study also consisted of three experimental groups; a 
control protein (CP) receiving 18% protein throughout pregnancy (see 2.5.2.2.1), a 
low protein early (LPE) group, receiving 9% protein (see 2.5.2.2.2) from day 0 
(mating) to day 65 then 18% protein thereafter to term (approx. ~147 days), and a 
low protein late (LPL) group, receiving 18% protein from day 0-65 then 9% protein 
from day 65 to term. Ewes were weighed and had their body condition score (BCS; 
(Russel et al., 1969)) recorded. For overview see Figure 2.1 
 
2.3.2 DIETARY DESIGN 
Due to the nature of ruminant protein nutrition it is difficult to differentiate 
between protein intake required for energy and non-energy uses, so it is difficult to 
calculate the exact maintenance protein requirement. 18% protein is a moderately 
high nutrient level in a normal ovine diet; therefore a 50% reduction (9% protein) is 
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expected to be sufficient to elicit changes in amino acid cycling in the sheep and 
reduce late gestation growth of the fetus (for more detail, see 5.2.). 
2.4 Postnatal Methodology 
2.4.1 POSTNATAL METHODOLOGY AT THE MACAULAY INSTITUTE, SCOTLAND (0-1.5YRS OLD) 
Once born, offspring from both studies (low energy and low protein) were treated 
equally and as a single group at all stages post-natally. After birth, ewes were 
offered 1.5kg of feed, with ad libitum hay to reduce any possible effects of the 
gestational nutrient restriction on milk quality during lactation. All male lambs were 
castrated shortly after birth. When the lambs were approx 2 weeks old they were 
vaccinated, the ewes and lambs were then put to pasture and Green Keil (2.5.2.1) 
was fed at a rate of 1kg/ewe/day for 4 weeks. After this period feed was offered at 
0.6kg pellets per head per day. Lambs were weaned aged 3 months. Liveweights 
and body condition scores of ewes and lambs were recorded at intervals of 3 weeks 
from birth, and blood samples (7ml) were collected every 3 weeks by jugular 
venepuncture to determine insulin concentration. 7 month old offspring underwent 
an insulin tolerance test and the following day a glucose tolerance test to assess 
insulin/glucose dynamics. The sheep were maintained on pasture with feed 
supplement until they were either euthanised or transported to Sutton Bonington 
Campus, University of Nottingham. Euthanasia was carried out using a lethal dose of 
sodium pentobarbital, followed by exsanguination. For overview see Figure 2.1.  
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2.4.2 POSTNATAL METHODOLOGY AT SUTTON BONINGTON CAMPUS, ENGLAND (1.5-2YRS OLD) 
2.4.2.1 Overview 
A cohort of 39 sheep at 1.5 years of age were moved to Sutton Bonington Campus 
for further in vivo investigation. On arrival all animals were randomly retagged, as 
well as having their body weight and condition score recorded and habituated to 
their new environment for 4 weeks. At this time, a further glucose tolerance test 
(GTT) was conducted on all sheep, this wilů ďĞ ƌĞĨĞƌƌĞĚ ƚŽĂƐ ƚŚĞ  “ůĞĂŶ'dd ? (see 
2.4.2.2) and, shortly after, the sheep underwent body composition analysis by dual 
energy x-ray analysis (DEXA- see 2.4.2.3) ? ƌĞĨĞƌƌĞĚ ƚŽ ĂƐ  “ůĞĂŶ y ?. Following 
these initial, lean investigations, the animals were exposed to an obesogenic 
environment (see 0 ? ?ǁŝƚŚƚŚĞŝŶƚĞŶƚŝŽŶŽĨŝŶĐƌĞĂƐŝŶŐƚŚĞĂŶŝŵĂůƐ ?ĨĂƚĚĞƉŽƐŝƚŝŽŶ ?All 
animals were encouraged over a period of 6 months to put on 50% of their original 
weight prior to their lean GTT. At this point thĞ 'dd  ? “ŽďĞƐĞ 'dd ?) and DEXA 
 ? “ŽďĞƐĞy ? ?were repeated, individual appetite was recorded (see 2.4.2.5) and a 
further insulin tolerance test conducted (ITT- see 2.4.2.6) followed by an insulin 
stimulated skeletal muscle biopsy (see 2.4.2.7). A week later all animals were 
euthanised (see 2.4.2.8). For overview see Figure 2.1. 
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Figure 2.1 Overview of Prenatal & Postnatal Study Design 
Figure showing the study design for both the Low Protein and Low Energy investigations, 
indicating the key interventions during both prenatal and postnatal life. GTT (Glucose Tolerance 
Test), ITT (Insulin Tolerance Test), DEXA (Dual Energy X-Ray Absorptiometry). Details of these 
methods are highlighted in the remainder of this chapter. 
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diets switched (fetal
tissues collected)
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2.4.2.2 Glucose Tolerance Test (GTT) 
2.4.2.2.1 GTT at 7 months of age  
Animals had an intra-jugular cannula implanted under local anaesthesia (lignocaine) 
on the day prior to the GTT. Cannula were kept patent by flushing with 1% 
heparinised (25000 units/ml) saline (0.9% NaCl). Animals were fasted overnight 
(1600-0900). A 5ml baseline blood sample was collected from each animal 45, 30 
and 15 minutes before the start of the GTT, and transferred into potassium EDTA 
tubes. A further baseline sample (2ml) was collected immediately prior to glucose 
infusion (40ml 50% w/v glucose solution). Samples continued to be collected at 15 
minute intervals until 135 minutes post infusion. Following blood centrifugation, 
plasma was isolated and frozen at -20
o
C until further analysis. All animals had 
cannulae removed and were returned to barn housing. 
2.4.2.2.2 GTT at 1.5 & 2 Years of age  
A similar protocol was conducted as described for the GTT at 7-months of age with 
a few exceptions; blood samples were collected at slightly different times but at 
intervals known to adequately characterise glucose tolerance in sheep (5 and 10 
minutes baseline and subsequently at 10, 20, 30, 60, 90, 120 minutes post infusion). 
Secondly, the glucose infusion rate was given at 1ml 50% w/v glucose solution per 
kg body mass. This was done to overcome any confounding factors had the animals 
gained variable weight during exposure to the obesogenic environment.  
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2.4.2.3 Dual Energy X-Ray Absorptiometry (DEXA) 
Animals were sedated (I.M. injection of 1.5 mg.kg
AL ?
 Ketamine with 0.1 mg.kg
AL ?
 
Xylazine) and scanned in a transverse position using a Lunar DPX-L (fast-detail whole 
body smartscan). The scan lasted ~15 min after which animals were allowed to 
recover in a pen and returned to the barn. Regular phantom spine and internal 
validations showed the DXA to be >97% reproducible for estimations of body 
composition. In addition, in a separate experiment, DXA-determined fat and fat-free 
body composition was validated against whole carcass chemical analysis. Briefly, 14 
half-carcasses were macerated (WolfKing macerator) and 250 g dried, homogenized 
and nitrogen content determined by a FlashEA1112 nitrogen analyzer (Thermo 
Scientific, UK). Percentage fat was determined by rapid soxhlet extraction using a 
Gerhardt Soxtherm (Wolflabs, York, UK). All procedures have been described 
previously in detail, (Daniel et al, 2007). There was a significant correlation between 
methods (Pearson correlation 0.92, P<0.001; Figure 2.2), but the DXA had a lower 
limit of fat detection in the sheep (at 4 W5% body fat) and estimated ~75% less body 
fat than complete chemical extraction, as indicated by a Bland-Altman plot (Figure 
2.2). 
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Figure 2.2 Validation of DXA-determined vs. chemically determined fat mass in sheep (top) with  
a representative Bland-Altman plot (bottom).  
Top) 14 sheep of differing body composition as determined by DXA were euthanised and body 
composition determined by chemical analysis (see 2.4.2.3 for details). The two methods were 
significantly correlated (P<0.001, Pearson correlation; spline with 95% CI shown) with an equation 
for the line of y=1.79x+3.51.  
Bottom) The Bland Altman plot illustrates the lower limit of detection for DXA in the sheep (4-5% 
fat) and that DXA vs. chemical analysis estimates ~75% less whole body fat. 
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2.4.2.4 Obesogenic Environment  
Animals had their dietary intake increased from maintenance feeding (1M) ~6-7 
MJ/day to 1.5M through a combination of increased dietary intake and an increase 
in the percentage fat of the diet (from 3% to 6% oil- see 2.5.2.3). As well as 
increasing food intake, energy expenditure was minimised through barn housing 
the animals, thus reducing physical activity (Williams et al., 2007), as well as 
potentially reducing the requirement for thermogenesis due to the increased 
shelter. All animals were weighed weekly in order to monitor their weight gain over 
this period, with the experimental end-point being a ~50% increase in weight 
between 1.5-2 years, which represents a theoretical change in BMI from ~22.5 to 
~32.5 (as the animals do not gain height at this age). After this period of weight gain 
and throughout the repeated experiments the animals were considered to be 
 ‘ŽďĞƐĞ ? ? 
2.4.2.5 Appetite Studies 
Over a one week period, animals were individually housed and daily food intake of 
pelleted feed and hay nuts measured over a minimum consecutive 3 day period, 
during which no other experimental procedures were taking place. On a further day 
appetite was assessed; briefly, animals were fasted overnight (at least 12hrs), and 
feed reintroduced ad libitum over a 2 hour period, when total intake was recorded 
(Sebert et al., 2008).   
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2.4.2.6 Insulin Tolerance Test (ITT) 
2.4.2.6.1 ITT at 7 months of age 
An ITT assesses whole body insulin-dependent glucose uptake from a euglycaemic 
baseline and correlates closely with the hyperinsulinaemic Weuglycaemic clamp 
technique (Bonora et al., 1989). The dose of insulin given is designed to reduce 
resting plasma glucose by 1 W1.5 mmol.L-1 over a 15 W16 min period and from this the 
KITT, which is the percentage decline in blood glucose concentration per minute 
(%min
-1
) from 4 to 16 min relative to baseline (0 and 2 mins), is calculated (Norton 
et al., 2007). The ITT was performed the day after the GTT following an overnight 
fast, allowing the cannula from the GTT to be reused. The cannula was flushed with 
heparinised saline 1% heparinised (25000 units/ml) saline (0.9% NaCl) to check the 
patency of the cannula. A 2ml baseline blood sample was collected in a potassium 
EDTA tube, as for all blood samples. Insulin was then infused (0.25 IU/kg; 
Novorapid, UK). Blood samples were then collected at 15 minute intervals post 
insulin infusion for 2 hrs post insulin infusion. Blood was centrifuged and plasma 
collected and frozen at -20°C.  
2.4.2.6.2 ITT at 2 years of age 
At 2 years of age, the sheep were infused with 0.75 IU/kg Insulin (Novorapid, UK) in 
order to reduce glucose by 1 W1.5 mmol.L-1 and to guarantee sufficient glucose 
clearance in the short term (15 minutes) to allow for assessment of peripheral 
insulin sensitivity. The dosage was increased as aging and the onset of obesity were 
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expected to have a negative effect on insulin sensitivity. Sampling times were 
reduced to concentrate on the short-term effects (i.e. first phase insulin response); 
hence blood was taken at 2, 4, 6, 8, 10, 12, 14, 16 minutes post insulin infusion and 
KITT calculated as before.  
2.4.2.7 Skeletal Muscle Biopsy 
At 20 minutes after the Insulin infusion from the ITT, a skeletal muscle biopsy was 
taken. Animals were individually restrained and an area of fleece was shorn off 
directly above the left vastus lateralis. Biopsies were performed using a Bergstrom 
muscle biopsy needle under local subcutaneous anaesthesia (lignocaine). The 
wound was sprayed with an antibiotic agent and sealed with skin clips. The isolated 
muscle samples were snap frozen in liquid nitrogen and stored at -80
o
C for future 
analysis. All biopsies were performed by the same individual. 
2.4.2.8 Euthanasia  
Animals were euthanised using electrocortical stunning followed by exsanguination. 
During the post mortem, organs (total brain, hippocampus, pituitary, perirenal fat, 
cardiac fat, omental fat, average kidney, average adrenal, liver, spleen, heart, 
septum, left ventricle, right ventricle, lungs, pancreas) were collected, weighed and 
snap frozen in liquid nitrogen prior to long term storage (-80
o 
C freezer).  
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2.5 Laboratory Investigation 
2.5.1 BLOOD ANALYSIS 
Plasma cortisol levels were investigated in maternal and fetal plasma at day 65. 
Plasma insulin concentration was assessed in postnatal bloods up to weaning. 7 
month GTT plasma was analysed for glucose and insulin concentrations at all time 
points. ITT data (7 month and 2yr) was analysed for glucose, NEFA, glycerol and 
TAG. At 1.5yrs and 2yrs, GTT baseline samples were analysed for amino acid and 
leptin concentrations, while baseline and 120 minute samples were auto analysed 
(2.5.1.1) for electrolytes and gaseous values. All GTT time points at these ages were 
analysed for insulin, glucose, NEFA, glycerol and TAG.  
2.5.1.1 Auto-Analyser 
GTT samples were auto-analysed (ABL805-FLEX, Radiometer, Crawley, UK) for 
[glucose, lactate, K
+, 
Na
+
, Ca
2+
, Cl
-
], pH, pvCO2, pvO2, and HCO3
-
, as well as % 
ŚĂĞŵŽŐůŽďŝŶ ?K^D ? ?ZĂĚŝŽŵĞƚĞƌ ?ƌĂǁůĞǇ ?h< ?ĂŶĚA?ŚĂĞŵĂƚŽĐƌŝƚ ďĂƐĞůŝŶĞ “ƉƌĞ-
'dd ?ĂŶĚ ? ? ?ŵŝŶƵƚĞƐĂĨƚĞƌglucose infusion  “ƉŽƐƚ-'dd ? ?
2.5.1.2 Randox Imola 
Plasma samples were thawed and analysed for [Glucose], [Urea], [Triglycerides 
(TAGs)], [Glycerol] and [Non-Esterified Fatty Acids (NEFAs)] (Randox RX Imola). In 
brief, the Randox RX Imola is a clinical chemistry auto-analyser performing 
automated pipetting, calibration and reading for clinical and non-clinical 
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photometric assays. A maximum of 150µl of sample is analysed in each assay with 
an intra and inter assay variance (%CV) <5%.  
2.5.1.3 Cortisol Radioimmuno Assay 
Plasma samples were assayed for cortisol by using a radioimmunoassay kit 
(Euro/DPC, Caernarfon, Gwynedd, UK) and following the recommended procedure. 
In brief, the kit contained cortisol antibody coated tubes, 
125
I cortisol and cold 
cortisol standards. Suitable dilutions were made of standards to improve accuracy 
at the lower end of the standard scale; in total seven standards varying from 0-276 
nmol.L
-1
 ǁĞƌĞ ƵƐĞĚ ? ƵƉůŝĐĂƚĞ  ? ? ʅů ƉůĂƐŵĂ ƐĂŵƉůĞƐ ǁĞƌĞ ŝŶĐƵďĂƚĞĚ ǁŝƚŚ 125I 
cortisol in each tube for 45 minutes at 37°C, decanted and counted for 1 min/tube 
with a gamma counter. The detection limit, defined as the apparent concentration 
at 95% B/B0, was 5nmoles.L
-1
. The intra- and inter-assay coefficients of variation 
were 5.6% and <10%.  
2.5.1.4 Insulin Elisa  
Plasma insulin levels were assessed with an ovine specific insulin ELISA (Mercodia 
AB). Samples and calibrators were all pipetted in duplicate. Two pooled plasma 
samples of varying insulin concentration were also pipetted in duplicate to assess 
inter-assay variation. GTT samples from time points 20 and 30 minutes were diluted 
1:5 with the provided diluent, as undiluted samples were outside the range of the 
internal (per plate) standard curves (0-2.5µl/L). Plates were then read at 450nm 
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(Labsystems Multiskan Ascent plate reader plus Ascent software 2.6). A <15% inter- 
& intra-assay variation was accepted.  
2.5.1.5 Leptin Radioimmunoassay 
Plasma leptin concentrations (ng.ml
-1
) were determined using a validated double-
antibody radio-immuno assay (RIA) as previously reported (Delavaud et al., 2000; 
Williams et al., 2007). Samples were assayed in triplicate (200 ml) using a rabbit 
antiovine leptin primary antibody, iodinated ovine leptin and sheep anti-rabbit 
secondary antibody. The limit of leptin detection was 0.1 ng.ml
-1
 and the intra- and 
inter assay coefficients of variation for the assay was typically <5%. 
2.5.1.6 Amino Acid Profile 
Amino acids were isolated from plasma and derivatised using the EZ:Faast
TM 
amino 
acid kit (Phenomenex, Macclesfield, UK), as previously described (Sinclair et al., 
2008). 25µl of each sample was combined with 20nmol (100µl) norvaline which 
acted as an internal standard. This solution was passed through the EZ:Faast
TM
 solid 
phase extraction absorbent which was washed with 200µl propanol. A solution of 
propanol and sodium hydroxide (200µl) was then used to remove the absorbent 
(and the amino acids retained on it) from the pipette tip. 50µl chloroform and 100µl 
isooctane were then added to the solution to derivatise the amino acids which were 
recovered in the upper organic layer, dried under a stream of nitrogen and the 
sample re-dissolved in 100µl isooctane:chloroform (80:20 v/v) prior to analysis 
using Gas Chromatography WMass Spectrometry (GC-MS). For GC-MS analysis, 1µl of 
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the sample was injected in splitless mode (split closed for 10s) using an AS800 
autosampler (PerkinElmer, Beaconsfield, UK). The injector of the GC8000 gas 
chromatograph (Fisons, Manchester UK) was maintained at 250°C, with an initial 
oven temperature of 90°C which was increased to 320°C at 20°C/min (transfer line 
from the oven to mass spectrometer, 300°C). Helium (12psi) was used as the carrier 
gas to elute the amino acids from the ZB-AAA column (10m x 0.25mm ID). The 
MD800 mass spectrometer (Fisons) was operated in selected ion mode, recording 
ions at 101, 114, 116, 130, 144, 146, 155, 156, 158, 172, 180, 184, 243 and 244 
seconds with a dwell time of 0.03s. Calibration was achieved by comparison of peak 
areas for the amino acids in standard and sample runs after adjustment for 
variation in the peak area of the internal standard. The method permitted the 
analysis of 18 amino acids, cysteine and arginine not being detected.  
2.5.2 FEED COMPOSITION 
2.5.2.1 Green Keil 
Green Keil feed was used in the maternal low energy study during gestation, and by 
both the maternal low energy and protein studies during weaning. The dietary 
restriction was based on decreased feeding of Green Keil, as described in Table 2.1.  
12.5 MJ ME/kg dry matter (DM), 16% crude protein/MJ ME (North Eastern Farmers, 
Aberdeen, UK).  
2.5.2.2 Maternal Protein Study 
2.5.2.2.1 Maternal 18% Protein Diet 
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10.6 MJ ME/kg Fresh Weight, 18 % crude protein/MJ ME (Harbro Ltd, Turriff, UK). 
2.5.2.2.2 Maternal 9% Protein Diet 
9.2 MJ ME/kg Fresh Weight, 9% crude protein/MJ ME (Harbro Ltd, Turriff, UK). 
Both these diets were formulated by Dr Stewart Rhind (Macauley Research 
Institute) and Professor Emeritus John Robinson (Scottish Agricultural College). The 
higher protein content of the 18% diet comes from soya protein, while the lower 
protein content of the 9% diet comes from bran protein; therefore the 9% diet has a 
greater fibre composition, while sugar was used to try to balance the ME between 
the two diets.  
2.5.2.3 High Lipid diet 
Following the transportation of the offspring from the pastures of the Macauley 
Institute to the grounds at Sutton Bonington Campus, animals were acclimatised on 
ĂǭƐƚĂŶĚĂƌĚ ?ĨĞĞĚĐŽŶĐĞŶƚƌĂƚĞ- 
12.7 MJ ME/kg DM, 14% crude protein/MJ ME, 3% palm kernel oil (Manor Farm 
Feeds, East Leake, UK). 
Following basal, lean evaluation, animals were exposed to an obesogenic diet, 
which regarding dietary intake involved more feed being offered (200%) and an 
increased lipid content to the feed- 
13.3 MJ ME/kg DM, 14% crude protein/MJ ME, 6% palm kernel oil (Manor Farm 
Feeds, East Leake, UK). 
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2.5.3 STATISTICAL ANALYSIS 
2.5.3.1 Single determination continuous data 
Normally distributed data at a single time point e.g. maternal weight at mating or 
plasma glucose or baseline insulin for any 3 treatment groups (e.g. CP, LPE and LPL), 
were analysed by general linear mixed model (GLMM) with treatment, gender 
(male or female) and where appropriate fetal number (single or twin) as fixed 
effects. Non-normally distributed data, i.e. data from hormone assays, was 
converted logarithmically to produce log-normally distributed data. This data was 
then analysed as described above, with means presented as the back transformed 
values, so as not to present data in a logged format.  
2.5.3.2 Repeated measures analysis 
The main outcome i.e. the interaction of prenatal diet and postnatal environment 
(obesity) was assessed as a General Linear Mixed Model with Repeated Measures 
(GLMM-RM. i.e. data when lean and obese), therefore assessing time (becoming 
obese) as a fixed effect. A priori contrasts of interest to be examined were 
specifically time*treatment or time*treatment*gender interactions. Other effects 
of time within an individual animal, such as maternal changes during gestation, 
lamb insulin and responses to metabolic challenges were also investigated using 
GLMM-RM analysis in Genstat V13.  
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2.5.3.3 Area under the curve 
Area under the curve data was subtracted from baseline and hence an area under 
the response curve (AUC) was generated using the trapezoid rule in (Graphpad 
Prism 5). 
2.5.3.4 Power calculations  
All data are presented as predicted means from the above models with either 
standard error of the treatment mean (S.E.M) or standard error of the difference 
(S.E.D.) between comparisons, as appropriate, used to represent the variance. 
S.E.D. values are greater than S.E.M. values and therefore reflect the degree of 
variance more accurately. S.E.M. values are generated through SPSS (v16), whereas 
S.E.D. values were obtained through Genstat (v13). The S.E.D. or S.E.M. presented 
graphically is the variance associated with the significant effect demonstrated by 
the graph, for instance the treatment S.E.D. or the treatment*time interactive 
S.E.D. As an example of how to interpret S.E.D. values, for generalised linear mixed 
model (GLMM) statistical comparisons in the low energy study we had n=20 animals 
and therefore our total degrees of freedom (df) was 19 with 14 residual df 
(dftreatment,2; dfsex,1; dftreatment*sex,2); thus, the 95% confidence interval for probability 
testing was ±2.14 the S.E.D. for that comparison. Thus a difference between two 
means of greater than 2.14 multiplied by the S.E.D. equates to a significant 
difference. The study was designed to test the hypothesis that maternal 
undernutrition at a specific stage of gestation would influence offspring metabolic 
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function and this would be exacerbated when they became obese. In relation to the 
low protein study, for example, we had 90% power of being able to detect an 
increase in peak insulin (one-sided test) of 3.6 ng.ml
-1
, in a time*treatment*gender 
interaction design assuming a minimum of 3 males and 3 females per treatment 
ŐƌŽƵƉ ŵĞĂƐƵƌĞĚ ǁŚĞŶ ůĞĂŶ ĂŶĚ ŽďĞƐĞ ? ǁŝƚŚ ƐŝŐŶŝĨŝĐĂŶĐĞ  ?ɲ ? ƐĞƚ Ăƚ  ? ? ? ? ĂŶĚ ĂŶ
average (within-treatment) residual mean square (SD
2
) for insulin of 1.2 ng.ml
-1
 
(derived from the general linear model). Effects were deemed significant when 
P<0.05, but P=0.06-0.09 were also highlighted to indicate that the effects were 
close to the significance boundary, i.e. an insignificant trend.  
2.5.3.5 Analysis of amino acid concentrations  
Baseline plasma was analysed for amino acid concentration before each GTT test. 
Given the complex, non-independent interrelationships between amino acid 
pathways, simple univariate RM-GLM analysis for individual amino acids was not 
suitable to describe the changes in plasma concentration of multiple amino acids 
with obesity in sheep. Therefore the multivariate analysis principal component (PC) 
procedure was used to describe the change in amino acid levels with obesity. PC 
analysis indicated that most of the variation in amino acid concentrations between 
the lean and obese state could be explained by three principal components which 
explained >95% of the variation in amino acid concentrations. Scores were assigned 
for each of these components and were incorporated into a generalised linear 
regression model to identify whether the variation in amino acid concentration 
defined by each PC significantly explained the variation in the independent variate 
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e.g. resting [urea]. The latent vector loadings (which indicate the relative 
importance of the individual amino acids to a particular PC) for any PC that 
contributed significantly to a linear model were examined to determine which 
amino acids were most influential in defining the PC. All PC analyses were 
conducted using Genstat v13. 
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3. Low Energy Study  W conception to 18 months of age 
3.1 SUMMARY 
This chapter focuses on the effect of maternal energy restriction during early or late 
gestation on the ewe, the fetus, the weaned lamb and its development up to 1.5 yrs 
of age. A global energy restriction, 65% maintenance requirements, was applied 
from conception to day 65 of gestation (Low Energy Early; LEE) or a 70% restriction 
from day 66 of gestation through to day 128 (Low Energy Late; LEL) together with a 
control group fed 100% maintenance requirements throughout gestation (Control 
Energy; CE). Ewes undergoing nutrient restriction were significantly lighter during 
the restriction period compared to controls, while the body condition score of LEE 
ewes was significantly lower during early gestation compared to control mothers 
(P<0.001). No effect of diet was observed on maternal or fetal cortisol or post 
mortem tissue weights at day 65 of gestation. At birth, as expected, singletons were 
heavier than twins, while LEE offspring were significantly heavier than control 
(P<0.001). Singletons were born with a higher baseline insulin than twins (96 vs. 
0.58ng.ml
-1
 respectively. P=0.042), with the values aligning at 3 months of age. 
Following a glucose tolerance test at 7 months of age, female LEE and male LEL 
animals had the greatest peak insulin response to the glucose bolus, but no 
treatment effects were observed following an insulin tolerance test. At 1.5yrs, 
males were significantly heavier than females but undernourished groups (LEE & 
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LEL) had significantly lighter livers than controls (Liver- CE 907.2; LEE 833.1 & LEL 
780.8 g. SED 47.04. P=0.040).  
3.2 Introduction 
Extensive research has been conducted over the last 60 years into the nutrient 
requirements of ewes during pregnancy (Blaxter, 1957; Robinson, 1977, 1980; Wu 
et al., 2006). Initially, short-term pregnancy outcomes of economic importance 
were investigated such as better nutrition for reducing lamb mortality. As scientific 
understanding progressed and agricultural production pressure increased, farmers 
looked to maximise breeding performance, with birth weight being a key 
performance marker of the quality of ewe nutrition. With high fetal number (for 
example twinning) being a desirable selection trait (doubling ewe productivity), the 
research broadened to encompass the demands of ewes carrying multiple fetuses, 
which has additional nutrient demands in late gestation. Better formulation of 
sheep diets enabled various aspects of the pregnant ewe diet to be manipulated 
such as macro and micro-nutrient content to energy density. 
 
In the late 1980s evidence began to accumulate in humans that the prenatal 
environment can have long term postnatal health implications (Barker & Osmond, 
1986) and led to renewed interest in ewe nutrition, as the sheep was seen as an 
ideal model for the effects of changes in diet on gestational environment given the 
similarities between ovine and human fetal development and maturation (Wallace 
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et al., 2005). Thus the developing ovine fetus became the model of choice for many 
developmental physiologists investigating perturbations in the intrauterine milieu. 
No longer was the outcome simply production markers (agricultural scientists) or 
post mortem products of organogenesis (developmental physiologists), but now 
disturbances in postnatal cardiovascular and metabolic function were investigated 
(Gardner et al., 2005; Cleal et al., 2007a; Poore et al., 2007; Sinclair et al., 2007; 
Williams et al., 2007; Cripps et al., 2008; Chan et al., 2009).  
 
The capacity for fetal growth is governed by the permutation of fetal genotype (the 
combination of maternal and paternal genetics resulting in the fetuses `drive to 
ƚŚƌŝǀĞ ? ? ? ŵĂƚĞƌŶĂů ŐĞŶŽƚǇƉĞ  ?ƚŚĞ ĞǁĞ ?Ɛ ĂďŝůŝƚǇ ƚŽ ƉŚǇƐŝŽůŽŐŝĐĂůůǇ ƉƌŽǀŝĚĞ ĨŽƌ ƚŚĞ
fetus, e.g. her ability to gain and deliver substrates to the fetus) and finally the 
external environment (for example; maternal stress, fetal number, ewe nutrition 
and oxygenation) (Gootwine et al., 2007). As the fetus undergoes organogenesis, 
different organs develop at different times throughout gestation. Organogenesis 
involves, to varying extents, cells proliferating (multiplying or hyperplasia), 
committing to a cell fate i.e. differentiating (and thus developing functionality) and 
finally undergoing an increase in cell size (hypertrophy, further growth of existing 
cells). It is therefore understandable that intrauterine perturbations at certain times 
during gestation will impact upon the development of different tissues in different 
ways dependent upon the particular phase of the growth process that particular 
tissue is undergoing.  
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Many different models have been used in sheep to generate in utero growth 
retardation, from surgical and pharmacological to environmental insults such as 
nutritional modifications, stress and hypoxia. These insults can be chronic or acute, 
with acute models aiming to impact upon a specific period of organogenesis for an 
individual or multiple organ system. The model of choice for the present 
intrauterine growth restriction study was maternal global dietary restriction due to 
the vast knowledge from the agricultural nutritionists, the relatively low invasive 
nature of the study and the fact that it reflected our model of nutritional transition 
(i.e. from prenatal restriction to postnatal excess). Two restriction periods were 
chosen, one during early and one during mid-late gestation, with the intention of 
impacting before (early restriction) and during (mid-late restriction) skeletal muscle 
fibre differentiation (Fahey et al., 2005b) and thus potentially affecting muscle 
insulin sensitivity later in life.  
 
Cortisol is a hormone secreted by the ewe in response to stress, whether nutritional 
or emotional. One of the postulated mechanisms for maternal under nutrition 
leading to modifications in post natal health is via elevated fetal cortisol exposure 
(Gardner et al., 2006; Jaquiery et al., 2006; Chadio et al., 2007). The amount of 
maternal cortisol reaching the developing fetus is dependent upon the quantity 
secreted by the dam and the amount that is actually transferred from the maternal 
blood supply to the fetus by the placenta, since bioactive cortisol can be inactivated 
by placental  ? ?ɴ-ŚǇĚƌŽǆǇƐƚĞƌŽŝĚ ĚĞŚǇĚƌŽŐĞŶĂƐĞ ƚǇƉĞ  ?  ? ? ?ɴ,^ ? ? (Clarke et al., 
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2002). One of the widespread effects of cortisol is that it rapidly induces maturation 
of proliferating cells during organogenesis; hence excessive cortisol reaching the 
fetus could cause premature maturation of organs, thus permanently restricting 
their function in post natal life (Fowden & Forhead, 2009). It has also been 
hypothesised that in utero ĞǆƉŽƐƵƌĞ ŽĨ ƚŚĞ ĨĞƚƵƐ ƚŽ ĐŽƌƚŝƐŽů ǭƉƌŽŐƌĂŵŵĞƐ ? ƚŚĞ
ĨĞƚƵƐ ?Ɛhypothalamic-pituitary-adrenal function, which influences physiological 
function of the offspring in later life (Jaquiery et al., 2006; Bloomfield et al., 2007; 
De Blasio et al., 2007a; Seckl & Holmes, 2007).  
 
Insulin is a well-described regulator of glucose homeostasis, as well as being an 
anabolic hormone. The function of insulin as a growth promoter was first implicated 
in 1953 (Salter & Best, 1953). Since then the role of each of the somatotrophic 
factors (Growth Hormone, Insulin, Insulin-like Factors 1 & 2) and their interplay 
during fetal and neonatal development has been elucidated (Ogilvy-Stuart, 1995; 
Ogilvy-Stuart et al., 1998; Murphy et al., 2006; Saenger et al., 2007). Following 
intrauterine growth restriction, catch up growth is often observed, for which insulin 
has been inferred as a key regulator (De Blasio et al., 2007b; Fowden & Forhead, 
2009). Catch up growth following prenatal growth restriction results in greater 
adiposity, and hence reduced leĂŶ ŵĂƐƐ ĂĐĐƌĞƚŝŽŶ ŝŶ ĐŽŵƉĂƌŝƐŽŶ ƚŽ  “ŶŽƌŵĂů ?
growth. This period of catch up growth in small for gestational age babies has been 
implicated in the development of adult onset metabolic dysregulation, amongst 
other deleterious sequelae (Dulloo, 2008). Preterm (Singhal et al., 2003) and small 
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for gestational age births (Soto et al., 2003), associated with early catch up growth, 
have been implicated in insulin resistance in humans. While glucose tolerance and 
insulin resistance was predicted by catch up growth in a porcine model of low 
birthweight (Poore & Fowden, 2002, 2004) 
 
The initial focus of this study was therefore to investigate the impact of a modest, 
nutritional challenge during early or mid-late gestation on postnatal glucose 
homeostasis. When food is digested, it is broken down into absorbable units, in the 
case of carbohydrates the absorbable units are simple sugars, of which glucose is 
one. Glucose is an important metabolic substrate, whose dysregulation can have 
dire consequences. As glucose levels rise postprandially, insulin is secreted by the 
pancreas; in this state of hyperglycaemia (high blood glucose) and hyperinsulinemia 
(high blood insulin) the majority of excess blood glucose is cleared by skeletal 
muscle tissue (insulin stimulated glucose uptake) and by the liver (glucose 
stimulated glucose uptake) (Huang & Czech, 2007; Larance et al., 2008; Zaid et al., 
2008) and deposited (stored) as glycogen or oxidised to yield ATP. There is a 
growing evidence base to suggest that under nutrition during ovine gestation 
causes glucose intolerance and insulin resistance in the offspring, shown during a 
glucose tolerance test as a reduced ability to regain euglycaemia or by the hyper 
secretion of insulin in order to reattain euglycaemia (Gardner et al., 2005; Ford et 
al., 2007; Cripps et al., 2008). Todd et al., (2009) observed slightly conflicting results 
in comparison to the above mentioned studies, where by early gestational maternal 
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undernutrition in sheep resulted in postnatal glucose intolerance (increased 
Glucose AUC and decreased insulin AUC) in female sheep following a GTT. Thus, it 
was hypothesised that a deleterious effect of maternal nutrient restriction would be 
observed postnatally as effects on offspring glucose homeostasis. Effects have been 
observed following early (Poore et al., 2007), mid (Ford et al., 2007) and late 
(Gardner et al., 2005) gestational nutrient restriction (50% global nutrient 
restriction). Restricted body condition score and low maternal nutrient intake prior 
to and throughout gestation has also been shown to effect glucose tolerance 
(Cripps et al., 2008).  
 
Due to the importance of skeletal muscle in insulin stimulated glucose uptake and 
that skeletal muscle volume development is a late gestational event, then it was 
postulated that late gestation would hold the more critical window for development 
for glucose homeostasis in the adult offspring. During this late period, skeletal 
muscle fibres differentiate and undernutrition during this period has been shown to 
reduce skeletal muscle mass (Fahey et al., 2005a). As the hypothesis relates to a 
reduction in the capacity of the skeletal muscle tissue to uptake glucose in the 
insulin stimulated state, it was envisaged that a difference in glucose clearance 
would be shown via a glucose tolerance test (hyperglycaemia + hyperinsulinemia) as 
well as an insulin tolerance test (euglycaemia + hyperinsulinemia).  
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3.3 Materials and Methods 
See Chapter 2.2 for details of dietary design. In brief, Scottish blackface ewes were 
oestrus synchronised and mated to Scottish blackface rams. Ewes were fed either 
maintenance requirements throughout gestation, from day 0-term (Control Energy; 
CE) or they were allocated to a restriction protocol. The early restriction animals 
were fed 65% of CE feed rations from day 0- 65 gestation (Low Energy Early; LEE). 
On day 65 a proportion of CE and LEE animals were euthanised for collection of 
fetal tissues and blood (fetal and maternal cortisol was analysed- described in 
2.5.1.3). On day 66 the remaining LEE animals were switched to 100% maintenance 
requirements, while the late restriction group (Low Energy Late; LEL) was switched 
from 100% feed rations to 70%. LEE animals remained on 70% energy requirements 
until day 128, when they were aligned with CE and LEE animals on 100% feed until 
term. Maternal weight and body condition score (BCS) were recorded frequently 
throughout gestation. Males were castrated shortly after birth and all offspring 
were weaning aged 3 months. Lamb weights, BCS and blood were collected every 3 
weeks postnatally. Blood was analysed for plasma insulin (see Chapter 2.5.1.4). At 7 
months old offspring were cannulated, and a glucose tolerance test (GTT- see 
Chapter 2.4.2.2.1) and insulin tolerance test (ITT- see Chapter 2.4.2.6.1) were 
performed. Aged ~16 months, animals were either euthansied or transported to 
Sutton Bonington Campus, University of Nottingham for further investigation.  
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3.4 Results 
3.4.1 MATERNAL & FETAL DATA 
3.4.1.1 Ewe Weight 
Ɛ ĞǆƉĞĐƚĞĚ ? ƚŚĞ ĞǁĞƐ ? ǁĞŝŐŚƚincreased significantly as gestation progressed 
(P<0.001. Figure 3.1). As an average throughout gestation, ewes bearing singletons 
were significantly lighter than ewes carrying twins (P=0.025. singletons 60.41 vs. 
twins 63.77 kg, SED 0.44). A significant interaction between fetal number*time 
(P<0.001) was seen, with twin bearing ewes accruing more weight in late pregnancy 
than ewes carrying a single fetus. A significant treatment*time interaction (P<0.001) 
was observed on maternal body weight, with LEE ewes being lighter during early 
gestation and LEL being lighter in late pregnancy compared to controls (Figure 3.1).  
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Figure 3.1 Low energy study ewe weights throughout gestation 
Errors shown are ±1 SEM. Treatment groups are CE (Control Energy), LEE (Low Energy Early) and 
LEL (Low Energy Late).   
 
 
3.4.1.2 Ewe Body Condition Score (BCS) 
A significant effect of time was observed on ewe body condition score (BCS) during 
gestation (P<0.001), with BCS rising until day 84 and then declining rapidly during 
late pregnancy (Figure 3.2). Maternal nutrient restriction had a significant effect on 
BCS (P=0.002), with a treatment*time interaction showing that at the end of the 
early gestational nutrient restriction (day 65 LEE), the LEE ewe had a significantly 
lower BCS than control ewes. Fetal number had no effect on maternal BCS.   
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Figure 3.2 Ewe body condition scores following nutrient energy restriction 
BCS (Body Condition Score) is judged on an arbitrary scale between 1- emaciated and 5-severely 
overweight. Errors shown are ±1 SEM. Treatment groups are CE (Control Energy), LEE (Low Energy 
Early) and LEL (Low Energy Late).   
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3.4.1.3 Maternal & Fetal Cortisol 
At day 65 there was no significant effect of maternal nutrient restriction on fetal or 
maternal plasma cortisol levels (fetal control 51.08 vs. low energy 59.45 ng.ml
-1
, SED 
6.426; maternal control 53.19 vs. low energy 80.88 SED 34.61).  
3.4.1.4 Fetal Organ Weights 
A significant effect of gender (male 108.8 vs. female 98.3g, SED 5.1; P=0.030) was 
observed on fetal weight at day 65 gestation. No effect of treatment (CE 100.7 vs. 
LEE 106.4g. SED 4.5) or fetal number (singleton 103.4 vs. twin 103.7g. SED 5.6) was 
observed. No effects (treatment, gender, fetal number) were observed on heart 
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(grand mean 965.1mg, SE 49.3), kidney (grand mean 1292mg, SE 62.3), lungs (grand 
mean 5160mg, SE 252.5) or liver weight (grand mean 7274mg, SE 253.5), but a 
significant treatment effect was shown on brain weight (CE 3.458 vs. LEE 3.747g. 
SED 0.13; P=0.038.). No effects of maternal energy restriction, gender or fetal 
number were observed once data were expressed relative to fetal weight, 
indicating proportionate (allometric) changes to fetal and/or organ growth.  
3.4.2 BIRTH WEIGHT AND POSTNATAL GROWTH 
3.4.2.1 Birth Weight 
Maternal nutrient restriction had a significant effect on birth weight (P<0.001), with 
LEE offspring being significantly heavier than control (CE 4.44; LEE 4.75; LEL 4.49 kg. 
SED 0.07), while female but not male LEL offspring were also heavier than controls. 
As expected, singletons were born heavier than twins (4.99kg vs. 4.13kg. SED 0.06), 
while no effect of gender was shown on birth weight. A treatment*gender*fetal 
number interaction was observed (P=0.023, Figure 3.3), with male LEE and female 
LEL singletons being significantly heavier than control. The derivative interactions 
were also found to be significant (P<0.01).  
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Figure 3.3 Offspring birth weights following maternal nutrient energy restriction 
Predicted means are shown with the average SED for the treatment*gender*fetal number 
interaction (P=0.023). Treatment*fetal number (P<0.001), treatment*gender (P<0.001), fetal 
number*gender (P=0.010) interactions were also observed. Treatment groups are CE (Control 
Energy), LEE (Low Energy Early) and LEL (Low Energy Late). 
 
3.4.2.2 Weaning Weight 
At weaning, aged 3 months, the treatment*gender*fetal number interaction, and 
all derivative interactions, were still significant (all P<0.01. Figure 3.4). The strongest 
effects on weaning weight were fetal number (P<0.001, F stat 201.5), with twins 
generally being lighter than singletons (except CE females), and gender (P<0.001, F 
stat 53.43), where males were heavier than females, with the reverse being shown 
in control singletons.  
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Figure 3.4 Weaning weight for offspring following maternal nutrient energy restriction 
Data shown are predicted means ±1 average SED for the treatment*gender*fetal number 
interaction. Treatment groups are CE (Control Energy), LEE (Low Energy Early) and LEL (Low 
Energy Late).  
 
 
3.4.2.3 Lamb Insulin 
Lamb plasma insulin levels were recorded at regular intervals from birth to 6 
months of age. Lamb plasma insulin was significantly affected by time (P<0.001), 
with insulin levels declining after birth but then starting to rise again after 3 months 
of age. Values were not influenced by prenatal treatment or gender, but fetal 
number did have a significant effect (P=0.042), and a trend was observed with time 
(time*fetal number, P=0.059), with twin insulin at birth being lower than that of 
singletons, but values aligned by 3 months of age (Figure 3.5).  
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Figure 3.5 Lamb insulin from birth to 5.5 months. 
Values shown are back-transformed predicted means, following log transformation, using a 
generalized linear mixed model with standard errors (±1 SEM).    
 
3.4.3 RESPONSE TO A GLUCOSE TOLERANCE TEST (GTT) AGED 7MONTHS 
Following the administration of an intra-jugular glucose bolus, the plasma insulin 
level significantly elevated (P<0.001). A treatment*gender*time interaction was 
also observed (P<0.001) as shown in Figure 3.6, with female LEE having a 
significantly greater response to the glucose challenge than control females. Male 
LEL animals were also observed to have a higher insulin response to a glucose bolus 
in comparison to all offspring. A sex*time interaction was also seen (P=0.040) with 
male offspring having a greater peak insulin response compared to females.  
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Figure 3.6 The effect of a glucose bolus on plasma insulin levels in offspring aged 7 months 
from nutrient restricted mothers.  
Values are back-transformed predicted means following generalized linear mixed model analysis, 
errors are ±1 standard error. Treatment groups are CE (control), LEE (Low Energy Early) and LEL 
(Low Energy Late). Time (P<0.001) and treatment*time*gender (P<0.001) were seen to have a 
significant effect.  
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3.4.4 RESPONSE TO AN INSULIN TOLERANCE TEST (ITT) AGED 7 MONTHS 
Aged 7 months, glucose rapidly declined in response to an ITT with no significant 
effect of prenatal treatment on glucose KITT (CE, 3.00±0.33; LEE, 2.83±0.37; LEL, 
2.57±0.27 %/min) or AUC (CE, -6.10±0.60; LEE, -4.46±0.55; LEL, -4.44±0.49 mmoles 
decrease in 2h (Figure 3.7)). NEFA and glycerol exhibited a similar profile in 
response to the insulin infusion, with an immediate decline but shortly after a rapid 
increase in plasma appearance, peaking approximately one hour post infusion. The 
triglyceride response to the ITT showed no consistent pattern (Figure 3.7).   
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Figure 3.7 Plasma metabolite response to an I.V. insulin bolus in offspring aged 7 months old.  
Data shown are means ±1 SEM. Groups are CE (Control), LEE (Low Energy Early) and LEL (Low 
Energy Late). 
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3.4.5 ORGAN WEIGHTS 
Aged 1.5yrs, body weight was significantly affected by gender (P=0.002), with males 
being heavier than females (male 56.64 & female 50.64 kg. SED 1.674), although 
body condition score was not affected by gender. Body weight and body condition 
score were not affected by maternal treatment or fetal number. Grand means for 
post mortem tissues are shown in Table 3.1. Liver weight was significantly affected 
by maternal treatment (CE 907.2; LEE 833.1 & LEL 780.8 g. SED 47.04. P=0.040), 
while a trend was observed regarding the effect of maternal treatment on average 
ovary weight (CE 676.8; LEE 485.3 & LEL 511.4 mg. SED 93.75; P=0.058.), in both 
cases treatment groups had less ovarian mass than control animals. Both of these 
effects became stronger when organ weights were expressed relative to body 
weight (ovary, P=0.016, CE 13.25; LEE 9.64 & LEL 10.18g g/kg, SED 1.368) and (liver, 
P=0.017, CE 17.95; LEE 15.49 & LEL 14.64 g/kg. SED 0.7988). When organ weights 
were expressed relative to body weight, a gender effect was also observed on 
kidney (male 1.25 & female 1.42 g/kg. SED 0.08; P=0.033,) and average adrenal 
mass (male 34.97 & female 54.74 mg/kg. SED 8.843).  
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Absolute weight 
Relative weight 
(g/kg) 
Body weight (kg) 53.64±0.837 
 
Liver (g.kg) 840.4±19.2* 15.7±0.33* 
Heart (g.kg) 259.2±6.7 4.84±0.12 
Average Adrenal (mg.kg) 2.39±0.24 
 ?
44.86±4.421
#
 
Kidney (g.kg) 71.3±2.2 1.33±0.04
#
 
Spleen (g.kg) 270.7±17.54 5.08±0.32 
Average Ovary (mg.kg) 557.8±38.3 
 ?
11.02±0.56* 
Table 3.1 Post mortem grand means for low energy study animals aged 1.5yr. 
Values shown are grand predicted means. Relative weight is organ weight (g)/body weight (kg). 
 輀AĚƌĞŶĂů ĂŶĚ ĂǀĞƌĂŐĞ ŽǀĂƌǇ ƌĞůĂƚŝǀĞ ǁĞŝŐŚƚs are expressed as mg/kg. *Maternal treatment or 
#
Gender had a significant effect (P<0.005). 
 
 
 
3.5 Discussion 
In this study few effects of a modest, maternal energy restriction were observed in 
the young, lean offspring. Although the dietary restriction was lower compared to 
several other studies (0.65 maintenance vs. 0.50 maintenance; as used by (Gardner 
et al., 2005; Cleal et al., 2007b; Daniel et al., 2007; Ford et al., 2007), both the early 
and late nutrient restriction elicited a significant reduction in maternal body weight 
and/or maternal BCS.  
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No significant difference was observed as a result of the nutritional challenge on 
maternal or fetal cortisol levels, in contrast to previous studies reporting either an 
increase (Bloomfield et al., 2003a; Bloomfield et al., 2003b) or decrease (Bispham et 
al., 2003). However, spot samples of plasma cortisol are probably not reflective of 
overall HPA axis functionality across the maternal-placental-fetal compartments. 
For a better understanding of the effect of maternal cortisol levels on fetal tissues 
using this malnourishment model, more invasive research needs to be conducted 
measuring transplacental flux of cortisol across the placenta together with analyses 
of placental  ? ?ɴ,^ ?activity and expression; furthermore, the sensitivity of fetal 
tissues to cortisol (through GR expression analyses) would be required as well, 
outcomes beyond the remit of our study. Thus, whilst the current study illustrates a 
lack of effect of maternal nutrition on maternal and fetal plasma cortisol levels it is 
inconclusive with regard to the potential programming role of cortisol in this 
experimental paradigm. 
 
When tissues were collected on day 65 of gestation, no effect of treatment or fetal 
number was observed on any organ weight measured once tissue weights were 
expressed as a proportion of total fetal weight. Fetal weight was however 
significantly affected by gender, with males being found to be heavier than females. 
This is interesting and argues for a fundamental difference between the early 
development of males and females regardless of secondary sex hormone 
production and exposure. The lack of effect of maternal nutrient restriction on fetal 
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weight is unsurprising given the weight of the fetus at this time vs. weight of the 
dam (100g vs. ~70kg). 
 
These observations regarding total fetal weight were not maintained through to 
birth. No effect of gender was observed on birthweight, while singletons were 
found to be significantly heavier than twins, suggesting that the birth weight of a 
twin may be limited during late pregnancy. This observation is in line with the 
evidence base, which states that fetal growth is slow during the early stages of 
gestation, and then rapidly increases half way through gestation, with fetal growth 
being exponential in the later stages of pregnancy (Gootwine et al., 2007). With this 
in mind, a logical hypothesis would be that maternal global energy restriction during 
early pregnancy would have no effect on birthweight, while the same nutritional 
challenge in later pregnancy would decrease birthweight compared to control. Data 
from this study suggests that compensatory mechanisms must exist to counteract 
the maternal nutrient restriction, as both early (males and females) and late 
(females only) nutrient restricted ewes gave birth to offspring with significantly 
increased birthweight. When contrasted to other similar ovine studies where a 50% 
global energy restriction was performed during early pregnancy, no significant 
effect of birthweight was generally observed (Gilbert et al., 2005; Cleal et al., 2007b; 
Daniel et al., 2007; Ford et al., 2007; Poore et al., 2007) with Gardner et al., (2005) 
showing a significant decrease in birthweight. One possible compensatory 
mechanism is placental hypertrophy. Although placental weight was not measured 
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in this study (as lambs went to term), it has been observed that nutrient restriction 
during early to mid gestation causes placental growth restriction and thus restricts 
fetal nutrient supply. When the nutrient restriction is alleviated, compensatory 
placental hypertrophy occurs, increasing fetal nutrient supply beyond control. The 
consequence of this is even greater fetal growth in late gestation, resulting in 
increased birth weight compared to control (Kelly, 1992). Regarding the importance 
of altered birth weight in fetal programming models, Harding ?Ɛ (2001) review of the 
literature lead her to conclude that an over-importance has been given to 
modifications in birthweight as a prerequisite for fetal programming. She suggests 
that perturbations in fetal growth trajectories (the process) are far more relevant to 
postnatal health than birthweight (the endpoint) following in utero growth 
retardation via maternal nutrient restriction. This suggests that in utero catch up 
growth causing IUGR fetuses to reflect or overtake control birth weights, could be 
as dangerous in post natal life as being born under weight.  
 
Maternal treatment had no effect on plasma insulin levels at birth or throughout 
weaning. Plasma insulin was observed to be significantly lower in twins compared 
to singletons, which fits with the observation that twins were lighter than 
singletons, as fetal insulin is an important in utero growth (anabolic) hormone in the 
later stages of gestation (Fowden et al., 1989). Research suggests that when a fetus 
is exposed to hypoinsulinaemic conditions during late pregnancy (by fetal 
pancreatectomy), it is growth that is restricted, while tissue development and 
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differentiation remains normal (Fowden et al., 1998). Hence, once the twins in this 
study become euinsulinaemic, due to elevated glucose or amino acid supply, then 
their growth rate should start to recover in line with singleton offspring.  
LEE female offspring were observed to have a significantly higher insulin response 
to a glucose bolus than other female offspring, while male LEL offspring had the 
greatest insulin response out of all the offspring. While the GTT elicited these 
treatment effects, there was no observed treatment effect during the ITT. As 
glucose uptake during a GTT is both glucose stimulated (liver & pancreas) and 
insulin stimulated (skeletal muscle & adipose tissue), while during an ITT, glucose 
uptake is purely insulin stimulated in peripheral tissues, the data would suggest that 
the observed differences in glucose handling by LEL males and LEE females is 
probably due to central (hepatic) differences although it is not possible to clarify 
this hypothesis in the current program of work.  
 
At weaning and at 1.5 yrs, males were significantly heavier than females, as 
expected (despite being gonadectomised). Females that were exposed to nutrient 
restriction prenatally had significantly lighter ovaries than control females. Although 
ovarian tissue has not been investigated, it is possible that the smaller ovaries 
would reflect a reduced reproductive function and link the prenatal environment to 
postnatal fertility, as reviewed by Gardner et al., (2008). Interestingly, livers of 
offspring (mainly LEL) from nutrient restricted ewes were lighter at post mortem 
aged 1.5 yrs when compared to control animals. This finding helps to support the 
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postulation above that the differences in glucose homeostasis observed in offspring 
are perhaps due to prenatally-induced modifications in hepatic functionality. In 
ŵĂŶǇ ƌĞƐƉĞĐƚƐ ? ƚŚĞƐĞ ŚǇƉŽƚŚĞƐŝƐĞĚ ĚŝĨĨĞƌĞŶĐĞƐ ƐŚŽƵůĚ ďĞ  ‘ƌĞǀĞĂůĞĚ ? Žƌ ďĞĐŽŵĞ
more obvious when challenged with obesity and therefore in the following chapter, 
ƚŚĞŽĨĨƐƉƌŝŶŐĨƌŽŵ ? ? ?ƚŽ ?ǇĞĂƌƐŽĨĂŐĞǁĞƌĞƌĞĂƌĞĚŝŶĂŶ ‘ŽďĞƐŽŐĞŶŝĐ ?ĞŶǀŝƌŽŶŵĞŶƚ
to test this hypothesis.   
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4. Low Energy Study  W 1.5 to 2 years of age 
4.1 SUMMARY 
Offspring from global nutrient restricted ewes as described in Chapter 3 were 
further analysĞĚ ĂŐĞĚ  ? ? ? ǇƌƐ  ? “ůĞĂŶ ? ? ĂŶĚ ƌĞĂƐƐĞƐƐĞĚ Ăƚ  ? ǇƌƐ ŽůĚ  ? “ďĞƐĞ ? ?
following a 6 month exposure to an obesogenic environment. This comprised access 
to 150% maintenance feed requirements, on a diet containing twice the lipid 
content of standard feed (6%) with reduced physical activity (barn housing). Animals 
gained approximately 50% of their starting weight (~50kg to 75kg). Lean mass 
significantly decreased, while percentage fat mass doubled (~15 to 30%). No major 
effects of time*treatment interactions were observed on body composition, daily 
food intake, appetite or response to an insulin tolerance test. Weight gain caused 
baseline glucose, total amino acid, urea, glycerol, non-esterified fatty acid (NEFA) 
and low density lipoprotein concentration to decrease, while triglyceride (TAG), 
leptin, total cholesterol, high density lipoprotein all increased. Following a glucose 
tolerance test plasma glucose and insulin increased compared to basal levels, while 
NEFA, glycerol and TAG decreased. The peak insulin response and area under the 
curve were significantly greater in obese male LEL offspring, compared to obese 
control offspring (time*treatment*gender interaction, P<0.05).  The onset of 
obesity blunted the metabolic response to a glucose bolus in most of the blood 
biochemical factors measured. There were no interesting differences in organ 
weights at post mortem.  
Chapter 4 86 
Low Energy Study ± 1.5 to 2 years of age 
4.2 Introduction 
It is estimated that, at present, every 3-4 out of 10 adults worldwide are obese, 
ĚĞĨŝŶĞĚ ĂƐ Ă ďŽĚǇ ŵĂƐƐ ŝŶĚĞǆ ŽĨ A? ? ? ŬŐ ?ŵ2 (International Obesity Taskforce; 
http://www.iotf.org/database/index.asp) which represents a huge economic 
burden (Allender & Rayner, 2007). The early (fetal and neonatal) developmental 
environment has been proposed as a key sensitive period for increasing 
susceptibility to adult-onset obesity (Dietz, 1994). Programming of body 
composition and non-communicable disease (for which obesity is a significant risk 
factor) has been identified by the Grand Challenges Global Partnership as a research 
priority in order to mitigate the rising rise of diabetes and cardiovascular disease 
(Daar et al., 2007). 
 
To date, several laboratory animal concept studies have shown proof-of-principle 
ǁŝƚŚ ƌĞŐĂƌĚ ƚŽ ƚŚĞ ĚĞǀĞůŽƉŵĞŶƚĂů  ‘ƉƌŽŐƌĂŵŵŝŶŐ ? ŽĨ ĂĚƵůƚ ŚĞĂůƚŚ ? ĨŽƌ ƌĞǀŝĞǁ ƐĞĞ 
(Armitage et al., 2004; McMillen & Robinson, 2005). Most of these studies have 
used the laboratory rodent in which marked reductions or increases in 
macronutrient provision during gestation may or may not reduce birth weight, and 
when coupled with marked hypercaloric nutrition postnatally e.g. of fat or simple 
ƐƵŐĂƌƐ ? ƚŚĞŶ Ă  ‘ƉƌŽŐƌĂŵŵĞĚ ? ĚŝƐĂĚǀĂŶƚĂŐĞŽƵƐ ƉŚĞŶŽƚǇƉĞ ĞŵĞƌŐ Ɛ (Khan et al., 
2004; Ozanne & Hales, 2004). It is important, however, when extrapolating such 
interesting results to the human that the marked differences in energy partitioning, 
allometry, metabolic rate and life history traits between laboratory and larger 
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animals are taken into account (Gillooly et al., 2001; Demetrius, 2004; Phelan & 
Rose, 2005). Therefore, to conduct similar nutritional and metabolic studies in 
larger animal models is imperative and to date the sheep and pig has been widely 
used.  
 
In pigs, it has been shown that reduced birth weight enhances fat deposition which 
impacts upon glucose tolerance in these animals (Poore & Fowden, 2002). In the 
sheep, historically used as the animal model of choice for fetal developmental 
physiological studies because of the similarities in fetal physiology, endocrinological 
maturity and weight at birth to the human fetus (McMillen & Robinson, 2005), 
prenatal undernutrition has been shown to have a number of physiological 
consequences on the adult offspring dependent upon the stage of gestation the 
nutritional insult occurs (Daniel et al., 2007; Gardner et al., 2007). However, in these 
large animal studies the experimental endpoint has invariably been to characterise 
a given phenotypic consequence, and have been conducted when the animals have 
been raised in an environment appropriate for that species (e.g. for sheep, on 
pasture for 1-3 years; (Gopalakrishnan et al., 2004; Gardner et al., 2005)). Thus, 
invariably, at the time of study these animals are relatively lean and are physically 
active on a daily basis making the results of limited applicability to the current 
ŚƵŵĂŶĐŽŶĚŝƚŝŽŶŝŶƚŚĞtĞƐƚĞƌŶtŽƌůĚ ?/ŶĂĚĚŝƚŝŽŶ ?ŐŝǀĞŶƚŚĞŝŶĐƌĞĂƐĞĚ ‘ŵĞƚĂďŽůŝĐ
ƌĞƐĞƌǀĞ ? ŽĨ ůĂƌŐĞƌ ĂŶŝŵĂůƐ ŝ ?Ğ ? ƚŚĞŝƌ ŐƌĞĂƚĞƌ ĂďŝůŝƚǇƚŽ ĂĐĐŽŵŵŽĚĂƚĞ ƉĞƌŝŽĚƐ ŽĨ
undernutrition and their relatively slower metabolism, compared with laboratory 
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rodents (Gillooly et al., 2001), it is all the more remarkable that developmental 
programming has been shown at all in larger animals. Clearly, therefore, early 
ĞŶǀŝƌŽŶŵĞŶƚĂů  ‘ŵĞƚĂďŽůŝĐ ŝŵƉƌŝŶƚŝŶŐ ? ŽĨ Ă ƚŚƌŝĨƚǇ ƉŚĞŶŽƚǇƉĞ ? ŝ ?Ğ ? ĂĨƚĞƌ ŵĂƚĞƌŶĂů
undernutrition (Hales & Barker, 2001) has the potential to have an enormous 
impact in the context of the nutrition transition in the Western world (Popkin, 
2006). In an experimental context, it is important to challenge the nutrition-
transition paradigm i.e. the interaction between the pre- and postnatal nutritional 
environments, as has been done often in laboratory studies (Khan et al., 2004; 
Ozanne & Hales, 2004), but much less so in larger animal work.  
 
Consequently, we have previously developed a model of juvenile-onset obesity 
after prenatal undernutrition in sheep to test the predicted low-high/thin-fat 
deleterious phenotype. We find, as expected, that juvenile-onset obesity per se is 
metabolically disadvantageous but the pre-postnatal nutritional interactions are not 
always so clear cut or indeed evident (Williams et al., 2007; Sebert et al., 2009; 
Sharkey et al., 2009). To the best of our knowledge, no study to date in larger 
animal models has directly tested an interaction between prenatal undernutrition 
followed by a regime of postnatal nutritional excess adopted as an adult. Adult 
obesity is known to influence the function of multiple organs, encapsulated in the 
ƚĞƌŵ ‘ŵĞƚĂďŽůŝĐŝŶĨůĞǆŝďŝůŝƚǇ ? (Storlien et al., 2004) in which animals have a reduced 
ability to switch substrate-level oxidation between carbohydrate and lipid sources 
(Koves et al., 2008). Epidemiological evidence from the Dutch Hunger Winter 
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Famine suggests that specific periods of gestation may impact upon different organ 
systems in adult life to induce a metabolic phenotype that leads to obesity (Painter 
et al., 2005). Thus, in this study, we aim to test the hypotheses that prenatal global 
nutrient restriction in sheep will interact with postnatal obesity to influence 
metabolic flexibility in the adult offspring and the response will be dependent on 
the gestational stage at which the nutritional insult occurred. Metabolic flexibility 
will be assessed in the lean and obese state (body composition determined by dual-
energy X-ray absorptiometry) by measurement of carbohydrate, fat and the protein 
metabolite response to a glucose tolerance test. 
4.3 Materials and Methods 
In brief, offspring were transported from the Macaulay Institute and acclimatised at 
Sutton Bonington Campus. Following acclimatisation a further glucose tolerance 
ƚĞƐƚ ?'dd ?ǁĂƐĐŽŶĚƵĐƚĞĚŽŶĂůůƐŚĞĞƉ ?ƚŚŝƐǁŝůůďĞƌĞĨĞƌƌĞĚƚŽĂƐƚŚĞ “ůĞĂŶ'dd ? ?ƐĞĞ
2.4.2.2) and, shortly after, the sheep underwent body composition analysis by dual 
energy x-ray analysis (DEXA- see 2.4.2.3 ? ? ƌĞĨĞƌƌĞĚ ƚŽ ĂƐ  “ůĞĂŶ y ? ? &ŽůůŽǁing 
these initial investigations, when lean, the animals were exposed to an obesogenic 
environment (see 0); ǁŝƚŚƚŚĞŝŶƚĞŶƚŝŽŶŽĨŝŶĐƌĞĂƐŝŶŐƚŚĞĂŶŝŵĂůƐ ?ĨĂƚĚĞƉŽƐŝƚŝŽŶ ?ůů
animals were encouraged over a period of 6 months to put on 50% of their original 
ǁĞŝŐŚƚƉƌŝŽƌ ƚŽ ƚŚĞŝƌ ůĞĂŶ'dd ?ƚ ƚŚŝƐƉŽŝŶƚ ƚŚĞ'ddǁĂƐ ƌĞƉĞĂƚĞĚ  ? “ŽďĞƐĞ 'dd ? ?
ĂŶĚ y  ? “ŽďĞƐĞ y ? ? ? ŝŶĚŝǀŝĚƵĂů ĂƉƉĞƚŝƚĞ ǁĂƐ ƌĞĐŽƌĚĞĚ  ?ƐĞĞ2.4.2.5) and a 
further insulin tolerance test conducted (ITT- see 2.4.2.6) followed by an insulin 
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Experimental Group 
 
Statistics 
 Gender CE LEE LEL s.e.d T G T*G 
Fat (%) male 16.93 15.95 19.57     
  female 13.75 13.67 13.2 2.76 NS 0.02 NS 
Fat mass 
(kg) 
male 8.94 9.17 11.54     
female 5.97 6.65 6.18 1.69 NS 0.002 NS 
Lean 
mass (kg) 
male 44.31 48.11 47.18     
female 37.57 42.37 40.12 4.39 NS 0.02 NS 
BMD 
(g.kg
3
) 
male 1.1 1.12 1.11     
female 1.09 1.06 1.09 0.03 NS NS NS 
BMC (g) male 1368 1398 1436     
female 1121 1211 1193 118 NS 0.006 NS 
Table 4.1 Body composition of prenatally undernourished sheep when lean at 1.5 years of age. 
Data are predicted means with the average standard error of the difference (s.e.d with 14 degrees 
of freedom in all cases) for the comparison. CE, Controls (n=6); LEE, Low Energy Early (n=6), LEL, 
Low Energy Late (n=7). BMD- Bone Mineral Density. BMC- Bone Mineral Content. T, main effect of 
treatment; G, main effect of gender; T*G, interaction between treatment and gender. 
stimulated skeletal muscle biopsy (see 2.4.2.7). A week later all animals were 
euthanized (see 2.4.2.8). 
4.4 Results 
4.4.1 BODY COMPOSITION, WEIGHT GAIN & APPETITE 
4.4.1.1 DEXA body composition 
In  ‘lean ? animals aged 1.5yrs i.e. before exposure to the obesogenic environment, 
there were no effects of the prenatal environment on any aspect of body 
composition (Table 4.1). However, significant effects of gender were observed, 
males had higher % body fat (17.48 vs. 13.54%, s.e.d. 1.60) and greater absolute fat 
mass, (9.88 vs. 6.27 kg, s.e.d. 0.98), lean mass (46.53 vs. 40.02 kg s.e.d. 2.54) and 
bone mineral content (1400 vs. 1170 kg s.e.d. 60) than females (Table 4.1).  
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4.4.1.2 Weight gain 
During the 6 month exposure to the obesogenic environment, all animals put on 
significant mass (Figure 4.1). When considering the change in weight with time, all 
measured variables significantly increased (P<0.001 all cases) except lean body mass 
which significantly decreased. For most comparisons, there were no significant 
time*treatment or time*treatment*gender interactions for any aspect of the 
change in body composition after prolonged exposure to an obesogenic 
environment (i.e. Table 4.1 vs. Table 4.2). However, some effects were noted; there 
was a trend (P=0.08) for LEL to put on less fat mass (effect size, -1616g s.e.d. 1189) 
and the increase in BMD was greater in LEE females (effect size, 0.12 s.e.d. 0.03) vs. 
control groups.  
 
However, the previously observed gender effects remained; obese males had higher 
% body fat (32.67 vs. 30.27%, s.e.d. 1.85) and greater absolute fat mass, (21.38 vs. 
16.70 kg, s.e.d. 1.48), lean mass (44.06 vs. 38.32 kg s.e.d. 2.1.76) and bone mineral 
content (1746 vs. 1500 g s.e.d. 72) than females (Table 4.2).  
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Figure 4.1 tĞŝŐŚƚŐĂŝŶŝŶƐŚĞĞƉƌĞĂƌĞĚŝŶĂŶ ?ŽďĞƐŽŐĞŶŝĐ ?ĞŶǀŝƌŽŶŵĞŶƚ ? 
Data are Means±SEM. Sheep were group housed in a barn and fed at 1.5M for a period of 6-7 
months to achieve a specified weight gain (see 2.4.2.4). Baseline studies were conducted when 
ĂŶŝŵĂůƐǁĞƌĞĚĞƐŝŐŶĂƚĞĚĂƐ ‘ůĞĂŶ ?ĂŶĚǁĞƌĞƌĞƉĞĂƚĞĚǁŚĞŶ ‘ŽďĞƐĞ ? ?dŚĞƌĞǁĞƌĞŶŽĚŝĨĨĞƌĞŶĐĞƐŝŶ
weight gain between treatment groups.    
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  Experimental Group   Statistics 
 Gender CE LEE LEL s.e.d T G T*G 
Fat (%) male 31.73 32.02 34.27     
female 32.95 29.93 27.93 3.19 NS NS NS 
Fat mass 
(kg) 
male 21.16 20.82 22.15     
female 17.05 17.66 15.4 2.55 NS 0.01 NS 
Lean mass 
(kg) 
male 45.42 44.15 42.6     
female 34.77 41.11 39.05 3.04 NS 0.09 NS 
BMD 
(g.kg
3
) 
male 1.21 1.14 1.14     
female 1.15 1.16 1.13 0.03 0.09 NS NS 
BMC (g) male 1832 1710 1695     
female 1450 1599 1450 124 NS 0.01 NS 
Table 4.2 Body composition of prenatally undernourished sheep when obese at 2 years of 
age.   
Data are predicted means with the average standard error of the difference (s.e.d with 14 
degrees of freedom in all cases) for the comparison. CE, Controls (n=6); LEE, Low Energy Early 
(n=6), LEL, Low Energy Late (n=7). BMD- Bone Mineral Density. BMC- Bone Mineral Content. T, 
main effect of treatment; G, main effect of gender; T*G, interaction between treatment and 
gender.  
 
 
4.4.1.3 Appetite 
Individual food intake (over 24h) and appetite (over 2h) were assessed. There was 
no effect of treatment or gender on daily food intake (CE, 20.0; LEE, 21.3; LEL, 19.2 
MJ/day s.e.d. 1.80) or appetite (i.e. 2h intake for CE, 13.6; LEE, 13.3; LEL, 13.8 
MJ/day s.e.d. 1.73). 
4.4.2 GTT & ITT BLOOD ANALYSIS 
4.4.2.1 Insulin 
4.4.2.1.1 Baseline 
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Fasted plasma insulin concentrations were not different between dietary groups 
(CE, 0.29; LEE, 0.37; LEL, 0.35 ng.ml
-1
 s.e.d. 0.09) or gender (male, 0.30 vs. 0.38 
ng.ml
-1
 s.e.d. 0.07). Fasted plasma insulin when obese remained at a similar level as 
when lean (CE, 0.38; LEE, 0.42; LEL, 0.43 mmol.L
-1
 s.e.d. 0.09) and was similar 
between sexes (male, 0.35 vs. female, 0.47 mmol.L
-1
 s.e.d. 0.07).  
4.4.2.1.2 Response to a Glucose Bolus (GTT) 
As expected, following the intra-jugular glucose injection, the plasma insulin level 
rose significantly, peaking around 20 minutes after the bolus was administered. In 
lean animals there were no effects of treatment, gender or treatment*gender 
interactions on insulin sensitivity (area under the insulin response curve - see Figure 
4.2). In obese animals the insulin AUC was significantly greater than in lean animals 
(P<0.001. lean 137.3; obese 318.8. SED 21.61). A time*treatment*gender 
interaction (P=0.04) was observed for the insulin AUC (Figure 4.2. CP lean 151.3 vs. 
obese 231.3, LPE lean 129.3 vs. obese 423.3, LPL lean 131.3 vs. obese 302.0. SED 
58.36); as well as the peak plasma insulin response being significantly greater in 
male LEL relative to both CE and LEE males (Figure 4.3).  These interactions show 
that obese male LEL offspring had a greater insulin response (AUC and peak insulin) 
in relation to lean values from the same animal or values from other male offspring 
in the study.  
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Figure 4.2 The response of prenatally energy restricted adult sheep to a glucose tolerance test 
when lean and obese.  
Data are Mean ± SEM. Glucose was administered I.V. (0.5g.kg-1) and blood samples collected for 
measurement of plasma glucose and insulin (by ELISA, see 2.5.1.4). CE, Controls (n=6); LEE, Low 
Energy Early (n=7), LEL, Low Energy Late (n=7). Statistics are *, P<0.05 LEL vs. CE and LEE for peak 
insulin concentration. 
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Figure 4.3 Peak plasma insulin in lean and obese male and female prenatally nutrient restricted 
adult sheep during a glucose tolerance test.  
Data are predicted means and SEM. CE, Controls (n=6); LEE, Low Energy Early (n=7), LEL, Low 
Energy Late (n=7). Data were analysed by repeated measures general linear model revealing a 
significant effect of time (*; P<0.001 all cases) or a significant interaction (P<0.05) between 
ƚŝŵĞ 踁騁?ĞĂƚŵĞŶƚ 踁?ĞŶĚĞƌ ? 較? ?
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4.4.2.2 Glucose 
4.4.2.2.1 Baseline 
When lean, fasted plasma glucose concentrations were similar between dietary 
groups (CE, 3.65; LEE, 3.95; LEL, 3.70 mmol.L
-1
 s.e.d. 0.49) and gender (male, 3.91 vs. 
female, 3.61 mmol.L
-1
 s.e.d. 0.40). On becoming overweight, fasted plasma glucose 
concentrations significantly reduced (P<0.01) relative to when lean but remained 
similar between dietary groups (CE, 3.28; LEE, 3.29; LEL, 3.08 mmol.L
-1
 s.e.d. 0.17) 
and gender (male, 3.12 vs. female, 3.31 mmol.L
-1
 s.e.d. 0.14).  
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4.4.2.2.2 Response to a Glucose Bolus (GTT) 
Following the administration of the glucose bolus intravenously, the plasma glucose 
level rose significantly in both lean and obese animals, peaking around 10 minutes 
post injection. In lean and obese animals, there were no treatment, gender or 
treatment*gender interactions on glucose tolerance (area under the glucose 
response curve). There was however a significant increase in the glucose AUC in the 
obese state compared to lean (Figure 4.2. P<0.001. lean 742.2 vs. obese 1105.0. SED 
47.41).  
4.4.2.2.3 Response to an Insulin Bolus (ITT) 
Following the I.V. insulin injection, the plasma glucose level rose slightly but then 
decreased as expected (Figure 4.4). The rate glucose was removed from the blood 
following the insulin bolus (Kitt) was not affected by prenatal treatment, however it 
was significantly affected by sex (male 2.47±0.24 female 3.30±0.28 mmol.L
-1
; 
P=0.041,), reflected in the glucose AUC (male 4.483±0.581 female 6.556±0.662 
mmol.L
-1
; P=0.034,).  
4.4.2.3 Insulin:Glucose Ratio 
A insulin:glucose ratio was calculated by dividing the Insulin AUC in response to a 
GTT by the Glucose AUC in lean offspring and comparing it to the equivalent ratio 
for obese offspring. The intention of this was to evaluate the confounding effect of 
administering differing glucose qualities in lean vs. obese offspring. A significant 
effect of time (P<0.001. lean 0.1702; obese 0.3129; SED 0.0332) was observed, with 
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Figure 4.4 The glucose, NEFA and triglyceride response of prenatally nutrient restricted adult 
sheep to an insulin tolerance test when obese. 
Data are Mean±SEM. Insulin (0.75IU.kg
-1
) was injected I.V. at time zero. Statistics are *, P<0.05, 
relative to baseline. 
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obese offspring being observed to have a greater insulin response to the glucose 
load following the development of obesity. No treatment or sex effects were 
observed.  
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4.4.2.4 Lipid Metabolism 
In lean and obese animals in this study, very few treatment, gender or 
treatment*gender effects were shown on the various components of lipid 
metabolism that were assessed, except lean baseline glycerol was reduced in LEL vs. 
control and obese baseline cholesterol was less in LEE vs. control (Table 4.3). The 
development of obesity significantly elevated baseline plasma triglyceride, total 
cholesterol, HDL, and leptin levels, as well as significantly reducing glycerol and 
NEFA levels, but LDL levels were unaffected (Table 4.3). A treatment*time 
interaction was observed for baseline glycerol, (LEL baseline decreased less than 
control with the onset of obesity).  
 
 
Figure 4.5 Graph showing the effect of sex on glucose clearance following an ITT aged 2yrs. 
Graph showing the predicted means and 1±SEM for the sex effect on glucose clearance following 
an insulin bolus (ITT). Males had a significantly greater glucose clearance than females, both in 
respect to the KITT (P=0.041) and glucose AUC (P=0.034). 
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  Experimental Group  Statistics 
 
Triglyceride  
(mmol.L
-1
) 
Time CE LEE LEL s.e.d T Ti T*Ti 
lean 0.16 0.15 0.14  
0.02 
 
NS 
 
<0.001 
 
NS obese 0.22 0.23 0.22 
Glycerol  
(µmol.L
-1
) 
lean 110 88 69  
10 
 
0.04 
 
0.006 
 
0.03 obese 70 66 71 
NEFA  
(mmol.L
-1
) 
lean 0.99 0.88 0.84  
0.11 
 
NS 
 
<0.001 
 
NS obese 0.73 0.65 0.65 
Total cholesterol 
(mmol.L
-1
) 
lean 1.44 1.33 1.42  
0.21 
 
0.04 
 
<0.001 
 
0.08 obese 2.52 1.75 2.31 
HDL  
(mmol.L
-1
) 
lean 0.66 0.63 0.66  
0.14 
 
0.08 
 
<0.001 
 
0.09 obese 1.43 0.99 1.36 
LDL  
(mmol.L
-1
) 
lean 0.25 0.23 0.23  
0.04 
 
NS 
 
NS 
 
NS obese 0.31 0.21 0.25 
Leptin  
(ng.ml
-1
) 
lean 4.10 3.90 4.13  
2.08 
 
NS 
 
<0.001 
 
NS obese 12.63 10.99 10.36 
Table 4.3 The effect of adult-onset obesity on lipid metabolites in sheep.  
Data are predicted means with the average standard error of the difference (s.e.d with 14 degrees 
of freedom in all cases) for the comparison. CE, Controls (n=6); LEE, Low Energy Early (n=6), LEL, 
Low Energy Late (n=7). NEFA, non-esterified fatty acids, HDL  W High density lipoprotein. LDL  W Low 
density lipoprotein. T, main effect of treatment; Ti, main effect of time (i.e. becoming obese); T*Ti, 
interaction between treatment and time.   
 
 
Following an injection of glucose plasma NEFA, TAG and glycerol concentrations 
declined (P<0.01) in both lean and obese animals. The area under the curve (AUC) 
for this response, was not affected by treatment, but the plasma NEFA AUC was 
significantly lower in the obese relative to lean state in both males and females but,  
for triglyceride, the AUC was significantly greater in obese females relative to all 
other groups (Figure 4.6).  
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Figure 4.6 The lipid metabolite response to a glucose tolerance test in male and female lean and 
obese sheep.  
Data are Mean±SEM for areas under the glucose response curve (respective AUC units). 
Statistics are *, P<0.05, lean vs. obese or 
 ?
, for a time*gender interaction.  
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During the ITT, under hyperinsulinemic, euglycaemic conditions plasma NEFA 
increased immediately and was sustained (P< 0.05), whereas plasma TAG only 
increased transiently (Figure 4.4). Plasma glycerol, measured at three time points 
during the ITT (0, 8 and 16mins), matched the NEFA profile i.e. a sustained increase 
was observed. There were no significant treatment, gender or treatment*gender 
interactions observed for the TAG, NEFA or glycerol response to the ITT.  
4.4.2.5 Protein Metabolism 
As an index of lean mass metabolism, the fasted plasma concentrations of amino 
acids and urea in the lean and obese state were measured. In general, plasma 
amino acid concentrations and urea were significantly lower in the obese relative to 
the lean state, (8191 vs. 5289 (s.e.d. 639) nmoles.ml
-1
; urea 8.59 vs. 5.70 (s.e.d. 
0.42) mmol.L
-1
), with no effect of prenatal diet or gender or any interactions on this 
response. Given the multiple levels of interaction between individual amino acids a 
multivariate analysis tool was employed, principal components analysis, to identify 
any components that may explain the majority of the variation in amino acids with 
obesity. Three principal components were identified that accounted for >95% of the 
variation in amino acid concentrations between groups from the lean to obese 
phenotype; PC1 accounted for 85.6% of the variation, PC2, 8.1% and PC3, 2.4%. For 
PC1, the greatest latent vector loadings (i.e. indicating those amino acids 
contributing most to the variation) were the reductions in the plasma concentration 
of glycine (0.9660), alanine (0.1437), valine (0.0887) and glutamic acid (0.0687) and 
the increases in the plasma concentration of serine (-0.1518). The respective 
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Figure 4.7 Amino acids contributing most to the variation in concentration with adult-onset 
obesity. 
Data are Mean±SEM for amino acid concentrations. Statistics are *, P<0.01, lean vs. obese. 
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changes in the absolute plasma concentration for these amino acids are given in 
Figure 4.7. Using the principal component scores for PC1, as independent variates in 
a general linear regression model indicated that the amino acid variation reflected 
by PC1 was significantly associated with the decline in plasma [urea] concentration. 
There was no effect of prenatal treatment or gender on these effects.  
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 Baseline concentration Statistics 
 Lean  Obese s.e.d P 
pH 7.38 7.43 0.01 0.07 
PvCO2 (mmHg) 47.22 41.71 1.93 0.01 
HCO-3 (mmol.L
-1) 25.38 26.37 0.81 ns 
PvO2 (mmHg) 35.31 51.94 4.95 0.01 
ABE (mEq.L-1) 2.47 3.06 0.78 ns 
Na+ (mmol.L-1) 143 140 0.41 0.001 
K+ (mmol.L-1) 4.26 4.03 0.07 0.01 
Ca2+ (mmol.L-1) 1.16 1.21 0.01 0.008 
Cl- (mmol.L-1) 104 104 0.9 ns 
Table 4.4 Baseline blood biochemistry in lean and obese adult sheep. 
The change in resting blood biochemistry from a lean to obese state as measured on an ABL-
800Flex (Radiometer Ltd, UK). Data are Grand Means with standard error of the difference and 
the df for the comparison of 14. P, for effect of time (i.e. onset of obesity). ns, not significant. 
 
4.4.2.6 Electrolytes and Haemodynamics 
4.4.2.6.1 Baseline 
Fasted blood biochemistry when lean and obese are given in Table 4.4. With 
obesity, animals became more alkalotic as reflected in increases in blood pH, pvO2 
and acid-base excess and a decrease in PvCO2. In addition, blood electrolytes also 
changed significantly; Ca
2+ 
increased, whilst Na
+
 and K
+
 declined (Table 4.4). No 
time* treatment effects were observed.  
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4.4.2.6.2 Response to a Glucose Bolus (GTT) 
Changes in metabolic flexibility were indicated from a comparison of the delta 
change in lipid metabolites during the lean or obese GTT, for example, the blunting 
of the increase in plasma NEFA (Figure 4.4). Therefore, the delta change (i.e. values 
at 120mins minus values at 0mins) in blood biochemistry was considered to mark 
metabolic flexibility: again, no effect of sex and little effect of prenatal diet 
(treatment) influenced this response (Table 4.5). However, the delta change in 
blood biochemistry during a GTT changed with obesity (i.e. a significant effect of 
time was indicated); the changes in pH, PvCO2, PvO2, ABE, were all blunted (Table 
4.5). Haemoglobin (Hb) concentrations and haematocrit (Hct) were similar in all 
groups when measured as obese animals (Hb: CE, 14.0±0.7; LEE, 15.3±0.6; LEL, 
12.9±0.6 g.dL
-1
; Hct: CE, 36.5±2.2; LEE, 36.4±1.9; LEL, 37.1±1.9 %). 
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  Experimental Group  Statistics 
 
pH  
 
Time CE LEE LEL s.e.d Tr Time Tr*Time 
lean 0.06 0.07 0.06  
0.03 
 
NS 
 
0.01 
 
NS obese -0.01 0.02 0.01 
pCO2  
(mmHg) 
lean -7.73 -5.58 6.00  
4.31 
 
NS 
 
0.02 
 
NS obese 0.45 -1.17 -1.17 
pO2  
(mmHg) 
lean 9.48 6.91 8.45  
9.17 
 
NS 
 
0.02 
 
NS obese -14.65 -1.98 1.42 
ABE  
(meQ.L
-1
) 
lean 0.36 2.30 1.90  
1.32 
 
NS 
 
0.04 
 
NS obese -1.35 1.60 -0.01 
K
+
  
(mmol.L
-1
) 
lean -0.46 -0.43 -0.22  
0.20 
 
NS 
 
NS 
 
NS obese -0.30 -0.32 -0.12 
Na
+
  
(mmol.L
-1
) 
lean -1.00 -0.85 -1.85  
1.13 
 
0.06 
 
NS 
 
NS obese 1.83 -1.42 -1.42 
Ca
2+
  
(mmol.L
-1
 
lean -0.02 -0.02 -0.01  
0.02 
 
NS 
 
NS 
 
NS obese -0.03 -0.04 -0.01 
Cl
-
  
(mmol.L
-1
) 
lean 0.83 -0.85 0.00  
 1.22 
 
NS 
 
NS 
 
NS obese -0.16 -0.57 -0.42 
Table 4.5 The delta change in metabolites during a GTT when lean or obese. 
Data are predicted means with the average standard error of the difference (s.e.d with 14 degrees of 
freedom in all cases) for the comparison. CE, Controls (n=6); LEE, Low Energy Early (n=6), LEL, Low 
Energy Late (n=7). Tr, main effect of treatment; Time, main effect of time (i.e. becoming obese); 
Tr*Time, interaction between treatment and time. 
 
4.4.3 ORGAN WEIGHTS 
There were no treatment effects on absolute or relative wet organ weights at 2 
years of age. Absolute weights were greater in male relative to female offspring, as 
expected, but when expressed in relative terms, few effects were observed with the 
exception of the brain, which was significantly larger in females than in their male 
counterparts (Table 4.6).  
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  Absolute weights P Relative weights (g/kg) P 
  Male Female   Male Female 
 
Body weight (kg) 82.2±01.5 66.5±1.2 *** - - - 
Brain (g) 103±2 95±4 ns 1.26±0.03 1.44±0.06 ** 
 ?
Pituitary (g) 0.81±0.12 0.65±0.08 ns 9.71±1.27 9.87±1.07 ns 
Perirenal Fat (kg) 2.88±0.30 2.39±0.30 ns 33.5±2.7 37.1±2.8 ns 
Pericardial Fat (g) 219±15 161±9 * 2.53±0.11 2.56±0.13 ns 
Omental Fat (kg) 3.88±0.30 2.88±0.18 ns 2.53±0.11 2.56±0.13 ns 
Total kidney (g) 150±8 117±3 *** 1.82±0.07 1.76±0.03 ns 
 ?
Total adrenal (g) 5.39±0.80 3.64±0.45 ns 66.4±11.2 54.7±6.7 ns 
Liver (g) 697±89 627±20 ns 8.55±1.11 9.42±0.21 ns 
Pancreas (g) 70.7±5.8 61.8±4.1 * 0.86±0.07 0.93±0.06 ns 
Spleen (g) 121±9 100±9 ns 1.48±0.12 1.49±0.12 ns 
Lungs (g) 594±26 552±43 ns 7.25±0.39 8.28±0.59 ns 
Heart (g) 316±9 271±8 *** 3.86±0.14 4.07±0.10 ns 
Septum (mm) 18.3±0.99 14.4±0.36 *** - - - 
Left Ventricle 
(mm) 
17.6±0.89 15.6±1.0 ns - - - 
Right Ventricle 
(mm) 
7.42±0.52 6.71±0.60 ns - - - 
Table 4.6 Post Mortem organ weights in male and female sheep. 
Body and organ wet weights of male (n=11) and female (n=9) offspring at post mortem. Data are 
Grand Means ±1 SEM. Statistics are *, **, ***, P<0.05, P<0.01 or P<0.001 respectively for male vs. 
ĨĞŵĂůĞ ?ŶƐ ?ŶŽƚƐŝŐŶŝĨŝĐĂŶƚ ? 較?ƌĞůĂƚŝǀĞĂĚƌĞŶĂůĂŶĚƉŝƚƵŝƚĂƌǇǁĞŝŐŚƚĞǆƉƌĞƐƐĞĚĂƐ ?Ő ?ŬŐ-1) ×103.  
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4.5 Discussion 
We have shown that global nutrient restriction of the pregnant ewe from mid-late 
gestation leads specifically to a greater early-phase (first 20 mins) increase in 
plasma insulin in response to an intravenous glucose bolus in the adult offspring. 
The response was sex-specific (greater in males > females) and only observed when 
the adult offspring were obese. In addition, for this study we broadly assessed 
metabolic health in the adult offspring when lean and the deterioration in 
metabolic health when they became obese. Obesity was clearly detrimental to 
metabolic health in many respects (lipoprotein and cholesterol profile, insulin 
sensitivity) but, contrary to our hypothesis, we found little evidence of greater 
deterioration of health in those offspring prenatally undernourished by global 
energy deficit. Taken together, the current study provides evidence to suggest that 
prenatal energy deficit has a sex-specific effect on adult glucose-insulin sensitivity 
when, and only when, excess calories are consumed; if the offspring remain lean 
and physically active through adolescence and early adulthood then good metabolic 
health prevails. The extent to which metabolic deterioration in programmed 
offspring may by exacerbated by older age cannot be determined by this study but 
clearly, prevention of excess weight gain through controlled food intake and lots of 
habitual physical activity can be inferred.   
 
Pregnant women that suffered the Dutch Hunger Winter Famine during WWII, with 
the severe nutrient deficiency that it entailed gave birth to babies that were on 
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average only ~300g less than contemporaneous women that were un-exposed 
(Roseboom et al., 2001). The middle-aged adult offspring, however, had elevated 
plasma lipids, obesity and an increased incidence of coronary heart disease if 
exposed during early gestation (Roseboom et al., 2000), whereas those exposed 
during late gestation had reduced glucose tolerance (Painter et al., 2005). The 
current study broadly concurs with these epidemiological observations and suggests 
the liver as the likely candidate for reduced whole body glucose tolerance (e.g. 
blunted first pass insulin metabolism and insulin-induced suppression of hepatic 
glucose output). This is inferred from our results indicating greater early (0-20mins) 
plasma insulin concentrations in LEL (exposed to undernutrition during late 
gestation) relative to control animals in response to the GTT, but no difference in 
their response to an I.V. ITT (i.e. as a measure of insulin-dependent peripheral 
glucose uptake). In particular, we noted a clear treatment*gender interaction in the 
response to the GTT when obese, with male offspring mounting a much greater first 
phase insulin response relative to females. Given that no such interaction was 
observed during the ITT, as previously shown by Poore et al., (2007), suggests that 
in offspring undernourished during late gestation the major sites of peripheral 
glucose uptake (skeletal muscle and adipose tissue) are not overtly resistant to 
insulin action per se. Rather, when hyperglycaemia and hyperinsulinaemia co-exist, 
such as postprandially (or, for example, after a GTT), differences in other insulin-
sensitive tissues (pancreas and liver) that are not activated during the ITT but are 
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during the GTT must account for the observed significant treatment*gender 
interaction.  
 
In terms of the developmental programming paradigm the sex-specificity of many 
diverse programmed sequalae has been the source of much debate, but in general, 
it would appear that the male offspring are particularly vulnerable. For example, 
such a sex-specific effect on glucose-insulin metabolism has also been observed in 
the male offspring from mothers that were methyl-deficient around the time of 
conception (Sinclair et al., 2007) or placentally restricted during gestation, in 
similarity to the current study (Owens et al., 2007). Males also appear more 
susceptible with respect to the programming of function in alternative organs e.g. 
the heart and kidney (McMullen & Langley-Evans, 2005; Elmes et al., 2008). In the 
present study the males were castrates, therefore mitigating any effect of postnatal 
reproductive hormones. Thus, the sex-specific differences may relate to either 
female reproductive hormones (Ojeda et al., 2007; Grigore et al., 2008) or a delayed 
effect pertaining to sex-specific differences in the intrauterine response to nutrient 
deficit per se (Hattersley & Tooke, 1999). From the present results and taking into 
account other studies it is still not clear what mechanism may underlie the sex-
specificity of developmental programming, although recent work would suggest 
there is differential sensitivity to epigenetic programming and altered methylation 
of key genes could underpin many of the sex-specific responses (Lillycrop et al., 
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2005; Sinclair et al., 2007); the results, however, do emphasise the importance of 
including sex as a factor in the design of developmental programming experiments. 
 
We have previously shown that late gestation undernutrition can marginally reduce 
glucose tolerance in lean adult sheep (Gardner et al., 2005) in contrast to the 
current study, where reduced glucose only became apparent with significant 
obesity. The reason for this difference is likely due to the milder nutritional 
challenge employed over late gestation and birth in the current study (i.e. a 35% 
reduction in the current study vs. 50% in the previous study (Gardner et al., 2005)). 
In addition, it is important to reiterate that ewes in the current study were also 
gradually realimented from day 128 to term to avoid any potential confounding by 
carry-over effects of prenatal undernutrition into lactation (Hammond et al., 1976). 
This can be considerable and likely affects many previous studies in this area; in the 
current study, that singles and twins grew at equivalent rates during lactation 
suggests that the lactational ability of ewes in our study was not hampered by 
prenatal undernutrition. Our study therefore uniquely illustrates that isolated mid-
late gestation global undernutrition can have specific long-term effects on glucose-
insulin dynamics in the adult male offspring when they become overweight.  
 
In the ruminant in the resting state (euglycaemia), glucose clearance is likely 
orchestrated by Glut4-mediated insulin-dependent transfer into skeletal muscle and 
adipose tissue. During hyperglycaemia, clearance is additionally coupled to mass-
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action passive glucose transfer into pancreatic and hepatic cells (via Glut2, which 
has a high Km for glucose (Sasaki, 2002)).  Thus, in contrast to our previous 
observation in which a reduction in adipose Glut4 was associated with the decline in 
insulin sensitivity (Gardner et al., 2005), in the current study it would appear that 
ƚŚĞ ŬĞǇ  ‘ƉƌŽŐƌĂŵŵĞĚ ? ĞĨĨĞĐƚ ŝƐ ŽŶ Ğŝƚher hepatic insulin resistance i.e. decreased 
first-pass hepatic insulin extraction, which is approximately 50% in the sheep under 
basal conditions, (Brockman & Bergman, 1975) or insensitivity to insulin-induced 
blunting of hepatic glucose output (via gluconeogenesis or glycogenolysis) and/or 
pancreatic dysfunction e.g. insulin hypersecretion (Gower et al., 2002). As yet, we 
are unable to discern a pancreatic from hepatic effect, although the available 
evidence from other animal models that have attempted to address this conundrum 
suggests a combination of both (Kim et al., 2007). Certainly, it would appear that at 
a systemic level potential changes in skeletal muscle fibre type (Daniel et al., 2007) 
and/or skeletal muscle insulin signalling protein expression (Ozanne et al., 2005) are 
not important in mediating the differences in early insulin secretion in the current 
study.  
 
From literature in Man and in animal models it is apparent that following a deficit in 
growth, rapid weight loss or undernutrition there is a period of preferential fat 
ĂĐĐƌĞƚŝŽŶ Žƌ  ‘ĐĂƚĐŚ-ƵƉ ĨĂƚ ? (Dulloo, 2008). This paradigm is akin to the original 
 ‘ƚŚƌŝĨƚǇ ƉŚĞŶŽƚǇƉĞ ? ŚǇƉŽƚŚĞƐŝƐ (Hales & Barker, 2001) ? ƚŚĞ ůĂƚĞƌ  ‘ŵŝƐ-ŵĂƚĐŚ ?
(Gluckman & Hanson, 2004) or alternative thin-fat (Popkin, 2006) hypotheses. Here, 
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nutritional insufficiency leading to deficits in weight and/or growth (particularly 
during the key developmental periods of gestation and lactation) when coupled 
with postnatal nutritional excess increase the risk of adult metabolic disease (Sayer 
et al., 2004; Singhal & Lucas, 2004; Barker et al., 2005) and actually reduce lifespan 
in male mice (Ozanne & Hales, 2004). Hence, in the current study we specifically 
designed the experiments, using a relevant large animal model, to test this 
hypothesis. Our results largely agree with the null hypothesis in that few 
time*treatment interactions were observed; prenatal undernutrition did not make 
the adults more susceptible to greater adipose tissue gain per se. There are a 
number of reasons that may go some way to explaining this variance with the 
prevailing literature. First, when measured in a lean condition the animals had been 
in their habitual environment for 1.5 years, were relatively active and eating a low 
energy dense diet, in stark contrast to laboratory species (Vickers et al., 2000) and 
much epidemiological data in Man. The animals were still relatively young (1.5 
years) when sheep may live up to 12 years, however, catch-up fat has been 
observed from a young age (Dulloo, 2008). Alternatively, 30% global nutrient 
restriction of the pregnant sheep could be considered a relatively milder challenge 
when compared to, for example, 50% protein restriction in the rat (Armitage et al., 
2004; McMillen & Robinson, 2005). The long-term consequences of prenatal 
programming may therefore be relatively harder to elucidate in larger animal 
models in comparison to small because of species-specific allometry and the 
ŵĞƚĂďŽůŝĐ ‘ďƵĨĨĞƌ ?ŽĨĨĞƌĞĚďǇƚŚĞůĂƌŐĞƌďŽĚǇƐƵƌĨĂĐĞĂƌĞĂ PǀŽůƵŵĞƌĂƚŝŽŽĨƚŚĞƐŚĞĞƉ 
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(Gardner et al., 2007). Nevertheless, with time, common programmed end-points 
have been shown to develop in larger animal species (Dodic et al., 2001; 
Gopalakrishnan et al., 2004; Cleal et al., 2007a).   
 
In this study we uniquely measured the development of obesity in sheep by 
repeated DXA which has a very low internal coefficient of variation and is very 
accurate for tissue weights from 500g to 90kg. However, we sought to further 
assess DXA against chemically determined body composition. Whilst there was 
good correlation between the two methods, chemical extraction of tissue for fat 
increased the apparent % fat determined by 75%. This is likely due to the Soxhlet 
method extracting absolutely all lipids available in that tissue (extracellular, 
intracellular, and membraneous) rather than those that are simply metabolically 
available. Thus, the Soxhlet method is useful for determining fat composition of 
food to be eaten (as all fat will be extracted intestinally) but is perhaps less relevant 
in metabolic studies whereas DXA is a more appropriate method to determine body 
composition for assessing effects of adiposity on metabolism in vivo. Indeed, the 
value of 30% whole body fat mass in the current study determined by DXA concur 
with levels achieved previously by us after juvenile-onset obesity (Sebert et al., 
2009). Adult onset obesity in the current study was associated with a significant 
decrement of lean mass (~2-3kgs), contrary to the often-reported increase with 
obesity, presumably as a consequence of increased weight-bearing (Wells et al., 
2006). Previous work in sheep, however, has also reported a reduction in carcass 
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protein content with adult-onset obesity induced by overconsumption of feed 
(Bergman et al., 1989). The similar responses observed in that study and the current 
one, together with the reductions in plasma amino acid and urea concentrations, 
suggest reduced protein turnover in obese sheep, perhaps due to the reduced 
ĂĐƚŝǀŝƚǇ ŽĨ ƚŚĞ ƐŚĞĞƉ ǁŝƚŚŝŶ ŽƵƌ  ‘ŽďĞƐŽŐĞŶŝĐ ? ĞŶǀŝƌŽŶŵĞŶƚ ? /Ŷ DĂŶ ? ŝŶĐƌĞĂƐĞĚ
protein catabolism has been observed with obesity, related to the resistance of 
glucose and protein metabolism to insulin and the increased hepatic supply of 
glucogenic amino acids (Chevalier et al., 2006). However, the fact that no overt 
peripheral insulin insensitivity was observed and the majority of the change in 
plasma amino acids could be attributed to only those few amino acids originally 
present in the highest concentrations in the plasma suggests, by the law of 
parsimony, that the increased dietary fat incorporation in the current study (from 3 
to 6%) reduced rumen microflora protein synthesis and thus overall amino acid 
availability; the net effect being reduced protein turnover, and reduced measured 
amino acid and urea concentrations. Taken together with the changes in fat 
metabolism it would appear that obesity in sheep engendered by 7-8months 
ĞǆƉŽƐƵƌĞƚŽĂŶ ‘ŽďĞƐŽŐĞŶŝĐĞŶǀŝƌŽŶŵĞŶƚ ?ĐƌĞĂƚĞĚďǇŝŶĐƌĞĂƐŝŶŐĨŽŽĚĂŶĚĨĂƚŝŶƚĂŬĞ
and reducing physical activity has put the sheep into a state of decreased protein 
turnover (likely through reduced protein synthesis) with net lipid deposition and 
decreased oxidation (as reflected in reduced plasma NEFA and glycerol) (Bergman 
et al., 1989). 
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/Ŷ ĂĚĚŝƚŝŽŶ ? ŽďĞƐŝƚǇ ŝŶ ƐŚĞĞƉ ǁĂƐ ĐŚĂƌĂĐƚĞƌŝƐĞĚ ďǇ Ă ĚĞĐůŝŶĞ ŝŶ ƚŚĞ ŝŶĚŝǀŝĚƵĂůƐ ?
capacity to transition between metabolic substrates under conditions of rapidly 
changing fuel supply, here recreated after a glucose tolerance test. The obese 
individual, in response to elevated blood glucose, responded with markedly blunted 
excursions in plasma metabolites and biochemistry. ^ƵĐŚĂƌĞĚƵĐƚŝŽŶŝŶ ‘ŵĞƚĂďŽůŝĐ
ĨůĞǆŝďŝůŝƚǇ ? ? ĨŽƌ ĞǆĂŵƉůĞ Ă ƌĞĚƵĐĞĚ ƚƌĂŶƐŝƚŝŽŶ ĨƌŽŵ ĨĂƚƚǇ ĂĐŝĚ ĞĨĨůƵǆ ƚŽ ƐƚŽƌĂŐĞ ŝŶ
response to a carbohydrate rich meal (Storlien et al., 2004) has recently been 
characterised in obese individuals and is thought to contribute to Metabolic 
Syndrome. We observed no overall effect of the prenatal diet on this response. 
However, for LEL, that had a greater plasma insulin response to high glucose 
coupled with reduced metabolic flexibility from being obese, then over time (i.e. 
longer exposure to the obesogenic environment), overt peripheral insulin resistance 
would perhaps be more likely to develop and be more pronounced in those sheep 
undernourished during late gestation (Galgani et al., 2008). 
 
In our study, there is potential that the effect is confounded by the study design in 
two ways; first, the increase in weight with obesity necessitated an increase in 
delivered glucose (administered v/w) relative to the first or lean GTT, therefore 
precipitating an overall greater response when obese. In defence, we highlight the 
fact that the gain in body weight was equivalent between treatment groups and 
that statistical adjustment of the insulin response to GTT for the weight gain 
(included as a co-variate) and thus the increased delivery of glucose, actually 
Chapter 4 117 
Low Energy Study ± 1.5 to 2 years of age 
increased the F-statistic for the treatment*gender interaction, indicating a specific 
effect of the mismatch between pre- and post-natal diet on first phase insulin 
response in male offspring. The increased insulin to glucose AUC ratio also supports 
the fact that the obese offspring produced a greater insulin response than when 
lean. Secondly, we acknowledge that following prior consultation with a statistician 
our best option for testing the hypothesis that prenatal undernutrition interacts 
deleteriously with postnatal nutritional excess was to use a repeated measures 
design. Such a design offers greater precision in testing for potential 
time*treatment*gender interactions as within animal variation is generally less 
than between animal variation. Furthermore, if no interactions are present (e.g. 
with time) then the study can more precisely determine potential main effects as 
the second measurement acts as a replicate of the first (i.e. the benefits of a 
factorial design); such experimental designs are therefore encouraged by the 
National Centre for the Reduction, Refinement and/or Replacement of animals in 
research (NC3Rs) (Festing et al., 2004). Nevertheless, we are unable to control for 
an overall effect of time (being confounded with acquisition of obesity). However, 
we suggest that a 6-month period in an adult animal that may live for up to 12-15 
years is not a significant length of time and that a doubling of fat-mass over that 
period is by far the over-riding effect. In addition, all treatment groups were 
randomly group housed together over this period, thus any effect of time per se 
would be expected to act equally on each individual sheep; given that our 
longitudinal design increased our sensitivity to observe time*treatment*gender 
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interactions and we only observed such an effect of time (i.e. obesity) in one 
treatment*gender combination (male LEL) suggests that male LEL specifically differ 
with respect to groups in their response to adult-onset obesity.  
 
/ŶĐŽŶĐůƵƐŝŽŶ ?ŐůŽďĂůŶƵƚƌŝĞŶƚƌĞƐƚƌŝĐƚŝŽŶŽĨƐŚĞĞƉŚĂĚůŝƚƚůĞĚĞůĂǇĞĚ ‘ƉƌŽŐƌĂŵŵŝŶŐ ?
effect on carbohydrate, fat and/or protein metabolism in the adult offspring when 
they were lean and physically active. However, when coupled with an obesogenic 
environment, those male sheep that experienced a poor diet during late gestation 
exhibited evidence of reduced insulin sensitivity. 
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5. Low Protein Study  W conception to 18 months of age  
5.1 SUMMARY 
This chapter describes the effects of a modest, isocalorific, maternal protein 
restriction (18% vs. 9%) from conception to day 65 gestation (Low Protein Early; 
LPE) or from day 66 to term (Low Protein Late; LPL). The low protein diet had no 
effect on maternal weight in either treatment group in comparison to control, 
although LPE ewes had a significantly lower body condition score during trimester 
one and two than control ewes. Maternal dietary regime had no effect on maternal 
and fetal cortisol levels, or fetal weight at day 65 gestation; at this time, however, 
males were heavier than females (P=0.002). At term, singletons were heavier than 
twins, as expected, but LPL singletons were growth restricted (~500g. P<0.001); an 
effect still evident at weaning (3 months of age). Furthermore, at term, LPL 
offspring had significantly lower basal plasma insulin that persisted for ~2 weeks. In 
the adolescent offspring at 7 months of age and in response to a glucose bolus, the 
peak insulin (P=0.024) and incremental area under the curve (P=0.048) were greater 
in LPE offspring than control. However, there was no treatment effect following an 
insulin tolerance test at the same age and all offspring were morphologically similar 
at post mortem.  
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5.2 Introduction 
The fact that total ruminant nitrogen uptake cannot be simply quantified from fed 
sources makes ruminal protein nutrition research less clear cut than monogastric 
nutritional research. Samuel Brody was one of the first animal scientists to calculate 
ovine protein requirements (Brody, 1945). He calculated the protein requirement of 
a non-pregnant ewe to be 3.6g digestible crude protein per kg W 
0.73
 (where W is 
ƚŚĞƐŚĞĞƉ ?Ɛmass), which equates roughly to 60g digestible crude protein for a 50kg 
ewe. The first estimates for pregnant ewes were published in 1959 (Phillipson, 
1959; Thomson & Aitken, 1959), where digestible crude protein requirement for a 
pregnant ewe was calculated to be twice that of a non pregnant ewe. As the 
knowledge of nutrition improved, these estimated requirements were subsequently 
reconfigured. The seminal work of JJ Robinson and colleagues has greatly advanced 
the field of ovine nutrition, in particular of pregnant ewes and developing ovine 
fetuses (Robinson & Forbes, 1966, 1967; Guada & Robinson, 1974; Robinson, 1977, 
1980). Robinson & Forbes (1967) recalculated the nitrogen requirement of a 
pregnant ewe nearing parturition as 77g of digestible crude protein for a 68kg ewe, 
rather than 120g (Phillipson, 1959; Thomson & Aitken, 1959). This difference was 
mainly attributed to the nitrogen retention rate being recalculated as 62g protein 
for a 68kg ewe, which is higher than previous estimates by Klosterman et al., (1951).  
Robinson highlighted the importance of metabolisable energy supply when 
calculating ewe protein requirements during pregnancy. As energy intake increases, 
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the digestibility of crude protein decreases, which is important as during pregnancy 
both metabolisable energy and protein requirements elevate. As pregnancy 
progresses the nitrogen retention from the ewe increases without a subsequent 
increase in urinary nitrogen output, which infers an increase in nitrogen utilisation 
(Robinson & Forbes, 1967). McNeill et al., (1997) observed a significant correlation 
between maternal protein intake and nitrogen accretion in twin bearing ewes in 
late gestation, although the efficiency at which absorbed nitrogen was deposited 
was elevated with protein restriction. Amino acid utilisation during pregnancy will 
depend on the stage of gestation as well as the energy supply. During early to mid 
gestation there is no additional protein requirement of the pregnant ewe over that 
of the non-pregnant ewe (Robinson & Forbes, 1967), with placental development 
accounting for a high proportion of the increased tissue accretion at this time. As 
the ewe enters the later stages of gestation, not only will the fetus have a high 
demand for amino acids to support its exponential growth rate, but it will also 
utilise amino acids alongside glucose as a fuel for oxidative metabolism (Robinson & 
Symonds, 1995). The interplay between protein and energy nutrition during 
pregnancy, especially nearing term, is why it is crucial to try to maintain an 
isoenergetic diet when investigating protein requirement, as reductions in energy 
supply will repartition amino acids towards oxidative catabolism rather than fetal 
protein synthesis.  
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The daily flux of metabolic substrates is influenced by hormonal status and 
glucocorticoids help mediate this process (Dallman et al., 1993). Glucocorticoids 
have long been thought to act as intermediary factors that transcribe the 
developmental programming sequalae of maternal nutrient restriction and there is 
much evidence in animal models (Gardner et al., 1998; Phillips et al., 1998) to 
suggest just such a role. In sheep the change in maternal cortisol with 
undernutrition appears age-dependant, being elevated with late gestation 
undernutrition (Bloomfield et al., 2003a) and reduced with early to mid gestation 
undernutrition (Bispham et al., 2003). Interestingly, periconceptional undernutrition 
has been shown to markedly activate fetal HPA axis activity in late gestation leading 
to preterm birth in sheep (Bloomfield et al., 2003b). Thus in this study we sought to 
broadly characterise the effects of maternal protein undernutrition on maternal and 
fetal plasma cortisol. 
 
The effect of protein malnourishment on in utero fetal development and postnatal 
production characteristics of ovine offspring has been studied extensively, as 
detailed above.  Until the current study, little evidence was known about the effect 
of restricted protein nutrition during specific periods of gestation on ovine postnatal 
health factors. The low protein model of fetal programming is an extensively used 
research model in rats, with the advantage over some models that the combined 
process (maternal protein malnourishment) and end point (IUGR fetuses) are 
frequently observed in the human populous (Symonds et al., 2009). The rat low 
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protein model was established by Snoeck et al., (1990) and Dahri et al., (1991), and 
has been further developed and extensively characterised since (Langley-Evans et 
al., 1996; Fernandez-Twinn et al., 2003; Bellinger & Langley-Evans, 2005; 
Fernandez-Twinn et al., 2005; Erhuma et al., 2007b; Mallinson et al., 2007; Harrison 
& Langley-Evans, 2009).  
 
As previously mentioned, the low protein model offers a more mechanistic insight 
into fetal programming versus global energy restriction (Symonds et al., 2009); with 
this in mind, the sheep has many physiological benefits when investigating human 
in utero development and postnatal health (reviewed by Luther et al., (2005) and 
Wallace et al., (2005)). The level of protein restriction in this study (9% vs. 18%) was 
chosen on an agricultural basis, rather than as a replication of the protein levels 
utilised during rat studies (Harrison & Langley-Evans, 2009). A crude protein level of 
18% more than meets adequacy for pregnant ewes, but 9% dietary crude protein 
was selected to represent the minimal protein availability that a sheep would 
naturally be exposed to if it was to consume a relatively high tannin diet. Tannins 
are polyphenolic compounds found in high concentrations in many plant species, 
including heathers (Calluna vulgaris). When ruminants consume tannins, the 
tannins form strong complexes with protein molecules in the rumen, thus reducing 
nitrogen uptake, although tannins may also reduce ruminant protein uptake by 
inhibiting enzymes due to tannin-protein (enzyme) complex formation (Frutos et al., 
2004). In similarity and to provide a dietary contrast, two periods of gestation were 
Chapter 5 124 
Low Protein Study ± conception to 18 months 
 
chosen to feed the low protein diet, 0-65d gestation (Low Protein Early; LPE) and 
66-120d gestation (Low Protein Late; LPL).  
5.3 Materials and methods 
See Chapter 2.3 for details of dietary design. In brief, Scottish blackface ewes were 
oestrus synchronised and mated to Scottish blackface rams. Ewes were fed either 
maintenance protein requirements (18% protein) throughout gestation, from day 0-
term (Control Protein; CP) or they were allocated to a restriction protocol. The early 
restriction animals were fed 50% of CP protein intake (9% protein) from day 0- 65 
gestation (Low Protein Early; LPE). On day 65 a proportion of CP and LPE animals 
were euthanised for collection of fetal tissues and blood (fetal and maternal cortisol 
was analysed- described in 2.5.1.3). On day 66 the remaining LPE animals were 
switched to the 18% protein diet, while the late restriction group (Low Protein Late; 
LPL) was switched from 18% protein feed to 9% and they remained on this until 
term. Maternal weight and body condition score (BCS) were recorded frequently 
throughout gestation. Males were castrated shortly after birth and all offspring 
were weaning aged 3 months. Lamb weights, BCS and blood were collected every 3 
weeks postnatally. Blood was analysed for plasma insulin (see Chapter 2.5.1.4). At 7 
months old offspring were cannulated, and a glucose tolerance test (GTT- see 
Chapter 2.4.2.2.1) and insulin tolerance test (ITT- see Chapter 2.4.2.6.1) were 
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performed. Aged ~16 months, animals were either euthanised or transported to 
Sutton Bonington Campus, University of Nottingham for further investigation.  
 
5.4 Results 
5.4.1 MATERNAL & FETAL DATA 
5.4.1.1 Ewe Weight 
Maternal weight was significantly affected by the time of gestation (P<0.001), with 
the ewe continually accruing body mass throughout pregnancy (Figure 5.1). 
Maternal weight was also influenced by the number of fetuses the ewe was carrying 
as pregnancy progressed (fetal number*time P<0.001), with the disparity between 
single and twin bearing ewes increasing, such that at the last time point (gestation 
day 124) twin bearing ewes weighed ~8kg more than singleton bearing ewes.  
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Figure 5.1 Ewe weight throughout gestation 
Weights shown are means ±1 SEM. Treatment groups are CP (Control Protein), LPE (Low Protein 
Early) & LPL (Low Protein Late). A significant effect of time (P<0.001) and fetal number*time 
(P<0.001) was observed.   
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5.4.1.2 Ewe Body Condition Score (BCS) 
Ewe body condition score (BCS) changed significantly with the stage of gestation 
(P<0.001), with a dramatic decline in maternal BCS in the later stages of pregnancy 
(Figure 5.2). A treatment*time interaction was also observed (P=0.013), with LPE 
ewes having a lower BCS compared, in particular, to LPL during the first and second 
trimester of pregnancy.  
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Figure 5.2 Ewe Body Condition Score for Maternal Low Protein Study. 
BCS (Body Condition Score) is judged on an arbitrary scale between 1- emaciated and 5-severely 
overweight. Errors shown are ±1 SEM. Treatment groups are CP (Control Protein), LPE (Low 
Protein Early) and LPL (Low Protein Late).   
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5.4.1.3 Maternal & Fetal Cortisol 
At day 65 there was no significant effect of maternal nutrient restriction on fetal or 
maternal plasma cortisol levels (fetal control 63.52 vs. low protein 65.07ng.ml
-1
; 
maternal control 63.81 vs. low protein 57.92 ng.ml
-1 
SED 16.39).  
5.4.1.4 Fetal Organ Weights at day 65 gestation 
The gender of the fetus had a significant effect on the weight of the fetus (male 
110.8 & female 92.6g, SED 5.1; P=0.002.), but maternal protein restriction had no 
effect (CP 100.6 & LPE 102.8g, SED 5.103). A sex effect on heart (male 1.07 & female 
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0.89g, SED 0.08) and liver weight (male 8.72 & female 7.11, SED 0.51) was observed, 
although both these effects were removed when these organs were expressed 
relative to fetal weight. No effect of gender or treatment was seen on brain weight 
(grand mean 3.466g, SE 0.05), kidney weight (grand mean 1.59g SE 0.06) or lung 
weight (grand mean 5.19g SE 0.34), although brain:body weight ratio was 
significantly (P=0.006) influenced by gender (male 0.032 & female 0.037 g/kg, SED 
0.001).  
5.4.2 BIRTH WEIGHT & POSTNATAL GROWTH 
5.4.2.1 Birth Weight 
A significant effect (P<0.001) of treatment and fetal number was observed on birth 
weight; LPL singletons were significantly lighter than control singletons, while 
maternal protein restriction elevated the birth weight of LPE twins compared to 
control (Figure 5.3). Gender had no main or interactive effect on birth weight.  
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Figure 5.3 Graph showing the effect of maternal protein restriction and fetal number on birth 
weight. 
Values shown are predicted ±1 SED. SED is the average SED for the interaction between 
treatment and fetal number. Treatment groups are CP (Control Protein), LPE (Low Protein Early) 
and LPL (Low Protein Late). A significant effect of fetal number and treatment group was 
observed on birth weight (P<0.001). 
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5.4.2.2 Weaning Weight 
Weaning weight, like birth weight, was significantly influenced by maternal 
treatment (P=0.008) and fetal number (P<0.001) (Figure 5.4), but at this time there 
was no effect of gender. LPE and LPL singleton offspring were significantly lighter 
than controls, while singletons were still observed to be higher than twins.  
 
 
 
Chapter 5 130 
Low Protein Study ± conception to 18 months 
 
 
Figure 5.4 A graph showing the effect of maternal protein restriction and fetal number on 
weaning weight. 
Values shown are predicted means ±1 SED. Treatment groups are CP (Control Protein), LPE (Low 
Protein Early) & LPL (Low Protein Late).  
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5.4.2.3 Lamb Insulin 
Lamb plasma insulin levels changed significantly over the ůĂŵďƐ ?ĨŝƌƐƚ ? ?ŵŽŶƚŚƐŽĨ
postnatal life (P<0.001, Figure 5.5). A significant interaction between 
treatment*time (P=0.009) was also observed, although this seems to be derived 
from the significant treatment effect on lamb insulin levels at birth (P=0.007), with 
LPL plasma insulin being significantly lower than both control and LPE offspring.   
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Figure 5.5 Graph showing the effect of maternal nutrition on plasma insulin concentration. 
Values are predicted means ±1 SED. Error bars shown are the average SED for treatment & fetal 
number. Treatment groups are CP (Control), LPE (Low Protein Early) and LPL (Low Protein Late).  
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5.4.3 RESPONSE TO A GLUCOSE TOLERANCE TEST (GTT) AGED 7 MONTHS 
5.4.3.1 Plasma Glucose 
As expected, plasma glucose was significantly elevated following the administration 
of an I.V. glucose bolus (P<0.001, Figure 5.6). No effect of maternal treatment, 
gender or fetal number was observed on baseline glucose or the incremental 
glucose AUC.  
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Figure 5.6 A graph showing the effect of maternal protein restriction on plasma glucose levels 
following a GTT aged 7 months. 
Values shown are predicted means following generalized linear mixed model analysis. Error bars 
are ±1 SED (SED is the average SED for the time*treatment interaction). Treatment groups are CP 
(Control Protein), LPE (Low Protein Early) and LPL (Low Protein Late).   
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5.4.3.2 Insulin 
Following the injection of the glucose bolus, plasma insulin rose significantly 
(P<0.001, Figure 5.7). A significant effect of treatment was observed on the insulin 
AUC (P=0.048) and peak insulin response (P=0.024, Figure 5.7) with LPE animals 
having a greater peak insulin response and therefore a greater AUC in response to a 
glucose bolus compared to control and LPL animals.  
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Figure 5.7 A graph showing the effect of maternal protein restriction on the plasma insulin 
response to a GTT aged 7 months. 
Values shown are back transformed predicted means from generalized linear mixed model 
analysis. Error bars are average SED for the treatment*time interaction. Treatment groups are CP 
(Control Protein), LPE (Low Protein Early) and LPL (Low Protein Late).   
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5.4.4 RESPONSE TO AN INSULIN TOLERANCE TEST (ITT) AGED 7 MONTHS 
Aged 7 months old, there was no effect of prenatal treatment on glucose KITT (CP, 
2.80±0.51; LPE, 3.56±0.49; LPL, 3.70±0.21 %/min) or AUC (CP, -5.35±0.45; LPE, -
6.38±0.45; LPL, -5.78±0.32 mmoles decrease in 2h (Figure 5.8). Whilst NEFA and 
glycerol increased similarly during the challenge, the plasma triglyceride response 
tended to reflect the change in NEFA and glycerol, with LPL offspring having a 
greater initial plasma clearance followed by a restricted elevation after 30mins.   
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Figure 5.8 Plasma metabolite response to an insulin bolus aged 7 months old.  
Data shown are means ±1 SEM. Groups are CP (Control), LPE (Low Protein Early) and LPL (Low 
Protein Late).   
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Absolute 
weight 
Relative weight 
(g/kg) 
Body weight (kg) 48.6±0.8 
 
Liver (g) 783.7±13.4
#
 16.15±0.26 
Heart (g) 241.0±9.0 4.96±0.17 
Average Adrenal (g) 1.98±0.25 
 ?
40.28±4.58 
Kidney (g) 64.92±1.96 1.34±0.03 
Spleen (g) 232.5±25.0 4.76±0.49 
Average Ovary (mg) 606±23 
 ?
12.76±0.47 
Table 5.1 Post mortem values for 1yr old offspring from the low protein study  
Values shown are grand predicted means. Relative weight is organ weight (g)/body weight 
 ?ŬŐ ? ?  輀AĚƌĞŶĂů ĂŶĚ ĂǀĞƌĂŐĞ ŽǀĂƌǇ ƌĞůĂƚŝǀĞ ǁĞŝŐŚƚs are expressed as mg/kg. #Gender had a 
significant effect (P<0.005).  
 
5.4.5 ORGAN WEIGHTS 
No effect of maternal treatment, gender or fetal number was observed on any 
organ weight (Table 5.1), with the exception of the liver (P=0.021), which was 
significantly influenced by gender (male 816.1 & female 751.2 g. SED 26.77). Males 
had larger livers, but not when expressed relative to body weight.  
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5.5 Discussion 
In this Chapter it has been shown that a maternal low protein diet in sheep does not 
affect maternal weight or body condition in early gestation, or fetal weight utilising 
our experimental protocol. Thus maternal and fetal cortisol levels were also 
unaffected. However, the dietary regimen clearly impacted fetal growth in late 
gestation with singleton LPL being growth restricted at term and at weaning. 
Nevertheless, of interest, whilst the growth restricted LPL offspring had significantly 
lower basal plasma insulin at term when glucose-insulin metabolism was challenged 
at 7 months of age, it was the period of early protein restriction that appeared to 
have most affect i.e. increased peak insulin and incremental area under the curve. 
This was observed despite no obvious effect on peripheral insulin-mediated glucose 
uptake, as reflected in an ITT, but all offspring were morphologically similar at post 
mortem. 
 
Throughout gestation neither of the two maternal protein restriction periods had 
any significant effect on ewe weight. As pregnant ewe protein requirements are 
calculated to be the same as non-ƉƌĞŐŶĂŶƚĞǁĞ ?Ɛuntil mid gestation (Robinson & 
Forbes, 1967), no significant effect of the LPE diet was expected to be observed on 
ewe weight and BCS. With the elevated protein requirements of the pregnant ewe 
in late gestation, a significant drop in ewe weight might have been expected, but 
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none was observed, although twin-bearing ewes were significantly heavier than 
singleton bearing mothers, as expected (Gootwine et al., 2007). As fetuses, there 
was no effect of the treatment on overall weight or on their early organ 
development, which is again unsurprising given their weight relative to that of the 
ewe, although male fetuses were heavier than females indicating, as described 
previously for the low energy study that there is something fundamentally different 
about the early development of male and female embryos. However, at term, LPE 
and control offspring birth weights were not significantly different, while LPL 
offspring were significantly lighter, an effect which carried through to weaning. 
When this observation is viewed alongside the ewe weight data, it supports the fact 
that the dietary restriction was not supra-physiological (as occurs in many 
developmental programming studies) as maternal weight and BCS were maintained 
relative to control, but clearly illustrates that the diets were having knock-on effects 
on the fetal environment, reflective of a deficit in substrate for fetal protein 
accretion. The reduction in birthweight of LPL offspring suggests that dietary 
protein supply was not sufficient to maintain birthweight, even though ewe weight 
was preserved. This could be due to maternal protein demands being met at the 
expense of feto-placental compartment and therefore the ewe not mobilising her 
lean tissue reserves to continue to support the placenta and developing fetal 
tissues, as suggested by McNeill et al., (1997), where maternal dietary nitrogen 
retention was negative following exposure to a low protein diet in late gestation. 
Ovine placental nutrient transfer is readily restricted in response to undernutrition, 
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via reduced placental size, changes in morphology and expression/functionality of 
transporter proteins, as reviewed by Fowden et al., (2006), which could be a 
potential mechanism behind the reduced birthweight.  It has been shown in rats 
that placental amino acid transfer is reduced in late gestation following maternal 
consumption of a low protein diet  (Jansson et al., 2006). The reduction in 
birthweight independent of a reduction in maternal weight could suggest an 
indirect effect of undernutrition, for instance increased fetal exposure to cortisol via 
increased maternal production or decreased placental inactivation by  ? ?ɴ,^ ?
(Whorwood et al., 2001). Indeed, maternal undernutrition in late gestation has 
been shown to increase maternal and fetal cortisol (Edwards & McMillen, 2001). 
Since, plasma insulin levels are significantly lower in LPL offspring at birth compared 
to control, it is entirely plausible that low birthweight in this group is due to low 
nutrient supply (specially amino acids), leading to hypoinsulinaemia and a resultant 
decrease in the anabolic effects of insulin, consequently restricting birthweight 
(Fowden et al., 1989). 
 
At day 65 of gestation, no effect of dietary restriction was observed on maternal or 
fetal plasma cortisol level. Glucocorticoids have, from early in the genesis of the 
programming of health and disease hypothesis, been thought to act as intermediary 
factors that transcribe the developmental programming sequalae of maternal 
undernutrition, from the early rodent studies (Gardner et al., 1998) to later large 
animal models (Challis et al., 2000; Edwards et al., 2001; Bloomfield et al., 2004). 
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However, a causal relationship has proved difficult to ascertain as there are two 
HPA axes to consider (maternal and fetal) and the fetal HPA axis gradually develops 
increased function with gestation (Challis & Brooks, 1989). Furthermore, the 
placenta can contribute in some species to fetal HPA axis development and function 
(Florio et al., 2002), and acts as a control point for maternal glucocorticoid entry 
into the fetal compartment through the expression and activity of the two 11ß-
hydroxysteroid dehydrogenase isoforms 1 & 2 (Seckl, 1997). Consequently the initial 
response of maternal-fetal HPA axes to maternal undernutrition has only been 
partially described and appears gestational age dependent. Thus early to mid 
gestation global undernutrition reduces maternal resting plasma cortisol levels 
(Bispham et al., 2003) whereas late gestation undernutrition appears to elevate 
them (Edwards & McMillen, 2001). In the current study we have shown that specific 
protein undernutrition within an isoenergetic diet has no effect on maternal or fetal 
plasma cortisol levels at day 65, and therefore longer-term sequalae of feeding 
these diets are unlikely to be due to gross changes in maternal and/or fetal HPA axis 
function.  
 
In the adolescent offspring, we assessed glucose-insulin metabolism through a 
combination of a GTT and ITT to assess whole body (GTT) and specifically peripheral 
(ITT) glucose uptake or disappearance from the circulation. Interestingly, whilst LPL 
were of lower birth weight it was the LPE offspring that appeared to display early 
signs of metabolic dysfunction such as a significantly higher insulin response to the 
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GTT and increased AUC. All animals were of a similar weight at this time (except 
male female differences) and thus one caveat, that an equal dose of glucose was 
given to all animals, can be disregarded as contributing to the greater response in 
LPE. To our knowledge, this is the first time postnatal glucose homeostasis has been 
evaluated in sheep following maternal protein restriction in sheep and in this 
chapter the adolescent (~7 months of age) offspring were assessed. The adult 
offspring were also re-assessed at 1.5 years when lean and 2 years of age (when 
obese) and much of the discussion as to the effects of a maternal low protein diet 
on offspring glucose-insulin metabolism is in these chapters. In brief, and in relation 
to the relatively young offspring, it is of interest that the offspring who showed the 
perturbation in glucose handling (LPE) were born with a normal birthweight, hence 
ǭĨĞƚĂůƉƌŽŐƌĂŵŵŝŶŐ ?ŽĨŐůƵĐŽƐĞŚĂŶĚůŝŶŐǁĂƐŽďƐĞƌǀĞĚ ŝŶĚĞƉĞŶĚĞŶƚŽĨĂƌĞĚƵĐƚŝŽŶ
in birthweight. Birthweight and intrauterine growth restriction were originally seen 
as key markers of disturbances in the fetal milieu (Frankel et al., 1996; Rich-Edwards 
et al., 1997), but a growing evidence base suggests that many offspring born with 
normal birth weights may still be influenced by the consequences of `fetal 
ƉƌŽŐƌĂŵŵŝŶŐ ?. /ƚ ŝƐŶŽǁĂƉƉĂƌĞŶƚƚŚĂƚǁŚŝůƐƚďŝƌƚŚǁĞŝŐŚƚ ŝƐĂƵƐĞĨƵů  ‘ŝŶĚŝĐĂƚŽƌ ?ŽĨ
prenatal development for large scale epidemiological studies it is not overly 
important in the context of subtle physiological changes as a result of 
developmental programming. For example, Sinclair et al., (2007) observed 
substantial effects on glucose handling and cardiovascular independent of a 
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significant reduction in birthweight following ovine exposure to a methyl deficient 
environment during the periconceptional period.  
 
The GTT data suggests that LPE offspring have got a heightened insulin response to 
a glucose load. The ITT data suggests that insulin stimulated glucose uptake 
pathways (skeletal muscle and adipose tissue glucose uptake via GLUT4) are not 
affected by maternal low protein. When these two findings are combined, it infers 
central (pancreatic & hepatic) dysregulation rather than peripheral (skeletal muscle 
& adipose tissue) dysfunction. ĞŶƚƌĂůĚǇƐƌĞŐƵůĂƚŝŽŶĐŽƵůĚďĞ ĚƵĞ ƚŽƉĂŶĐƌĞĂƚŝĐɴ
cell hypersecretion or reduced hepatic insulin clearance. A vast amount of research 
has been conducted into the endocrine pancreas following maternal low protein 
diet (reviewed in (Holemans et al., 2003). Snoeck et al., (1990) observed reduced 
ƉĂŶĐƌĞĂƚŝĐ ɴ ĐĞůů ƉƌŽůŝĨĞƌĂƚŝŽŶ ? ƐŝǌĞ ĂŶĚ ǀĂƐĐƵůĂƌŝƐĂƚŝŽŶ ĨŽůůŽǁŝŶŐ ĞǆƉŽƐƵƌĞ ƚŽ Ă
maternal low protein diet. These observations were supported by Petrik et al., 
(1999) ? ǁŚŽ ĂƐ ǁĞůů ĂƐ ŽďƐĞƌǀŝŶŐ ĚĞĐƌĞĂƐĞĚ ƉƌŽůŝĨĞƌĂƚŝŽŶ ŽĨɴ ĐĞůůƐ ? ĂůƐŽ ƐŚŽǁĞĚ
ŝŶĐƌĞĂƐĞĚ ɴ ĐĞůů ĂƉŽƉƚŽƐŝƐ ?Hepatic dysregulation has also been observed in the 
offspring from maternally protein restricted rats, with reduced glucose uptake by 
glucokinase (Burns et al., 1997). Male offspring have been observed to have a 
higher blood insulin concentration and reduced expression of hepatic glucose 
homeostatic enzymes (Desai et al., 1997). In general, it seems to be the male 
offspring that exhibit a more detrimental phenotype following maternal low protein 
nutrition in rats (Petry et al., 2001; Sugden & Holness, 2002; Ozanne et al., 2003), 
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although this is not the case in all studies (Fernandez-Twinn et al., 2005; Chamson-
Reig et al., 2006; Chamson-Reig et al., 2009) or at this time point (7 months) in this 
study.  
 
In addition, in response to either high glucose and high insulin, or high insulin alone 
there were no apparent differences in adipose tissue sensitivity to insulin, reflected 
as similar excursions in plasma NEFA and glycerol in response to the challenges. 
Furthermore, the animals were all proportionate, despite being different at birth 
and weaning (LPL) illustrating that in large animal species, much of the early, 
neonatal differences can be overcome with sufficient time allowance to restore 
ďŽĚǇƐŝǌĞƐďĂĐŬƚŽŶŽƌŵĂů ?ŬŶŽǁŶĂƐ ‘ƌĞŐƌĞƐƐŝŽŶƚŽƚŚĞŵĞĂŶ ? ?This is also the case 
with twinned animals, who were born with a lower birthweight, but postnatally 
appear to be relatively unaffected by this intrauterine restriction. Thus, in the 
context of developmental programming it is important to firstly observe the 
programmed animals at later ages and witness if age reveals any aspect of 
programming and secondly, to challenge the programmed phenotype with an insult 
known to be bad for physiological health. Chapter 6 therefore follows these animals 
to 1.5 years and exposes them to an obesogenic environment to encourage 
significant weight gain ĂŶĚƚŚƵƐ  ‘ƌĞǀĞĂů ?ŐƌĞĂƚĞƌŵĞƚĂďŽůŝĐĚǇƐĨƵŶĐƚŝŽŶ ?ƚŚĂŶǁŚĞŶ
the animals were lean.  
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6. Low Protein Study  W 1.5 to 2 years of age 
6.1 SUMMARY 
In this chapter the interaction between maternal protein restriction during early 
(conception- day 65 gestation; LPE) or late (day 66 -term; LPL) gestation and adult 
exposure to an obesogenic environment in post pubertal (1.5 yrs) offspring was 
examined. When  ‘lean ?aged 1.5 yrs, there was no effect of treatment on body 
composition as assessed by DXA. After a 6-month period of excessive nutrient 
consumption on a higher lipid diet, combined with reduced physical activity, all 
offspring went from a healthy body condition score (BCS) of 2.5 to an overweight 
BCS of 4.5 with no marked differences between groups on the amount of fat 
deposited internally. Over this period, females generally had less lean mass than 
males, with males across all groups having a greater daily intake than females. 
There was a small difference in food intake, with LPE offspring having a lower daily 
food intake (and appetite) than control offspring. Of interest, when obese LPE males 
(but not females) had an increased baseline insulin and a markedly greater (P=0.009 
for treatment*time*gender interaction) peak insulin and area under the insulin 
response curve than control offspring following a glucose tolerance test. In addition, 
a treatment*gender interaction was observed in baseline glucose in lean offspring, 
with LPE males and LPL females having an elevated baseline glucose. With respect 
to protein metabolism then we saw a general decrease in plasma urea and total 
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amino acid concentrations with the onset of obesity. Metabolic flexibility also 
decreased with obesity, reflected as decreased excursions of plasma metabolites 
and electrolytes compared to when lean. In similarity to the adolescent data 
(Chapter 5), we saw no treatment effect on insulin-mediated glucose uptake during 
an ITT which was corroborated by no differences in the expression profile of genes 
in the insulin-signalling pathway in muscle as assessed by microarray. However, the 
majority (87%) of differentially-expressed genes were in the LPE group, which were 
predominantly down-regulated and associated with proteosomal activity and 
ubiquitination.  
6.2 Introduction 
To the best of our knowledge, this is the first time that offspring from ĞǁĞƐ ? protein 
malnourished during early or late gestation have been assessed for metabolic 
health before and after exposure to an obesogenic environment. As deleterious 
effects of maternal low protein during early gestation have been described in this 
model (Chapter 5), it was hypothesised that these effects would be exacerbated by 
rapid weight gain, leading to a worsening of glucose homeostasis following a 
glucose or insulin challenge.  
 
As the names of fetal programming theories ( “dŚƌŝĨƚǇWŚĞŶŽƚǇƉĞ,ǇƉŽƚŚĞƐŝƐ ? ? “&ĞƚĂů
KƌŝŐŝŶƐ ,ǇƉŽƚŚĞƐŝƐ ? ?  “WƌĞĚŝĐƚŝǀĞ ĚĂƉƚŝǀĞ ZĞƐƉŽŶƐĞ ? ĂŶĚ  “DŝƐ-DĂƚĐŚ dŚĞŽƌǇ ? ? ƚŽ
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name but a few) change with time and the growing evidence base, the overriding 
principle remains unchanged - that prenatal insults affect fetal development, invoke 
a fetal adaptive response which either becomes disadvantageous later in life (thrifty 
phenotype) or advantageous (predictive-adaptive response) if exposed to a similar 
insult post-natally. The ŐƌĞĂƚĞƌ ƚŚĞ  ‘mis-match ? (fetal-postnatal transition) the 
greater the adverse health problems later in life (mismatch hypothesis). Thus, in 
Chapter 5 it was observed that LPL offspring were low birth weight, then it follows 
that when these offspring are exposed to a hypercaloric, obesogenic environment 
they will have a reduced functional capacity to adapt and exhibit greater evidence 
of physiological dysfunction. This Chapter challenges that hypothesis. 
  
In the commonly studied maternal low protein rat model, perturbations in fetal 
growth and postnatal performance are suggested to occur through alterations in 
the pattern of amino acid supply to the fetus (Jackson et al., 2002). For example, 
research suggested that one consequence of the 8% maternal low protein diet is 
that it lowers maternal and fetal plasma taurine levels (Reusens et al., 1995). Cherif 
et al., (1998) fed pregnant rats the 8% low protein diet, but also offered the dams a 
2.5% aqueous taurine solution and found that supplemented offspring had normal 
insulin secretion. Similarly, supplementation of glycine to an alternative low protein 
diet prevented the development of higher blood pressure in the offspring (Jackson 
et al., 2002).  
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Thus, increased delivery of specific amino acids to low protein fed dams can prevent 
the programmed phenotype from developing, implying that the pattern of protein 
intake during pregnancy is critical with respect to later physiological function. 
Indeed, it may be critical with respect to longer term gene expression. Jaenisch & 
Bird (2003) stateĚ  “Cells of a multicellular organism are genetically homogeneous 
but structurally and functionally heterogeneous owing to the differential expression 
of genes ? ƚŚƵƐenvironmental cues can modify the mechanisms controlling this 
tissue specific gene expression regulation ?Žƌ ‘ĞƉŝŐĞŶĞƚŝĐƐ ?. Of interest to this study 
is how perturbations in fetal nutrient supply can cause lifelong changes in gene 
expression and even potentially transgenerational implications (Harrison & Langley-
Evans, 2009). One of the mechanisms for epigenetic regulation is gene silencing by 
increased methylation. DNA methylation involves the addition of a methyl group (-
CH3) ƚŽ ƚŚĞ Ɖ'ĚŝŶƵĐůĞŽƚŝĚĞƐ ĨŽƵŶĚ ŝŶ ƚŚĞ  ? ?ŐĞŶĞ ƉƌŽŵŽƚĞƌ ƌĞŐŝŽŶ (Bird, 2002), 
thus preventing the binding of RNA polymerase and silencing the gene. The 
methylated cytosine residues then facilitate the binding of CpG binding protein 
(MeCP)-2 which allows the binding of histone modification complexes (Fuks et al., 
2003). These complexes cause the deacetylation and methylation of histones, which 
cause the histones to form a closed chromatin structure, thus preventing gene 
expression (Fuks et al., 2003). It then follows that hyper-methylated DNA is 
generally silenced, while hypo-methylated DNA is transcribable. DNA methylation is 
an important factor during organogenesis and cellular differentiation; hence a 
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supply of maternal dietary methyl donors is vital to fetal developmental and 
postnatal health (Oligny, 2001; Reik et al., 2001). Dietary sources of methyl donors  
include folic acid (vitamin B12), choline and the amino acid methionine (Niculescu & 
Zeisel, 2002). Homocysteine is methylated to form methionine via methyl donation 
from choline or folate, the methionine goes on to form S-adenosylmethionine 
which in turn donates the methyl group to macromolecules such as DNA (Niculescu 
& Zeisel, 2002), see Figure 6.1 (Maloney et al., 2007). It therefore follows that 
maternal dietary restriction of folate, choline and methionine will cause fetal DNA 
hypo-methylation, as reviewed by Burdge et al., (2007).  
 
Figure 6.1 Diagram showing the interplay between methyl donors prior to DNA methylation 
SAM, S-adenosyl methionine; SAHcy, S-adenosylhomocysteine; 5-CH3-THF, methyl 
tetrahyrofolate; 5,10-CH2-THF, methylene tetrahydrofolate; DHF, dihydrofolate; THF, 
tetrahydrofolate. (a) serine hydroxymethyl transferase; (b) glycine N-methyl transferase; (c) 
cystathionine synthase. Diagram and legend taken from Maloney et al., (2007). 
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Petrie et al., (2002) observed elevated homocysteine in the pregnant rat following 
low protein feeding, while Andersson et al., (1992) found that maternal 
homocysteine is reduced by as much as 50% during pregnancy in healthy women, 
with homocysteine returning to non-pregnant levels shortly after parturition. 
Andersson et al., (1992) hypothesised that the reduction in homocysteine was due 
to the high fetal requirement of methionine. Lillycrop et al., (2005) showed that the 
deleterious effects of the maternal low protein diet in the rat could be overcome by 
folate supplementation, suggesting a mechanistic role for methyl deficiency in the 
developmental programming of disease induced by a maternal low protein diet. 
Indeed, ewes rendered methyl deficient around the time of conception produced 
offspring with higher blood pressure, reduced insulin sensitivity and altered 
immune function at 2 years of age (Sinclair et al., 2007).  
 
It was postulated that a maternal low protein diet in sheep would influence 
offspring physiological function, functions that became worse when the animals 
were metabolically stressed with obesity. It was hypothesised that maternal protein 
restriction would have effects on organogenesis, especially in a tissue with a 
demonstrated high plasticity following changes in the plane of maternal nutrition, 
such as the skeletal muscle. Furthermore, given that there is much information on 
the sensitivity of skeletal muscle to intrauterine growth restriction (Wigmore & 
Stickland, 1983; Handel & Stickland, 1987; Dwyer et al., 1994; Dwyer et al., 1995; 
Greenwood et al., 2000; Maltin et al., 2001; Brameld, 2004; Zhu et al., 2004; Fahey 
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et al., 2005a; Zhu et al., 2006; Daniel et al., 2007; Mallinson et al., 2007; Du et al., 
2010), reflected as changes in fibre type and fibre number and that skeletal muscle 
is the primary site for insulin-mediated glucose uptake, hence it was postulated that 
the expected changes in skeletal muscle morphology would persist into adult life 
and cause deleterious effects on glucose homeostasis in both the hyperglycaemic 
and hyperinsulinemic state. In order to obtain a global assessment of gene 
expression changes in this tissue type a X-species affymetric microarray was 
employed, as recently demonstrated in the horse (Graham et al., 2009).  
6.3 Materials & Methods 
6.3.1 GENERAL METHODS 
In brief, offspring were transported from the Macaulay Institute and acclimatised at 
the Sutton Bonington Campus. Following acclimatisation a further glucose tolerance 
ƚĞƐƚ ?'dd ?ǁĂƐĐŽŶĚƵĐƚĞĚŽŶĂůůƐŚĞĞƉ ?ƚŚŝƐǁŝůůďĞƌĞĨĞƌƌĞĚƚŽĂƐƚŚĞ “ůĞĂŶ'dd ? ?ƐĞĞ
2.4.2.2) and, shortly after, the sheep underwent body composition analysis by dual 
energy x-ray analysis (DEXA- see 2.4.2.3 ? ? ƌĞĨĞƌƌĞĚ ƚŽ ĂƐ  “ůĞĂŶ y ? ? &ŽůůŽǁŝŶŐ
these initial, lean investigations, the animals were exposed to an obesogenic 
environment (see 0), with the inƚĞŶƚŝŽŶŽĨŝŶĐƌĞĂƐŝŶŐƚŚĞĂŶŝŵĂůƐ ?ĨĂƚĚĞƉŽƐŝƚŝŽŶ ?ůů
animals were encouraged over a period of 6 months to put on 50% of their original 
ǁĞŝŐŚƚ ƉƌŝŽƌ ƚŽ ƚŚĞŝƌ ůĞĂŶ 'dd ? ƚ ƚŚŝƐ ƉŽŝŶƚ ƚŚĞ 'dd  ? “ŽďĞƐĞ 'dd ? ? ĂŶĚ y
 ? “ŽďĞƐĞy ? ?were repeated, individual appetite was recorded (see 2.4.2.5) and a 
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further insulin tolerance test conducted (ITT- see 2.4.2.6) followed by an insulin 
stimulated skeletal muscle biopsy (see 2.4.2.7). A week later all animals were 
euthanised (see 2.4.2.8). 
6.3.2 MICRO ARRAY 
6.3.2.1 DNA Isolation 
DNA was isolation using a Qiagen DNeasy Tissue & Blood Kit (Qiagen; Crawley, UK). 
In brief, 2.5g of frozen liver was ground under liquid nitrogen. The sample was 
placed in a micro centrifuge tube, 180µl of ATL buffer was added, followed by 20µl 
of Proteinase K. The solution was then vortexed and incubated for 3 hours at 56
o
C 
with occasional vortexing. 200µl of AL buffer and 200µl of 100% ethanol were then 
added to the lysed solution. The lysate was then pippetted into a DNeasy spin 
column with collection tube. This was centrifuged for 1 minute at 6,000g and the 
collection tube and its contents were discarded, and replaced with an empty tube. 
500µl of AW1 buffer was added to the column containing the DNA, this was then 
centrifuged for 1 minute at 6,000g, and the collection tube with contents were 
discarded and replaced again. 500µl of AW2 buffer was added to the column and 
centrifuged for 3 minutes at 20,000g. The collection tube and contents were 
discarded once again. The column was carefully placed into another collection tube. 
100µl of AE buffer was incubated in the column for 1 minute at room temperature 
and then centrifuged at 6,000g for 1 minute. A further 50µl of AE buffer was 
incubated and centrifuged through the column, as above. The collection tube 
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containing the DNA eluted in 150µl of AE was then analysed for quality and quantity 
by use of spectrophotometry (Nanodrop, Thermo Fisher). 
 
6.3.2.2 RNA Isolation 
0.75g of Vastus lateralis muscle was homogenised (Polytron) over ice in 7.5ml 
TRIreagent (Sigma) and then centrifuged (10 minutes, 12,000g at 4
o
C). The 
supernatant was isolated, allowed to stand for 5 minutes and 1.5ml chloroform was 
added. Samples were shook vigorously for 15 seconds, allowed to stand for 10 
minutes and then centrifuged (15 minutes, 12,000g at 4
o
C). The upper, colourless 
aqueous phase was decanted off and mixed 1:1 with isopropanol (Sigma). Samples 
were mixed by inversion, stood for 10 minutes and then centrifuged (10 minutes, 
12,000g at 4
o
C). The supernatant was discarded, the remaining RNA pellet was 
washed with 7.5ml 75% ethanol (Fisher Scientific), vortexed and then centrifuged (5 
minutes, 7,500g at 5
o
C). The supernatant was pippetted off, allowing the RNA pellet 
to dry. The RNA pellet was then dissolved in 50µl DEPC-treated water, whilst 
heating to 55
o
C for 10 minutes. Sample RNA quantity was then verified by 
spectrophotometry (Nanodrop, Thermo Fisher); this also gave a crude assessment 
of sample quality prior to capillary electrophoresis (Agilent Technologies).  
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6.3.2.3 Affymetrix Profiling 
X-species affymetrix investigation was used to investigate up or down regulation of 
mRNA from offspring skeletal muscle (Vastus lateralis). The microarray was 
ƉĞƌĨŽƌŵĞĚďǇƚŚĞEŽƚƚŝŶŐŚĂŵƌĂďŝĚŽƉƐŝƐ^ƚŽĐŬĞŶƚƌĞ ?Ɛ ?E^ ?^ƵƚƚŽŶŽŶŝŶŐƚŽŶ
Campus, University of Nottingham) microarray service. X-species Affymetrical 
analysis involves the hybridisation of genomic DNA from the species of interest, in 
this case Scottish blackface sheep, onto an Affymetric array from a heterologous 
species, in this case the GeneChip Human Genome U133 Plus 2.0 Array (9 samples) 
and GeneChip Human Genome ST Array (4 samples) (Affymetrix; High Wycombe, 
UK) as recently described by Graham et al., (2009) using an equine cross 
hybridisation. In brief, the genomic DNA hybridisation is used to develop a filter for 
normalisation, highlighting all the genes where the ovine DNA sequence is 
sufficiently homologous to the human DNA to allow analysis of mRNA regulation. 
Fluorescently labelled Scottish blackface mRNA was then pippetted into the 
GeneChip Human Genome Array (either U133 Plus 2.0 or ST), following the 
hybridisation of homologous mRNA, it was subsequently washed. The fluorescent 
intensity for each gene was then recorded and compared between treatment 
groups. mRNA was analysed from 4 animals at random per treatment group (i.e. 
4xCP, 4xLPE, 4xLPL).  
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6.3.2.4 Statistical analysis of microarray data 
Two genechip platforms were used in the study, one for n=9 samples and one for 
n=3 further samples (to increase study power). Therefore, prior to analysis, all data 
from both genechip platforms were combined (n=12 genechips) by mapping the 
genetic probes to gene symbols and subsequently normalized by using an Empirical 
Bayes cross-study method (Johnson et al., 2007). In addition, all equivalent data (i.e. 
from the n=9 U133 arrays only) were used as an alternative cross-checking input for 
the statistical analyses, as it contained replicates for all groups and therefore did 
not require further genechip normalization and reduction of results to only those 
overlapping genes from both platforms. Density and quantile-quantile plots before 
and after the cross-study normalization, indicated that the combined data, when 
normalised were suitable for formal statistical analysis and the results for a 
parametric and non-parametric normalization were very similar, but for the 
purposes of clarity only the equivalent geneset (U-133) are presented. 
  
For the statistical analysis of datasets, an empirical Bayes moderated t-statistic 
(eBayes) was used, where genes are sorted by q-value significance score adjusted 
for multiple testing according to the Benjamini-Hochberg method. All statistical 
analysis of microarray data were performed in a blinded fashion by Enrico Glaab, 
School of Computer science and are publicly available at 
http://www.arraymining.net/.    
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6.4 Results 
6.4.1 WEIGHT GAIN, BODY COMPOSITION & APPETITE 
6.4.1.1 Dual Energy X-Ray Absorptiometry 
At 1.5 years of age body weights were similar in each treatment group (CP, 55.0±2.0 
vs. LPE, 56.7±1.8 and LPL, 55.3±1.9 kg) and between males and females (57.5±1.6 
vs. 53.8±1.4 kg, respectively). At this time, body composition was also similar 
between treatment groups (Table 6.1), but bone mineral density was significantly 
different between females vs. males (Female, 1.12, Male, 1.063 SED 0.02).  
 
  Experimental Group   Statistics 
 Gender CP      LPE LPL s.e.d T G T*G 
Fat (%) male 15.4 14.3 8.9     
  female 13.6 13.8 16.1 3.29 NS NS NS 
Fat mass 
(kg) 
male 7.8 7.4 4.2         
female 6.1 6.4 7.9 1.85 NS NS NS 
Lean mass 
(kg) 
male 43.6 44.1 43.7         
female 42.1 40.3 40.1 3.47 NS NS NS 
BMD (g.kg
3
) male 1.088 1.04 1.06         
female 1.13 1.116 1.115 0.04 NS 0.016 NS 
BMC (g) male 1265 1171 1241         
female 1338 1177 1186 87.77 NS NS NS 
Table 6.1 Maternal Low Protein Study Offspring Body Composition for lean animals.  
Data are estimated marginal means ±1 SEM. CP, Control Protein (n=6); LPE, Low Protein Early 
(n=7), LPL, Low Protein Late (n=6). BMD (Bone Mineral Density) & BMC (Bone Mineral Content).   
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Considering the change in weight with time, there were no effects of treatment or 
gender on the gain in weight (all animals gained weight at ~107 g.day
-1
 for the first 
29 weeks) moving from a body condition score of ~2.5 to 4.5 arbitrary units. 
 
 
After the period of weight gain, body composition was similar between groups 
(Table 6.2), with the exception of bone mineral density (CP, 1.183, LPE, 1.133, LPL, 
1.151, SED 0.018) and bone mineral content which was significantly less in 
prenatally protein restricted groups (CP, 1.687, LPE, 1.594, LPL, 1.489kg, SED 0.061). 
In addition, females now had significantly less lean mass (female, 39.425 vs. male, 
45.83kg SED 2.06) and bone mineral content (female, 1532 vs. male, 1648, SED 
49.85) than male offspring (Table 6.2).  
 
  Experimental Group   Statistics 
 Gender CP LPE LPL s.e.d T G T*G 
Fat (%) male 28.73 28.80 17.55         
  female 30.40 29.60 29.63 4.15 NS NS NS 
Fat mass 
(kg) 
male 18.12 10.42 10.02      
female 17.84 16.75 16.24 4.01 NS NS NS 
Lean mass 
(kg) 
male 45.05 45.12 47.31         
female 40.03 39.81 38.43 3.51 NS 0.008 NS 
BMD 
(g.kg
3
) 
male 1.20 1.12 1.15         
female 1.17 1.15 1.16 0.03 0.028 0.028 NS 
BMC (g) male 1761 1648 1534         
female 1612 1540 1443 85.7 0.004 0.037 NS 
Table 6.2 Maternal Low Protein Study Body Composition in obese animals.  
Data are estimated marginal means±SEM. CP, Control Protein (n=6); LPE, Low Protein Early (n=7), 
LPL, Low Protein Late (n=6). BMD (Bone Mineral Density) & BMC (Bone Mineral Content).  
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The delta change in body composition was investigated using a repeated measures 
REML analysis to assess the additional main effect of time, together with the 
previous main effects of treatment and gender with possible interactions (Table 6.1 
vs. Table 6.2). Time, i.e. the exposure to the obesogenic environment, had a 
significant effect (P<0.001) on all measured variables excluding lean mass. However, 
the effect was clearly sex-specific with females putting on more fat mass (P=0.051), 
losing more lean mass (P=0.030) whilst male offspring gained a modest amount of 
lean mass, and thus the percentage fat mass also elevated more in females 
(P=0.048). Bone mineral density also increased less in the female, relative to male 
(P=0.005), offspring (Table 6.1 vs Table 6.2).  
6.4.1.2 Appetite 
Over a 3-4 day period, food intake was assessed each day. There was a significant 
effect (P=0.03) of treatment on daily food intake, with LPE eating significantly less 
(20.7±0.5 MJ/day) than either CP (22.2±0.5 MJ/day) or LPL (21.5±0.5 MJ/day), but 
this effect was not reflected during an acute 2h-intake study (CP, 12.4±0.9; LPE, 
13.2±0.8; LPL, 12.6±0.8 MJ/day). In addition, males tended (F,4.11; P=0.06) to eat 
more than females (22.1±0.4 vs. 20.9±0.4 MJ/day, respectively). Appetite, however, 
was not influenced by prenatal diet or gender with all animals eating on average 
13.2±0.8 MJ in the first 2 hours after 24h fasting. 
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6.4.2 GTT & ITT BLOOD ANALYSIS 
6.4.2.1 Insulin 
6.4.2.1.1 Baseline 
Lean fasted plasma insulin concentrations were similar for all dietary groups 
(pooled estimate, 0.39±0.07 ng.ml
-1
). In obese animals, fasted plasma insulin was 
significantly elevated (F, 7.12; P=0.009) in LPE males (0.61±0.08 ng.ml
-1
) vs. other 
males (pooled estimate, 0.24±0.07 ng.ml
-1
).  
6.4.2.1.2 Response to a Glucose Bolus (GTT) 
There were no main effects, treatment or gender, or interactive effects on insulin 
sensitivity (area under the insulin response curve) when the animals were lean 
(Figure 6.4). The peak insulin response and insulin AUC were significantly greater in 
all obese vs. lean animals (both P<0.001 Figure 6.4). For both the peak insulin 
response and insulin AUC in the obese animals there was a significant 
time*treatment interaction (P=0.010 & P=0.008, respectively). These significant 
effects were generated by the elevated insulin response to glucose in the LPE obese 
offspring. A time*treatment*gender effect was also observed for the Insulin AUC, 
this is mainly attributed to the greater insulin response between lean and obese LPE 
males compared to all other respective groups. 
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Figure 6.2 The response of prenatally protein restricted adult sheep to a glucose tolerance test 
when lean and obese.  
Data are Mean ±1 SEM. Glucose was administered I.V. (0.5g.kg-1) and blood samples collected for 
measurement of plasma glucose and insulin (by ELISA, 2.5.1.4). *indicates significant 
time*treatment interaction on insulin response (P=0.010) and AUC (P=0.008). CP, Control protein 
(n=6); LPE, Low Protein Early (n=7), LPL, Low Protein Late (n=6). 
0
1
2
3
4
5
6
7
8
-20 0 20 40 60 80 100 120
In
su
li
n
 (
n
g
.m
l-
1
)
Time (mins)
Lean Insulin
CP LPE LPL
0
1
2
3
4
5
6
7
8
-20 0 20 40 60 80 100 120
In
su
li
n
 (
n
g
.m
l-
1
)
Time (mins)
Obese Insulin
CP LPE LPL
0
5
10
15
20
25
-20 0 20 40 60 80 100 120
G
lu
c
o
se
 (
m
m
o
l/
L
)
Lean Glucose
CP LPE LPL
0
5
10
15
20
25
-20 0 20 40 60 80 100 120
G
lu
c
o
se
 (
m
m
o
l/
L
)
Obese Glucose 
CP LPE LPL
*
 
 
 
 
 
 
 
 
Chapter 6  159 
Low Protein Study ± 1.5 to 2 years of age 
 
 
 
 
 
Figure 6.3 GTT Insulin AUC to Glucose AUC Ratio 
Figure showing the Insulin AUC to Glucose AUC ratio in lean and obese offspring. Error bars are ±1 
SED. Treatment Groups are CP (Control Protein), LPE (Low Protein Early) and LPL (Low Protein 
Late). A significant effect of time, i.e. the development of obesity, was observed (P<0.001), while 
a time*treatment effect (P=0.01) and treatment*sex (P=0.054) trend were observed seen. 
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Figure 6.4 Plasma insulin peak response (top) and AUC (bottom) in lean and obese male and 
female prenatally protein restricted adult sheep during a glucose tolerance test. 
Data are predicted means ±1 SEM. CP, Control Protein (n=6); LPE, Low Protein Early (n=7), LPL, 
Low Protein Late (n=6). Data were analysed by repeated measures linear mixed model revealing a 
significant effect of time (Lean vs. obese; P<0.001 all cases), treatment*time (Peak Insulin P=0.010 
& Insulin AUC P=0.008) and an insulin AUC treatment*time*gender interaction (P=0.015).  
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6.4.2.2 Glucose 
6.4.2.2.1 Baseline 
A treatment*gender interaction was observed on baseline plasma glucose in lean 
animals (P=0.009). Male LPE animals had a higher baseline glucose than their 
female counterparts (male 4.00±.029 vs. female 3.22±.018 mmol/L), this effect was 
reversed in LPL animals (male 3.23±.029 vs. female 3.88±0.20 mmol/L, CP male 
3.61±0.20; female 3.53±0.29 mmol/L). In obese animals, fasted plasma glucose 
concentrations were similar, irrespective of treatment group or gender (pooled 
estimate, 3.19±0.14 mmol.L
-1
). In addition, fasted plasma glucose was significantly 
lower in obese animals compared to lean (P=0.020).  
6.4.2.2.2 Response to a Glucose Bolus (GTT) 
After administration of I.V. glucose, plasma glucose rose to a similar extent in all 
groups (Figure 6.2). No effect of prenatal treatment or gender was observed on lean 
or obese glucose tolerance (area under the glucose response curve), but a 
significant effect of time was observed (lean 742.2 vs. obese 1105.0 arbitrary AUC 
units; SED 47.4 P<0.001).  
6.4.2.2.3 Response to an Insulin Bolus (ITT) 
Following the administration of the insulin bolus, the blood glucose level initially 
elevated, but then declined (Figure 6.5), the rate and extent of decline was similar 
between groups (pooled estimate, KITT, 3.36±0.45; AUC, -5.84±0.68 mmoles in 2h).  
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Figure 6.5 The glucose, NEFA and triglyceride response of prenatally nutrient restricted adult 
sheep to an insulin tolerance test when obese.  
Data are Mean ±1 SEM. Insulin (0.75IU.kg
-1
) was injected I.V. at time zero. Statistics are *, P<0.05, 
relative to baseline. CP- Control Protein, LPE- Low Protein Early, LPL- Low Protein Late.  
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6.4.2.3 Insulin AUC : Glucose AUC Ratio 
A insulin:glucose ratio was calculated by dividing the Insulin AUC in response to a 
GTT by the Glucose AUC in lean offspring and comparing it to the equivalent ratio 
for obese offspring. The intention of this was to evaluate the confounding effect of 
administering differing glucose qualities in lean vs. obese offspring. A significant 
effect of time, i.e. the development of obesity, was observed (P<0.001), with a 
greater insulin to glucose response being observed in obese animals compared to 
control. A time*treatment effect (P=0.01) and treatment*sex (P=0.054) trend was 
observed (Figure 6.3). These observations relate to a greater insulin response in all 
obese LPE and female LPL offspring.  
6.4.2.4 Lipid Metabolism 
6.4.2.4.1 Baseline 
Error! Reference source not found. shows the observed treatment effects on 
components of lipid metabolism in lean and obese offspring. The only treatment 
effects observed were in lean animals; Glycerol (LPE > Control, P=0.029) and LDL 
(LPE < Control, P=0.050). An effect of gender was observed on lean plasma baseline 
NEFA (Female 0.7232 vs. Male 0.9871 mmol/L; SED 0.1205. P=0.041). A 
time*treatment*gender effect was shown on NEFA, (P=0.021), which is attributed 
to a shift in male LPE offspring with the onset of obesity (lean 1.37 vs. obese 0.6375 
mmol/L, SED 0.1721). The development of obesity significantly elevated baseline 
Chapter 6  164 
Low Protein Study ± 1.5 to 2 years of age 
 
plasma triglyceride, total cholesterol, HDL, and leptin levels, as well as significantly 
reducing glycerol and NEFA levels, LDL levels were unaffected (Error! Reference 
source not found.). A treatment*time interaction was observed for baseline total 
cholesterol (P=0.036) and HDL (P=0.020), both showing the same trend, male 
controls > treatment groups and female controls < treatment groups (total 
cholesterol CP female 1.23 & male 1.563, LPE female 1.51 & male 1.175, LPL female 
1.623 & male 1.165 mmol/L SED 0.20) (HDL CP female 0.53 & male 0.765, LPE 
female 0.746 & male 0.58, LPL female 0.73 & male 0.54 SED 0.1018). A time*gender 
effect (P=0.004) was observed for plasma baseline LDL levels with lean male LDL 
baseline being lower than female, but then obese male being far greater than the 
female baseline (female lean 0.2388 vs. obese 0.2467, male lean 0.2042 vs. obese 
0.2908 SED 0.02383).  
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  Experimental Group   Statistics 
 Time CP LPE LPL s.e.d T Ti T*Ti 
Triglyceride  lean 0.11 0.15 0.12     
(mmol.L
-1
) obese 
0.20 0.23 0.23 0.027 
NS P<0.001 NS 
Glycerol  lean 65.49 97.1 64.52  P=0.029*   
(µmol.L
-1
) obese 
69.13 58.15 56.08 11.24 
 
P=0.026 P=0.056 
NEFA  lean 0.84 1.05 0.68     
(mmol.L
-1
) obese 
0.63 0.68 0.71 0.12 
NS P=0.056 NS 
Total cholesterol 
(mmol.L
-1
) 
lean 1.40 1.34 1.39     
obese 2.46 2.04 2.15 0.19 NS P<0.001 P=0.037 
HDL  lean 0.65 0.66 0.64     
(mmol.L
-1
) obese 
1.44 1.18 1.17 0.11 
NS P<0.001 P=0.021 
LDL  lean 0.23 0.19 0.24  P=0.050*   
(mmol.L
-1
) obese 
0.28 0.26 0.30 0.03 
 P=0.004 NS 
Leptin  lean 3.40 4.23 3.88     
(ng.ml
-1
) obese 
11.48 11.93 7.32 2.84 
NS P<0.001 NS 
Table 6.3 The effect of adult-onset obesity on lipid metabolites in sheep.  
Data are predicted means with the average standard error of the difference (s.e.d with 13 degrees of 
freedom in all cases) for the comparison. CP, Controls (n=6); LPE, Low Protein Early (n=6), LPL, Low 
Protein Late (n=7). NEFA, non-esterified fatty acids, HDL  W High density lipoprotein. LDL  W Low density 
lipoprotein. T, main effect of treatment; Ti, main effect of time (i.e. becoming obese); T*Ti, interaction 
between treatment and time. Treatment effects observed for plasma glycerol and LDL were seen in 
lean animals only. 
 
6.4.2.4.2 Response to a Glucose Bolus (GTT) 
Components of lipid metabolism were also measured during the GTT (Figure 6.6). A 
treatment*gender*time interaction was observed in NEFA levels following the GTT 
(P=0.045; Figure 6.6), showing a greater response in lean LPE males to a GTT. 
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Figure 6.6 The lipid metabolite response to a glucose tolerance test in male and female lean 
and obese sheep.  
Data are Mean ±1 SEM for areas under the glucose response curve (respective AUC units). 
Treatment groups are CP (Control Protein); LPE (Low Protein Early) & LPL (Low Protein Late).  
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6.4.2.4.3 Response to an Insulin Bolus (ITT) 
Following the intra-jugular insulin injection, plasma NEFA level elevated and almost 
returned to baseline after the 16 min recording period (Figure 6.5). Plasma 
triglyceride levels peaked around 2 mins after the insulin bolus was injected, then 
dropped back to baseline levels by 16 minutes (Figure 6.5). Neither the NEFA or TAG 
response to the insulin (KITT) or the AUC were affected by gender or prenatal 
environment.  
6.4.2.5 Protein Metabolism 
As a crude measure of protein metabolism, plasma amino acid concentrations and 
urea were measured. No effects of maternal treatment or gender were observed, 
but a significant effect (P<0.001) was seen with the development of obesity, with 
total plasma amino acid and urea concentrations decreasing (total amino acid- lean 
9210 vs. obese 6282 nmoles.ml
-1
, SED 1113; urea- lean 8.805 vs. obese 5.155 
mmol.L
-1
, SED 0.4). Due to the interrelationship between the various amino acids, 
principle components analysis (PCA) was employed to draw out the amino acids 
which account for the majority of the variation between the lean and obese state. 
PC1 accounted for 79% of the variation, PC2 12% and PC3 5%, which in total 
accounted for >95% of the variability in amino acid concentrations between the 
lean and obese states. PC1 was then run as a variate within regression analysis and 
indicated a strong treatment*time interaction (P<0.001; Figure 6.6); with the 
average predicted means being (CP lean 4.169±0.4247 to obese -5.140±0.4247; LPE 
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Figure 6.7 Graph showing the interaction between time (lean or obese) and maternal 
treatment on the amino acid population.  
PC1 and PC2 are arbitrary values generated by principle components analysis to account for the 
variation across the entirety of the amino acids analysed. PC1 accounts for 79% and PC2 21% of 
the variation. Treatment, time and treatment*time all significantly (P<0.001) affected the PC1 
value. Circles around treatment groups represent 95% confidence intervals. Treatment groups 
are CP (Control Protein); LPE (Low Protein Early) & LPL (Low Protein Late). 
 
lean 4.936±0.4103 to obese -6.020±0.4103; LPL lean 7.396±0.4247 to obese -
6.567±0.4460).  The graph represents these means +/- 95% confidence interval of 
the mean and illustrates the main effect of becoming obese (e.g. time, PC1) 
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6.4.2.6 Electrolytes & Haemodynamics 
6.4.2.6.1 Baseline 
Fasted blood biochemistry when lean and obese are given in Table 6.4. With 
obesity, animals became more alkalotic as reflected in increases in blood pH, pvO2 
and acid-base excess and a decrease in PvCO2. In addition, blood electrolytes also 
changed significantly; Ca
2+ 
increased, whilst Na
+
 and K
+
 declined (Table 6.4). Apart 
from the effect of obesity, a significant effect of gender (P=0.031) was observed on 
lean PvO2 (female 47.24 vs. male 42.47 mmHg, SED 1.954) as was a 
treatment*gender interaction effect for lean K
+ 
(CP male 4.2 & female 4.3; LPE male 
4.3 & female 4.4; LPL male 4.5 & female 3.9, mmol.l
-1
, SED 0.2). Finally there was a 
significant interaction between the onset of obesity with treatment on PvCO2 (CP, 
lean 41.65 & obese 40.81; LPE lean 51.67 & obese 40.87; LPL lean 46.46 & obese 
45.01mmol.L-1. SED 3.61).  
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 Baseline concentration Statistics 
  Lean  Obese s.e.d P 
pH 7.396 7.424 0.02058 NS 
PvCO2 (mmHg) 46.59 42.23 1.731 0.014 
HCO-3 (mmol.L
-1) 26.14 26.4 0.8881 NS 
PvO2 (mmHg) 37.17 44.85 0.9845 <0.001 
ABE (mEq.L-1) 3.174 2.783 0.9623 NS 
Na+ (mmol.L-1) 143.6 140.9 0.4635 <0.001 
K+ (mmol.L-1) 4.246 4.038 0.07009 0.005 
Ca2+ (mmol.L-1) 1.171 1.232 0.0165 0.004 
Cl- (mmol.L-1) 104.5 103.3 0.8914 NS 
Table 6.4 Baseline blood biochemistry in lean and obese adult sheep.  
The change in resting blood biochemistry from a lean to obese state as measured on an ABL-
800Flex (Radiometer Ltd, UK). Data are Grand Means with standard error of the difference and 
the df for the comparison of 13. P, for effect of time (i.e. onset of obesity). NS, not significant. 
 
6.4.2.6.2 Response to a Glucose Bolus (GTT) 
Metabolic flexibility was assessed by measurement of blood metabolic markers, 
before and after a metabolic challenge such as glucose (GTT) or insulin (ITT) bolus. 
When blood biochemistry was investigated in response to a GTT, no effect of sex 
was observed, with the only variate affected by treatment being lean blood Ca
2+ 
concentration (Table 6.5). However, the delta change in blood biochemistry during 
a GTT changed with obesity (i.e. a significant effect of time was indicated) i.e.  the 
changes in pH, PvCO2, PvO2, ABE, and Na
+
 were all blunted (Table 6.5). Haemoglobin 
(Hb) concentrations and haematocrit (Hct) were similar in all groups when 
measured as obese animals (Hb: CP 13.1±0.9; LPE 15.8±0.9; LPL 14.3±0.9g.dL
-1
; Hct: 
CP 35.9; LPE 40.2; LPL 38.6 %. SEM 2.7).  
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Experimental Group Statistics 
 
Time CP LPE LPL s.e.d T Ti T*Ti 
pH  lean 0.02 0.12 0.08         
  obese 0.00 0.02 0.04 0.037 NS 0.009 NS 
PvCO2  lean -0.10 -10.92 -6.61         
(mmHg) obese -1.73 -0.41 -4.51 3.726 NS 0.042 0.045 
PvO2  lean -0.10 -10.92 -6.61         
(mmHg) obese -1.73 -0.41 -4.51 3.726 NS 0.042 0.045 
ABE  lean 1.44 3.35 1.41         
(meQ.L
-1
) obese -0.75 1.58 0.20 1.307 NS 0.011 NS 
K
+
  lean -0.35 -0.47 -0.40   
   (mmol.L
-1
) obese -0.06 -0.68 -0.48 0.176 NS NS NS 
Na
+
  lean -0.75 -2.35 -1.00         
(mmol.L
-1
) obese -1.63 0.95 0.13 1.078 NS 0.035 0.007 
Ca
2+
  lean 0.01 -0.03 -0.04         
(mmol.L
-1
 obese 0.01 -0.06 -0.07 0.026 P=0.017 NS NS 
Cl
-
  lean -0.88 -1.00 1.13         
(mmol.L
-1
) obese -0.25 0.05 0.88 1.231 NS NS NS 
Table 6.5 The delta change in metabolites during a GTT when lean or obese.  
Data are predicted means with the average standard error of the difference (s.e.d with 13 
degrees of freedom in all cases) for the comparison. CP, Controls (n=6); LPE, Low Energy Early 
(n=7), LPL, Low Energy Late (n=6). T, main effect of treatment; Ti, main effect of time (i.e. 
becoming obese); T*Ti, interaction between treatment and time. 
 
6.4.3 ORGAN WEIGHTS 
Organ absolute weight and organ:body weight ratios are presented in (Table 6.6). 
Although male offspring were significantly heavier than female, males had a 
significantly heavier brain, total kidney mass, liver, lungs and larger right ventricle 
wall. All of these effects were removed when organ weight/size were expressed as a 
ratio of body weight, except the lungs, which were still heavier in males than 
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females. Per unit of body weight, females had more omental fat than males. 
Treatment effects were also observed on left ventricular size, which was 
significantly larger in LPE (CP, 15.4±0.8; LPE 18.0±0.7; LPL 15.3±0.8 mm, P=0.038) 
who had more pericardial fat (CP, 196.15±18.83; LPE 262.63±18.19; LPL 
172.19±18.83 g, P=0.011), even when adjusted to body weight (CP, 2.69; LPE 3.41; 
LPL 2.39 g SEM 0.26, P=0.044). A treatment effect was also observed on the 
pituitary weight (CP, 11; LPE, 9; LPL, 8 g.kg
-1
 ×10
3
 SEM 1, P=0.022). A 
treatment*gender interaction was also observed on pancreatic tissue weight (CP 
male 0.94±0.07, female 1.02±0.1; LPE male 0.79±0.10, female 1.02±0.06; LPL male 
1.18±0.10, female 0.86±0.07).  
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  Absolute weights P Relative weights (g/kg) P 
  Male Female   Male Female 
 
Body weight (kg) 78.2±2.8 68.6±3.2 * - - - 
Brain (g) 107±3 91±3 ** 1.37±0.06 1.26±0.05 NS 
 ?
Hippocampus (g) 3.95±1.78 2.87±1.55 NS 56±28 41±25 * 
 ?
Pituitary (g) 0.67±0.06 0.75±0.05 NS 9±1 11±1 * 
Perirenal Fat (kg) 2.083±0.26 2.527±0.23 NS 26.71±3.64 35.66±3.17 NS 
Pericardial Fat (g) 220.9±16.2 199.7±14.1 NS 2.82±0.23 2.84±0.20 NS 
Omental Fat (kg) 2.62±0.35 3.31±0.30 NS 33.68±4.30 46.71±3.74 * 
Total kidney (g) 156±8 126±7 ** 2.03±0.12 1.77±0.10 NS 
 ?
Total adrenal (g) 4.06±0.41 4.51±0.35 NS 53±7 65±6 NS 
Liver (g) 789±35 662±31 * 10.26±0.45 9.34±0.39 NS 
Pancreas (g) 74.5±4.3 68.2±3.8 NS 0.97±0.05 0.97±0.05 NS 
Spleen (g) 103±7 89±6 NS 1.360.08 1.25±0.07 NS 
Lungs (g) 651±47 471±41 * 8.44±0.60 6.64±0.52 * 
Heart (g) 306±28 286±24 NS 3.96±0.33 4.03±0.29 NS 
Septum (mm) 17.8±1.0 17.7±0.9 NS - - - 
Left Ventricle 
(mm) 
16.1±0.7 16.3±0.6 NS - - - 
Right Ventricle 
(mm) 
8.3±0.4 6.9±0.3 * - - - 
Table 6.6 Post Mortem organ weights in male and female sheep.  
Body and organ wet weights of male (n=11) and female (n=9) offspring at post mortem. Data are 
Grand Means±SEM. Statistics are *, **, ***, P<0.05, P<0.01 or P<0.001 respectively for male vs. 
female. NS, not significant. 
 ?
, relative hippocampal, adrenal and pituitary weight expressed as  
(g.kg
-1
)×10
3
.  
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6.4.4 MICROARRAY RESULTS 
The independent and unbiased microarray data analysis suggested that of the top 
100 differentially expressed genes that satisfied our a priori statistical criteria, then 
three main outcomes were evident; 1) that the LPE group displayed by far the 
largest proportion of differentially expressed genes (87%, Figure 6.7), 2) that these 
differentially expressed genes in LPE were largely down-regulated relative to other 
groups, as indicated by the heat-map (Figure 6.8) and 3) that the only pathway or 
related gene-set that was significantly down-regulated, according to KEGG pathway 
ĐƌŝƚĞƌŝĂ ǁĂƐ  ‘ƵďŝƋƵŝƚŝŶ-ŵĞĚŝĂƚĞĚ ƉƌŽƚĞŽůǇƐŝƐ ? ? ǁŝƚŚ ƚŚĞ ŽƚŚĞƌpathways influenced 
(determined by geneset enrichment analysis; GSEA) being all associated with 
ubiquitination, intracellular proteosomal activity and protein degradation or TGF-
beta signaling. Importantly, in relation to our original hypothesis we saw no 
significant effects on pathways, or indeed individual genes, in the insulin-signalling 
pathway. 
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Figure 6.8 Graph showing the effect of maternal protein restriction on differential regulation 
of mRNA transcription. 
The graph shows the quantity of differentially regulated genes by maternal treatment groups 
using X-Species hybridisation with the GeneChip Human Genome U133 Plus 2.0 Array. 
Treatment groups are CP; Control Protein, LPE; Low Protein Early, LPL; Low Protein Late. 
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Figure 6.9 Heat map showing the up or down regulation of gene transcription following 
maternal protein restriction. 
Heat map showing differential regulation of mRNA transcription from the skeletal muscle (Vastus 
lateralis) of obese offspring following maternal protein malnourishment. Treatment groups are 
CP; Control Protein, LPE; Low Protein Early, LPL; Low Protein Late, n=3 in all groups. 
 
          LPE                     LPL                 CP 
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6.5 Discussion 
Aged 1.5 yrs and lean, maternal protein restriction had no effect on offspring body 
mass or body composition. With significant weight gain (essentially of fat), there 
was also no effect of maternal diet on the amount or distribution of the increase in 
fat mass but bone mineral content and density significantly reduced in offspring 
exposed to low protein during early or late gestation. The effects of maternal 
insults, such as low vitamin D status have been reported as a cause of reduced bone 
mineral content in children aged 9 yrs (Javaid et al., 2006). Mehta et al., (2002) also 
observed reduced bone area and mineral content in adult rat offspring following 
exposure to maternal low protein diet. Our observation that a reduction in bone 
mineral content and density relative to control was only observed after exposure to 
an obesogenic environment would fit with the mis-match theory of fetal 
programming, similar to the sequelae leading to the deleterious effects seen on 
cardiovascular function in sheep (Cleal et al., 2007a). It would appear that the 
protein restriction in utero altered underlying physiology that was only  ‘ƌĞǀĞĂůĞĚ ?
once the offspring were challenged with exposure to an obesogenic milieu, albeit 
relatively short-term  W emphasising the significance of prenatal programming and 
the importance of maternal consumption of a balanced diet.  
 
This study has once again revealed significant sex-specificity in response to 
alternation in maternal diet; effects only apparent after a nutritional transition in 
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adult life, with female offspring gaining more fat mass, losing more lean mass, thus 
increasing the percentage fat, as well as female bones increasing their bone mineral 
density to a lesser extent than males exposed to the same environmental 
conditions. Mendez et al., (2005) found that women seem to be particularly 
susceptible to obesity following the recent global nutritional transition (shifts in 
quality and quantity of food intake and reductions in physical activity). It is possible 
that one cause underlying this sex effect in female offspring in this study is that they 
were observed to consume more food in a 24hr period than male offspring, 
although their acute 2hr consumption was comparable to males. Although this 
could be an artefact of the appetite testing protocol, as female humans have been 
observed to eat more following exposure to a stressful situation (Epel et al., 2001); 
it is possible that the female offspring found the appetite testing regimen (e.g. 
individual housing etc) particularly stressful, and hence they consumed more than 
males.  
 
Once again, as discussed in Chapter 4, the levels of glucose and insulin response 
following the GTT were greater in obese animals compared to lean. This effect is 
attributed to both the biological effects of obesity (e.g. increased adipose 
deposition), as well as the study design. The glucose was administered per unit of 
body weight, so a larger glucose bolus was given to the obese animals compared to 
lean, which will result in a greater physiological response to retain euglycemia. The 
insulin to glucose AUC ratio helps to support the fact that we are observing a true 
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biological effect rather than a consequence of a confounding variable, as the obese 
ratio was significantly greater than the lean, and the treatment effects were also 
reflected in the LPE offspring. One other significant consequence of the onset of 
ŽďĞƐŝƚǇǁĂƐƚŚĞƌĞĚƵĐĞĚǭŵĞƚĂďŽůŝĐĨůĞǆŝďŝůŝƚǇ ?(Storlien et al., 2004), as assessed by 
the shift in metabolic and physiological parameters following a change in fuel 
supply, in this case a glucose bolus.  
 
Few effects of prenatal protein restriction were observed when the adult offspring 
were lean, although male LPE offspring had a significantly lower resting glucose and 
LDL concentration, with a significantly higher glycerol compared to control. With 
the transition to obesity, however, male LPE offspring had the greatest decrease in 
plasma NEFA concentration, a high baseline plasma insulin concentration and a 
markedly greater insulin response (both peak and AUC) following a glucose 
challenge (hyperglycaemia and hyperinsulinemia). These effects occurred without 
change to plasma glucose dynamics over the course of the challenge. It is of interest 
that the elevated insulin response to a GTT in 7 month old LPE male offspring was 
not as evident at 18 months, but had returned following significant fat mass 
accretion in adult life. One potential explanation may be that the response is linked 
to growth, in that at 7 months the offspring are going through a relatively high 
growth phase, at least in comparison to aged 18-24 months and again with 
significant fat accretion, there is a substantial redistribution/reallocation of energy. 
Growth hormone, IGF and other components of the growth hormone axis are 
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known to have negative consequences on insulin action and subsequently, glucose 
homeostasis (as reviewed by Holt et al., (2003)). It is possible that aged 7 months 
the animals were in a dynamic phase of their development, with a particularly 
active GH-IGF system causing elevating insulin resistance. One could only assume 
that this effect is only seen in the LPE offspring as the stimulated GH-IGF axis may 
exacerbate an underlying condition generated by the fetal protein restriction during 
early gestation. Aged 18 months the animals are deemed adult, having completed 
puberty, as well as reaching their genetic/epigenetic growth potential. In this more 
stable endocrine environment it would appear that offspring were more able to 
cope with the hyperglycaemia and subsequent hyperinsulinemia following a GTT. 
Aged 24 months, and once again undergoing a metabolically dynamic response to 
environmental conditions, then the disadvantageous phenotype reappeared.  
 
 
At this time, and in similarity to 7 months of age, the elevated insulin peak and AUC 
following a glucose challenge in LPE were observed independently from any 
significant effect on glucose disposal i.e. inferred from no difference in either the 
glucose curve after the GTT and glucose disposal rate after the ITT. As previously 
described in earlier Chapters, this suggests a deregulation of hepatic glucose 
handling (increased hepatic portal vein appearance of insulin coupled with 
decreased hepatic insulin removal). Work in the late 1980s aimed to elucidate the 
mechanisms involved in elevated insulin resistance in the obese state in sheep 
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(McCann et al., 1986; McCann et al., 1987; Bergman et al., 1989; McCann et al., 
1989). This work not only pointed to increased pancreatic insulin secretion (McCann 
et al., 1989), but also to reduced peripheral insulin receptor number/function, 
rather than peripheral post receptor malfunction (Bergman et al., 1989). The 
obesity model by this group in the later publication was an adult onset, chronic (one 
year), high fat/isocalorific model leading to a doubling of body mass (lean~50 to 
obese~100kg) during a relatively static growth phase. Whilst there are many 
similarities between this model and the second phase of the current study i.e. the 
phase of fat mass accretion, two major differences are key: firstly, the level of 
obesity we produced in the model described here is half that of the Bergman model 
and secondly, Bergmann observed elevated basal plasma glucose presumably 
through increased hepatic gluconeogenesis. In the present study, a significant 
decrease in basal plasma glucose was observed in obese relative to lean offspring. 
An acute (5 day) high fat/high calorific feeding study in healthy human subjects, 
without a predisposition to insulin resistance, resulted in hepatic insulin resitance 
rather than periphereal (Brons et al., 2009). Kim et al., (2007) investigated changes 
in glucose homeostasis following obesity induced by a high-fat diet in dogs, and 
concluded that hyperinsulinemia was as a result of a combined increase in 
pancreatic insulin secretion and reduced first pass insulin clearance by the liver. 
They suggest that reduced hepatic insulin clearance is an adaptive mechanism to 
ŚĞůƉƉƌĞǀĞŶƚɴ ĐĞůů ĞǆŚĂƵƐƚŝŽŶ ?ŐĞĚ  ?ǇƌƐŽůĚ ? ƚŚĞ>W male and all LPL offspring 
had reduced pancreatic tissue weight at post mortem. Bonner-Weir (Bonner-Weir, 
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2000a, b) explaŝŶƐƚŚĂƚĐŚĂŶŐĞƐŝŶƉŽƐƚŶĂƚĂůɴ-cell mass are due to 4 mechanisms, 
1) apoptosis, 2) neogenesis/differentiation of precursor cells, 3) proliferation and/or 
4) hypertrophy of existing cells. These may all operate albeit at different rates under 
different physiological environments and at different postnatal ages. Thus it is 
difficult to conclude in the current dataset which of these mechanisms may 
underpin the differences we observe in pancreatic mass, and even whether the 
ĚŝĨĨĞƌĞŶĐĞƐŝŶƉĂŶĐƌĞĂƚŝĐŵĂƐƐƌĞůĂƚĞƚŽĂƌĞĚƵĐƚŝŽŶŝŶɴĐĞůůŵĂƐƐ. ZĞĚƵĐƚŝŽŶƐŝŶɴ
cell mass and function postnatally are a consistent observation following maternal 
low protein diet in the rat model (Holemans et al., 2003). One potential hypothesis 
linking the lower pancreatic mass with the increased insulin response to a glucose 
challenge is that if LPE offspring are rendered less able to ŝŶĐƌĞĂƐĞ ɴĐĞůůŵĂƐƐ or 
have increased apoptosis within pancreatic tissue, then development of an 
alternative strategy to preserve ŝŶƐƵůŝŶ ĂŶĚ ƉƌĞǀĞŶƚ ɴ-cell exhaustion (such as 
reduced first pass hepatic insulin clearance) would seem a logical adaptation in 
order to maintain the longer term health of the animal, especially in a ruminant 
where the liver is central to the production of new glucose.  
 
As well as differences in LPE pancreatic tissue mass at post mortem aged 2yrs, 
differences were also observed in LPE hearts (increased pericardial fat mass and left 
ventricular width). Left ventricular hypertrophy has also been observed following 
prenatal energy restriction in combination with postnatal exposure to an 
obesogenic environment (Chan et al., 2009) ? ŚĂŶ ?Ɛ ƐƚƵĚǇ ĚŝĚ ŶŽƚ ŽďƐĞƌǀĞ ŵĂũŽƌ
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physiological effects, but cardiac lipid infiltration was observed, which may fit with 
our finding that pericardial mass was increased. Although in our study 
cardiovascular function was not assessed, these remodelling events (e.g. left 
ventricular hypertrophy) have been observed in obese humans with cardiovascular 
disease (Powell et al., 2006; Abel et al., 2008). Finally, prenatal protein restriction 
also significantly limited the size of the pituitary in obese offspring compared to 
control. However, given the effect size in this instance, the difference may reflect 
sampling variation and further confirmation in other studies would provide more 
convincing evidence of a specific effect of prenatal protein restriction on pituitary 
growth.  
 
In terms of the overall effect of programming on markers of protein metabolism 
then whilst lean, the adult offspring are relatively comparable despite a maternal 
low protein diet (Figure 6.6). Once offspring develop obesity, a definite downward 
shift in the amino acid profiles of all offspring occurs (toward lower total plasma 
amino acid) but in those that were maternally protein restricted, the downward 
shift separates them dimensionally from control offspring, in effect, the low protein 
exposed groups exhibit less intraspecific variation with obesity relative to controls.  
 
Although the intention was to investigate the specific amino acid profile of the 
offspring following maternal protein malnourishment, it has become clear that a 
snap shot approach (a single blood sample) would not give a true reflection of the 
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amino acid metabolism due to the high complexity of the interplay between various 
amino acids. The reduction in lean mass in female offspring, with modest lean mass 
accretion in male offspring, paralleled with the depleted blood total amino acid and 
urea concentration suggests a reduction in protein metabolism, especially in female 
offspring. A recent review on the effect of obesity on protein metabolism (Guillet et 
al., 2011) still fails to draw a firm conclusion as to the effect of fat mass accretion on 
protein synthesis and degradation, and without specific stable isotope measures of 
the rates of flux of essential amino acids into and out of the free amino acid pool it 
is difficult to draw firm conclusions as to the present results on protein metabolism 
with obesity. As discussed previously in Chapter 4, the elevated lipid content of the 
diet (6%) could be having an inhibitory effect on microbial protein synthesis, thus 
reducing host protein availability, amino acid absorption and hence plasma amino 
acid concentration. With decreased availability of amino acids, protein synthetic 
rate will be reduced and therefore in order to maintain skeletal muscle mass, it 
would follow that protein degradation must also be down-regulated to maintain 
relatively increased amino acid availability for synthesis.  
 
Hence, the microarray data from skeletal muscle in a fasted state are interesting; all 
analyses suggest that there is a relative decrease in ubiquitination in the LPE 
animals, and assuming ceteris paribus, this finding would suggest decreased protein 
degradation in these animals. The ubiquitin proteasome system is crucial in 
maintaining cytosolic health by degradation of non-functioning proteins and well as 
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removing rapid action proteins such as transcription factors (Goldberg, 2003; 
Varshavsky, 2005). This finding fits with the theory above that protein degradation 
might be reduced in the obese state. It would be of interest to know whether the 
reduction in ubiquitination transcripts was evident in lean animals, as protein 
degradation is a vital intracellular control mechanism, and thus it follows that a 
reduction could have deleterious effects on long term health. Nevertheless, it is 
clear that a global snapshot of transcriptomics indicates early protein restriction 
permanently altering the expression of genes to a much greater extent than a later 
and longer period of protein restriction. 
 
In hindsight, in view of the physiological evidence from this study and in relation to 
physiological investigations of glucose homeostasis in the obese state, the liver 
would appear to have been a better target organ for the microarray analysis instead 
of the skeletal muscle. Our hypothesis was that the maternal diet would illicit 
detrimental consequences on the skeletal muscle organogenesis of the offspring, 
with a prevailing legacy in postnatal life. It was therefore postulated that glucose 
homeostatic mechanisms would be modified, with the skeletal muscle contributing 
towards this physiological effect. There is one caveat to acknowledge in regard to 
the X-species microarray; it is possible that not all ovine genes mapped with a 
human homolog. Thus ƚŚĞƐĞ ŐĞŶĞƐ ĂƌĞ  ‘ŵŝƐƐŝŶŐ ? ĂŶĚ ĂƌĞ ƵŶĂǀĂŝůĂďůĞ ĨŽƌ ĂŶĂůǇƐŝƐ, 
and some may be important in the context of our globally developmentally 
programmed state. A `pĞƌĐĞŶƚƉƌĞƐĞŶƚ ?ĂŶĂůǇƐŝƐƌĞǀĞĂůĞĚ that 10% of genes bound, 
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whereas a human mRNA sample on the human chip would normally bind 35-55% of 
genes. Furthermore, two array platforms (U133 Plus and ST) were used and thus a 
cross study normalisation process was performed. Ultimately data are only 
presented from the full (U133) dataset, but in defence, the major effects noted and 
represented as the top 100 differentially expressed genes were very similar 
between the U133 Plus chip and the combined data from the U133 Plus and the ST 
array.  
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7. Summary, conclusions and future directions 
When comparing the maternal low energy study with the maternal low protein 
study, one of the most obvious contrasting effects is that energy restriction in late 
gestation, while protein restriction in early gestation has similar effects on the 
obese adult offspring i.e. an increased insulin response following a glucose 
challenge. This may suggest that if there is a uniform mechanism then it is not 
dependent on gestational age, but clearly is sex-specific; in both studies it was the 
male offspring most affected by the gestational insult. However, one could consider 
that a deficit in energy (and concomitantly of protein) in late gestation when fetal 
hypertrophic growth is highest is most likely to exert an effect whereas, an 
imbalance in the pattern of nutrients (but not overall energy quantity) when fetal 
rate-specific growth is highest is most likely to impact early hyperplastic growth. 
The data would appear to support this latter hypothesis. 
 
Although a number of modifications may be observed in tissues of these offspring, 
the organs which appear to have the most physiological relevance regarding 
glucose-insulin (intermediary metabolic) homeostasis are the liver and pancreas 
rather than the peripheral sites of primarily oxidation or deposition e.g. skeletal 
muscle and adipose tissue. The liver and pancreas especially most susceptible to 
physiological dysadaptation when challenged with the nutritional transition aged 2 
yrs, in both LPE and LEL males, which is in accord with the mis-match theory of fetal 
programming. Further work clarifying this effect is indicated but was beyond the 
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remit of the current program of work, as intra-abdominal catheterisation and 
hepatic biopsy are indicated.  
 
Pancreatic C-peptide is used as an index of pancreatic insulin secretion rate (Faber 
et al., 1981). C-peptide is secreted in equimolar concentrations to insulin, but unlike 
insulin which gets cleared from the blood by the liver (~70% on first pass), C-peptide 
passes through the liver into the post-hepatic circulation (Figure 7.1). The 
relationship between post hepatic plasma insulin and c-peptide concentrations can 
therefore be used to elucidate which organ contributes most to the homeostatic 
dysregulation.  
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Figure 7.1 Impact of pancreatic and hepatic dysregulation on post hepatic blood glucose 
concentration.  
Blue arrows represent insulin, while green arrows represent c-peptide. The diagram 
demonstrates that pancreatic hypersecretion of insulin and reduced hepatic insulin clearance 
result in the same plasma insulin concentration following a glucose challenge.  
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During the course of this study we partially developed an ovine specific assay for 
measurement of plasma C-peptide levels with a view to characterising the response 
post-GTT. As C-peptide has a low physiological function, its homology is poorly 
conserved between species. Of the commercially available c-peptide kits the pig has 
the closest homology to the ovine amino acid sequence (Peterson et al., 1972), but 
even a porcine RIA kit (LINCO Research; Missouri, USA) was not capable of 
producing a concentration curve using ovine plasma. As a consequence of this, a 
primary antibody was produced against a synthesised c-peptide sequence, in the 
hope of developing an ovine specific c-peptide RIA, but as yet this has not yielded 
any results. In future studies, a means of negating the requirement for c-peptide 
levels, as well as gaining a true quantitative value for hepatic insulin extraction, 
would be cannulation of the hepatic portal vein and hepatic vein. This method, as 
used by Kim et al., (2007), would allow for the measurement of insulin and glucose 
leaving the pancreas and entering the liver (hepatic portal vein), as well as insulin 
and glucose levels leaving the liver (hepatic vein), thus a measurement of liver 
function would be gained regarding glucose homeostasis.   
 
The models of maternal undernutrition (energy and protein) described here in 
sheep generally have less of an effect physiologically than previously observed in 
small laboratory animals, as well as other ovine models utilising a greater nutritional 
deficient, for example, the well published 50% energy restriction model compared 
to the 35% restriction used in this model. The general lack of treatment specific 
findings from this large animal, moderate restriction study demonstrate the 
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requirement to use large animal models (Roberts et al., 2009), especially in a fetal 
programming setting (Reynolds et al., 2010) when attempting to translate 
conclusions from small animals to the human condition. Small animal models (rats, 
mice, guinea pigs) have many advantages (low cost, lifespan, availability of 
molecular resources, monogastric omnivores, similarity in placentation) and 
disadvantages (high fetal number, differences in fetal and neonatal development) 
compared to farm animal models such as the sheep. Small animal models can 
magnify the effects of nutritional insults due to the lesser metabolic reserve of 
these animals compared to large animal models. The greater physiological 
relevance of the nutrient restriction shown in these studies, despite exposure to 
only a short-term obesogenic environment, highlights just how sensitive the fetal 
milieu is to environmental challenges. These effects are especially interesting as 
fetal programming was observed independently of birth weight (LPE), suggesting 
that subtle maternal insults, resulting in offspring with a normal birth weight, can 
have lifelong consequences in postnatal life, without any clear early prognostic 
marker. This emphasises the importance of clear-cut advice to pregnant women to 
ĐŽŶƐƵŵĞǁŚĂƚŝƐĐƵƌƌĞŶƚůǇĐŽŶƐŝĚĞƌĞĚƚŽďĞĂŶ ‘ŽƉƚŝŵĂů ?ĚŝĞƚĚƵƌŝŶŐƉƌĞŐŶĂŶĐǇŝ ?Ğ ?
one in which micronutrient and macronutrient needs are adequately met in order 
to support the growth of the products of conception.  
 
Here, the programming effects observed in late gestation are restricted to the fetal 
environment rather than the neonatal developmental period as lactational 
performance was preserved in the LEL offspring (and relative growth rates at this 
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time were similar between groups). This could be another reason behind the limited 
physiological effects observed following late gestation restriction in comparison to 
other studies of this kind (Gardner et al., 2005; Cripps et al., 2008), as well as in the 
Dutch Hunger Famine cohort (Ravelli et al., 1998), hence why cross-fostering is 
sometimes utilised in rat studies (Desai et al., 1996).  
 
Chapters 4 and 6 show the consistent phenotype observed following exposure to 
the prescribed obesogenic environment postnatally. This model of ovine obesity 
was developed over ~6 months in line with the human transition to obesity (higher 
energy intake), especially lipid content coinciding with reduced physical activity 
(Caballero, 2007). The transition caused decreased plasma glucose, NEFA, glycerol, 
and LDL concentrations, while increasing plasma TAG, leptin, HDL, total cholesterol. 
Another consistent observation was the decreased ability of the offspring to switch 
from one fuel source to another (metabolic inflexibility (Storlien et al., 2004; 
Galgani et al., 2008)), observed following a glucose challenge.  
 
Further work using tissues from these studies will hopefully elucidate further 
mechanistic insight into the causes behind the observed deleterious effects of fetal 
programming, as well as highlighting molecular irregularities which could have been 
involved in further metabolic dysfunction had the offspring aged further. The 
tissues of interest will be the liver and pancreas as implicated by the physiological 
data. Indeed, in further work on this model carried out by post-docs in the lab it has 
become clear that hepatic insulin resistance is present in LPE (from targeted qPCR 
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of genes in the insulin signalling pathway with associated down-regulation of 
protein abundance). Other potential laboratory investigations should include ɴĐĞůů
mass quantification and characterisation (e.g. immunohistochemistry for insulin), 
skeletal muscle characterisation (fibre typing and intramyocellular lipid infiltration) 
and hepatic ectopic lipid quantification. Given the importance of epigenetics to the 
developmental programming paradigm, then analysis of specific gene methylation 
status (e.g. of promoter regions) would also be inferred.  
 
Since my studies ended, further investigations are indeed being carried out in order 
to clarify the extent of change in the fetal amino acid environment in LPE offspring 
at the endstage of gestational protein restriction (day 65 gestation). This work will 
hopefully identify a pattern of amino acids that may be important with respect to 
programming the adult liver phenotype we have characterised here and will serve 
as a basis to conduct further, mechanistically-orientated hypothesis-driven research 
such as specific amino acid deficits and add-back together with observations on 
fetal pancreatic and liver development. 
  
The concept that a change in the diet of a mother may impact the metabolism of 
the offspring many years later, and potentially into further generations, is now 
firmly accepted, despite much robust criticism in the early years of the fetal origins 
hypothesis. There is now a Developmental Origins of Health and Disease learned 
society with its own world congress and journal, all dedicated to elucidating how 
the early environment may lead to and account for much of non-communicable 
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ĚŝƐĞĂƐĞ ŝŶ ƚŽĚĂǇ ?Ɛ ƐŽĐŝĞƚŝĞƐ ? dŚĞ ǁŚŽůĞ ĂƌĞĂ ŚĂƐ ƌĞŝŶǀŝŐŽƌĂƚĞĚ ? ĂŶĚ ƌŝŐŚƚůǇ ƐŽ ? Ă
research focus on various aspects of the pregnant mothers environment and the 
neonatal to childhood transition. These issues will all become more important in 
time as the demography of pregnancy shifts toward older, primiparous mothers, of 
whom a greater percentage will require assisted reproductive techniques and who 
are generally of high body mass index at conception  W a phenotype increasingly 
prevalent in the children as well.  
 
Non-communicable diseases like hypertension and insulin resistance are undeniably 
multi-faceted and developmental programming will only begin to explain a part of 
their induction; however, merely explaining a small proportion of a very large 
population (35-40% people have hypertension (www.who.int, 2009), estimated 300 
million with T2D (Wild et al., 2004)) will mean that many people will benefit from 
the research in this area.  
 
The present research in this thesis and many other models illustrate that adult-
onset obesity can only be deleterious to health. A state of permanent moderate 
obesity is simply not compatible with longevity in species in which the excess 
adipose is purely used as an excess energy store rather than for any functional 
purpose e.g. insulation against extreme cold. In addition, the preponderance of 
physical inactivity in modern life vs. the amount likely experienced as we evolved is 
leading to a physiological and metabolic conflict from which it is extremely hard to 
extricate ourselves (Booth et al., 2008).  
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